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Chapter 1
Introduction
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INTRODUCTION
This thesis concerns the effectiveness of a practice accreditation 
program on the quality of care in general practice with respect to 
patients with established cardiovascular diseases. Accreditation in 
healthcare is a widely used method to asses and improve the quality 
of healthcare organizations. Most accreditation systems assess the 
performance of organizations by comparing and appraising their 
compliance with standards, using methods such as self-assessment 
surveys, data review and structured visits by surveyors.1 Despite the 
substantial worldwide investments in accreditation, the evidence-base 
supporting its effectiveness is weak and contradictory.2 Given the time 
investments and effort required to implement accreditation programs it 
is important to know which program components and contextual factors 
contribute to the effects of accreditation on quality and outcomes of 
healthcare. In this thesis we explore the effectiveness of accreditation in 
general practice and explore which contextual factors contribute to its 
impact. We focus on patients with established cardiovascular diseases. 
Management of this group of patients remains high on the professional 
and societal agenda. 
 Accreditation
In many healthcare systems, regulatory strategies have been established 
for performance assessment such as, practice accreditation, pay-for-per-
formance, and public reporting of performance scores.3 These regulatory 
strategies to enhance quality of health care have been developed and 
implemented worldwide.4-6 Nevertheless, substantial numbers of patients 
do not receive recommended care and some provided care is potentially 
harmful or unnecessary.7,8 Regulation of healthcare providers has three 
main purposes. The first is to ensure that minimally acceptable standards 
of care are met. The second is to provide accountability of quality of care 
to authorities, purchasers and the public. The third aim is to enhance 
quality of care by providing insight into current practice and fostering 
improvements in performance.9 Accreditation programs may have 
positive effect on quality and safety of clinical care and organizational 
performance, but available studies mostly are observational and focused 
on hospitals.10
 In recent years many countries implemented accreditation 
programs also in general practice. However, in most health systems 
practice accreditation has yet to become widely accepted by general 
practitioners (GPs).11 To enhance continuous improvement in general 
practice, the Dutch College of General Practitioners (DCGP) initiated 
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exercise, healthy diet, weight reduction, and moderate alcohol use. 
Pharmacological treatment comprises cholesterol lowering drug therapy, 
antihypertensives, antithrombotic medication, and other disease specific 
medication. Usual care is unlikely to meet the new treatment targets. 
The DCGP has developed a number of products and activities to 
implement these guidelines, including a national kick-off conference for 
GPs (December 2005) and a supportive package (‘kwaliteitskoffer’) used 
in the accreditation program consisting of educational materials and 
software for assessment of cardiovascular risk.
 Better structuring of (primary) health care for patients with 
chronic diseases is expected to result in better outcomes for patients 
and societies.20 In the Netherlands, disease management programs are 
governed by so called “care groups”. A care group is an organization 
of 50-100 general practices which is responsible for the coordination 
and provision of contracted care in a particular region.21 Almost all care 
groups in the Netherlands have a bundled payment contract for the 
diabetes care program. However, few care groups have focused on  
CVD in the years that the research in this thesis was done. 
This thesis addresses the effect of practice accreditation on quality of  
care in general practice with respect to cardiovascular risk management.  
It is divided in two sections. The first section explores the effects of 
practice accreditation in general practice and its influence on quality 
of care in the context of cardiovascular care in general practice. The 
second section concerns aspects of care with a possible influence on 
the quality of cardiovascular care in general practice.
 In the Netherlands general practice is part of primary care. In  
the articles in this thesis, the terms general practice and primary care 
both are used.
 Section 1
 Accreditation in general practice 
Internationally, an increasing number of practice accreditation programs 
have been developed to assess and enhance quality and safety in 
general practice.11 Research evidence about the impact on quality of 
healthcare of regulatory interventions including accreditation is primarily 
drawn from observational studies. This implies that the links between 
regulation and improvements in quality cannot be interpreted as causal 
effects. Furthermore most studies are situated in the US, making the 
contextual interpretation challenging for other countries.22 A study of 
practice accreditation in general practices showed that it improved 
aspects of practice organization, but this study did not measure or 
a formal accreditation and improvement program. This practice 
accreditation program in the Netherlands is a service, which has been 
offered since 2005. Practices have to comply to some minimum standards 
in order to be eligible for participation.12 It is a comprehensive program 
including elements of clinical performance, practice organization 
and patient experiences. The program strongly focuses on chronic 
illness care, particularly diabetes mellitus (DM), asthma, COPD, and 
cardiovascular disease (CVD). The practice accreditation program 
comprises, firstly, a comprehensive audit and written feedback to the 
practice. This feedback covers a range of clinical domains (CVRM, DM, 
asthma and COPD), practice management, and patient experiences and 
consists of a comparison with benchmarks of other general practices 
and helps to identify substandard performance domains. The second 
obligatory component, the planning of improvements in the practice 
according to the principles of quality management, is based on this 
feedback. Practices which perform the procedure as planned are all 
accredited, so accreditation does not imply that a certain minimum 
score on performance indicators has been obtained. Practices receive a 
certification for the time period of one year which demonstrates (to the 
public) their involvement in continuous quality improvement. Every year 
the practice will be audited and every year new improvement plans have 
to be formulated. The practice accreditation program in the Netherlands is 
an innovative approach of accreditation because of its focus on learning 
and improving using improvement plans, and therefore distinguishing 
itself from other accreditation programs.
 Cardiovascular risk management in general practice
In the Netherlands, the majority of CVD patients are treated in general 
practices.13 Many activities have been developed to prevent CVD in public 
health and in general practice.14,15 Despite these activities and a range of 
practice guidelines,16,17 many individuals receive suboptimal cardiovascular 
risk management. Many cardiovascular disease patients do not attain the 
lifestyle, risk factor and therapeutic targets that are recommended.17, 18  
 A completely revised practice guideline on cardiovascular risk 
management was published by the DCGP late 2005 and a slightly revised 
version of this was published in 2006.19 The latest set of guidelines 
contain important changes in recommendations, such as different cut-
off levels (e.g. LDL<2,5 mmol/l and SBP<140 mmHg) and higher treatment 
targets for clinical intervention. The recommendations on cardiovascular 
risk management are based on explicit prediction of cardiovascular 
adverse events and on efficiency considerations regarding preventive 
interventions. Life style advice is targeted at stop smoking, physical 
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been shifted from physicians to nurses at varying degree. Re-allocation 
of such tasks from GPs to nurses has been found to be associated 
with improved, or at least equivalent, quality and outcomes of chronic 
disease care.33-37 In chapter 6 we outline the potential contribution of 
task allocation to nurses in general practice on the implementation 
of structured chronic care in general practice for patients with 
cardiovascular conditions. 
 Indicators for assessing quality and outcomes of healthcare 
delivery provide health care professionals feedback to enhance 
learning and improvement of clinical practice.38 Indicators should be 
valid and reliable and therefore need to be developed and evaluated 
systematically.39 Nevertheless methodological questions on indicator 
development procedures remain.40-47 In chapter 7 we will present a 
study in which we performed an indicator set development procedure 
comparing the results of different procedures and different panels.
In table 1 the main research questions and research methods are 
summarized. 
Table 1. Overview of research questions and methods used in this study.
Chapter Research Question Research 
methods
Measures
3 What is the effectiveness of 
improvement plans in practice 
accreditation in general practice?
RCT, block 
randomization 
design
Medical record 
audit
4 What factors and processes related to 
the practice accreditation program can 
be identified? Does organizational and 
policy context influence its outcomes?
Qualitative 
study
Interviews 
with quality 
coordinators
5 What is the impact of DM and Chronic 
Obstructive Pulmonary Disease on 
measures of cardiovascular risk 
management in patients with established 
cardiovascular disease?
Observational 
study
Medical record 
audit
6 What is the potential contribution of task 
allocation to nurses in general practice 
on the implementation of structured 
chronic care in general practice for 
patients with cardiovascular conditions?
Observational 
study
Practice 
questionnaire
7 Do different indicator development 
procedures give different indicator sets 
for cardiovascular risk management? 
What is the influence of Delphi panel 
composition on the indicator selection? 
Rand modified 
Delphi 
procedure
Questionnaire  
by e-mail
assess impact on clinical processes or outcomes.23 Overall, research 
evidence on effectiveness and efficiency of practice accreditation 
is limited.3,22,24 Effects of accreditation on clinical performance, 
organizational processes and financial status are inconsistent and  
most studies were done in hospitals.25
 The added value of formal accreditation in general practice 
remains unclear as most studies on accreditation have reported 
associations with quality of care in observational study designs. 
Furthermore, the organizational impact of accreditation programs 
remains unclear because of inconsistent findings in literature.25 Also 
more research is needed on tailoring methods, as not every GP needs 
the same type of intervention.26 
 In the first section of this thesis we first present the study 
protocol of the cluster randomized trial we performed as the studies 
in this section are based on data resulting from this trial. Chapter 
three reports the effects that we found in the cluster randomized trial. 
In chapter four we describe the process evaluation, which identified 
factors and processes related to the effects of the practice accreditation 
program. 
  Section 2 
  Contextual factors of influence on cardiovascular risk 
management in general practice  
There are numerous contextual factors that can influence the quality 
of care provided by health professionals. In the second section of 
this thesis we will draw attention to three potential contextual factors: 
patients’ comorbidity, substitution of care from GPs to nurses, and 
indicator development.
 Patient-related factors as the presence of comorbidity in CVD 
patients may have consequences for treatment outcomes.27-29 Although 
adherence to a guideline for one disease may have a negative effect in 
treatment of a co-existing disease, practice guidelines tend to ignore 
comorbidity.29 Whether higher guideline adherence results in better 
health outcomes in patients with comorbidity is, as yet, unclear. In 
chapter 5 we explore the impact of diabetes and Chronic Obstructive 
Pulmonary Disease (COPD) on measures of cardiovascular risk 
management in patients with established cardiovascular disease. The 
preventive treatment of DM, COPD and CVRM is overlapping, which is 
illustrated by overlapping quality indicators.19,30,31
 Practice development, particularly the introduction of practice 
nurses, could be crucially important to organize and provide structured 
chronic care.32 In general practice across the world clinical tasks have 
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ABSTRACT
  Background
Cardiovascular risk management is largely provided in primary 
healthcare, but not all patients with established cardiovascular diseases 
receive preventive treatment as recommended. Accreditation of 
healthcare organizations has been introduced across the world with 
a range of aims, including the improvement of clinical processes and 
outcomes. The Dutch College of General Practitioners has launched a 
program for accreditation of primary care practices, which focuses on 
chronic illness care. This study aims to determine the effectiveness and 
efficiency of a practice accreditation program, focusing on patients with 
established cardiovascular diseases.
  Methods/design
We have planned a two-arm cluster randomized trial with a block 
design. Seventy primary care practices will be recruited from those 
who volunteer to participate in the practice accreditation program. 
Primary care practices will be the unit of randomization. A computer list 
of random numbers will be generated by an independent statistician. 
The intervention group (n = 35 practices) will be instructed to focus 
improvement on cardiovascular risk management. The control group 
will be instructed to focus improvement on other domains in the first 
year of the program. Baseline and follow-up measurements at 12 
months after receiving the accreditation certificate are based on a 
standardized version of the audit in the practice accreditation program. 
Primary outcomes include controlled blood pressure, serum cholesterol, 
and prescription of recommended preventive medication. Secondary 
outcomes are 15 process indicators and two outcome indicators 
of cardiovascular risk management, self-reported achievement of 
improvement goals and perceived unintended consequences. The 
intention to treat analysis is statistically powered to detect a difference 
of 10% on primary outcomes. The economic evaluation aims to determine 
the efficiency of the program and investigates the relationship between 
costs, performance indicators, and accreditation.
 
  Discussion
It is important to gain more information about the effectiveness and 
efficiency of the practice accreditation program to assess if participation 
is worthwhile regarding the quality of cardiovascular risk management. 
The results of this study will help to develop the practice accreditation 
program for primary care practices.
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in this project. They contain important changes in recommendations, 
such as different cut-off levels (e.g., LDL-cholesterol <2.5 mmol/l and 
systolic blood pressure <140 mmHg). The DCGP has developed a number 
of products and activities to implement these guidelines, including a 
national kick-off conference for general practitioners (GPs) in December 
2005, and a supportive package (‘kwaliteitskoffer’) consisting of 
educational materials and software for assessment of cardiovascular 
risk. The practice accreditation program is an important approach to 
improve primary care, but controlled evaluations of its effect have not yet 
been done.
 Aims and objectives
The overall aims of the study are to determine the effectiveness and 
efficiency of the practice accreditation program in primary care, focused 
on its effect on CVRM. Key objectives are:
  1.   To determine the effectiveness of the program on primary 
performance indicators for CVRM by comparing practices in 
the accreditation program that focus their improvement plans 
on CVRM to practices in the accreditation program that focus 
their improvement plans on other domains of chronic care. 
Primary outcomes are documented controlled blood pressure, 
serum cholesterol, and prescription of recommended preventive 
medication (effect evaluation).
 2.   To determine the potential effect of the program on other 
indicators for CVRM, self-reported goal attainment in the 
intervention group, and unintended consequences. Secondary 
outcomes are all other indicators for CVRM, self-reported 
goal attainment in the intervention group, and unintended 
consequences (effect evaluation).
 3.   To determine the economic efficiency of the program in the 
observed period regarding the primary outcomes.
 4.   To explore what factors and mechanisms are associated with 
change (or absence of change) of performance in CVRM.
BACKGROUND
Cardiovascular diseases (CVD) remain an important cause of mortality 
and morbidity worldwide. In public health and in primary care, many 
efforts have been made to prevent CVD.1,2 Although cardiovascular care 
has improved in recent years,3 a substantial number of individuals receive 
suboptimal cardiovascular risk management (CVRM) and do not attain 
the lifestyle, risk factor, and therapeutic targets that are recommended.4,5 
A range of interventions to improve healthcare delivery is available.6-8 In 
recent years, programs have been developed for performance indicators, 
accreditation, pay-for-performance, and public reporting.9 These 
approaches make use of market forces and pressure for accountability, 
but research evidence on effectiveness and efficiency is limited.9-11 
  The slow improvement of cardiovascular primary care may 
be caused by the one-off and condition-specific character of many 
improvement activities (e.g., a continuing education session or audit 
without follow-up). To enhance continuous improvement in primary care 
in the Netherlands, the Dutch College of General Practitioners (DCGP) 
initiated in 2005 a nationwide comprehensive practice accreditation 
program for primary care practices. This program consists of a 
systematic audit on the basis of validated performance indicators for 
diabetes mellitus, CVRM, asthma, chronic obstructive pulmonary disease 
(COPD), practice organization, patient experience, educational feedback 
to practices, the requirement to develop structured improvement plans, 
and a check on the implementation of these plans after one year. If the 
procedure is performed, primary care practices receive a certificate that 
provides accreditation for a time period of one year. While accreditation 
serves a range of purposes, improvement of professional performance 
and practice organization are prominent among these.12-14 While the 
impact of audit and feedback is mixed and moderate,15 it is unknown 
what the added value of the accreditation procedure is. A study of 
practice accreditation in German primary care practices showed that 
it improved aspects of practice organization, but this study did not 
measure or assess impact on clinical processes or outcomes.16 Given the 
resources invested in accreditation schemes and the high expectations, 
an evaluation of the impact on quality and outcomes of care is needed.
  A substantial number of performance indicators used in the 
practice accreditation program is related to CVD. These indicators 
are derived from the completely revised guideline on CVRM that was 
published by the DCGP late 2005.17 The new set of guidelines on CVRM 
describes the clinical interventions to be implemented in patient care 
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  Randomization
General practices will be the unit of randomization. A computer list of 
random numbers will be generated by an independent statistician and 
then used to randomly allocate practices to equally sized intervention 
group or control group. This will be done in a randomized block 
design in blocks of four practices in order of enrolment. We assume 
that improvement activities in the control group will not influence 
cardiovascular care.
  The practice accreditation program
The practice accreditation program is an existing procedure provided 
since 2005 by an independent body (NPA) that has a license to use the 
accreditation procedure developed by the DCGP. The DCGP remains 
responsible for the content and further development of the procedure; 
it will be responsible for adequate delivery of the practice accreditation 
program in this study. The practice accreditation program comprises, 
firstly, of a comprehensive audit (using validated performance indicators) 
and written feedback to the practice, which covers a range of clinical 
domains (mainly chronic diseases), practice management, and patient 
experiences. The feedback, which consists of a comparison with 
benchmarks of other primary care practices, is discussed with a non-
physician observer in a feedback consultation and helps to identify 
substandard performance. The second obligatory component, the 
planning of improvements in the practice according to the principles 
of quality management, is based on this feedback. The practice team 
is supported by a trained non-physician consultant. Practices that 
perform the procedure as planned are all accredited, so accreditation 
does not imply that a certain minimum score has been obtained (the 
latter is usually labeled certification). In the practice accreditation 
program, validated instruments are used: the Visit Instrument to asses 
Practice management (Visitatie Instrument Praktijkvoering, VIP),19 
clinical performance, and Europep.20 Practices in the program receive a 
reimbursement of some insurance companies consisting of a bonus per 
patient per year. Furthermore they receive a certification for the time 
period of one year that demonstrates (to the public) their involvement in 
continuous quality improvement. Every year the practice will be audited, 
and every year new improvement plans have to be formulated that have 
to be approved by the auditor. 
  Intervention group
The intervention starts with volunteering for the practice accreditation 
program. After enrolment for the study, practices will be contacted by 
METHODS/DESIGN
  Trial design
The study design is a cluster randomized controlled trial with a block 
design, considering primary care practices as units of clustering.
  Ethical approval and informed consent
The Medical Ethics committee Arnhem-Nijmegen waived approval 
for this trial. At follow-up practices will send a letter of invitation and 
informed consent to 100 patients with established CVD. Patients return 
their letter with informed consent to Radboud University Nijmegen 
Medical Centre with permission for audit of their medical records. The 
privacy of the participating patients will be protected, and all data will 
be coded and processed anonymously. For the baseline-measurement, 
mandatory information on indicators for patients with established 
CVD will be used, collected by practices on behalf of the practice 
accreditation program.
  Participants
  Primary care practices
Seventy primary care practices will be recruited from practices in the 
Netherlands who voluntarily apply to start the practice accreditation 
program. An invitation letter for the study will be sent as part of the 
instruction manual for the program. Practices with a clear preference for 
a specific improvement plan will be excluded from participation in the 
study while participating practices will be randomized to a group which 
starts with an improvement plan on CVRM or to a group that does not. 
This also accounts for practices that participate in regional programs 
for enhancing disease management.
  Patients
The study focuses on patients with established CVD. This includes 
patients with angina pectoris, acute myocardial infarction in their 
medical history, other chronic ischemic heart diseases, transient 
ischemic attack (TIA), ischemic stroke, peripheral arterial disease, and 
aneurysma  aortae. Selection of patients out of electronic medical 
records with these conditions will be based on corresponding 
diagnostic International Classification of Primary Care codes (ICPC-
codes K74, K75, K76, K89, K90.3, K92.1 and K99.1), a worldwide system 
to label conditions in primary care.18
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Figure 1. Flow diagram
Baseline
measurement
Enrolment
Allocation
Follow-up
measurement
70 Practices
Randomized
Follow up 
measurement of 
cardiovascular 
indicators
Follow up 
measurement of 
cardiovascular 
indicators
telephone for further explanation of the study protocol and to schedule 
the data collection. After data is collected, practices are randomized. 
Practices allocated to the intervention group are instructed to focus  
their improvement plans on cardiovascular diseases in the first year of 
the program.
  Control group
The control group also starts with volunteering for the practice 
accreditation program and follows the same routine as described for 
the intervention group. Practices allocated to the control group are 
instructed to focus their improvement plans on other domains than 
cardiovascular disease and diabetes mellitus (they may target CVD later 
after the study period of one year). They are instructed to focus their 
improvement plans on other clinical areas than CVD or diabetes.
  Both intervention and control group receive feedback on 
CVD indicators as part of the normal practice accreditation program. 
Practices in the intervention group are instructed to set targets related 
to process and outcomes of cardiovascular care (and not just focused 
on improvement of registration of cardiovascular disease in the medical 
record system). All practices will receive a minimum of four hours of 
support by outreach consultants for no cost, which is available in all 
regions. Also, the practices are provided with examples of improvement 
plans, which saves time and would make study participation more 
attractive.
  Measurement procedures
In each practice, measurements are done at baseline and at follow-up 
(Figure 1). At baseline, medical records of 40 patients with established 
CVD are audited as part of the clinical performance measurements in 
the practice accreditation program. Data on performance indicators of 
CVRM as included in the practice accreditation program will be used for 
the analysis. At follow up, the following measurement methods will be 
used: medical record audit based on the same indicators of CVRM as in 
the baseline measurement, patient questionnaires, and a semi-structured 
interview for a contact person in each practice. Data will be collected 
consistently as this is done by two persons with similar training.
Allocated to 
intervention group 
(N= 35)
Quality improvement 
plans on cardio-
vascular risk 
management
Allocated to control 
group (N=35)
Quality improvement 
plans on other 
domains
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Table 1. Indicators for cardiovascular risk management 
Type of indicator
Process Smoking status 
Outcome Patient is a smoker
Process Stop smoking advice 
Process BMI measured
Outcome BMI <25 kg/m²
Process Influenza vaccination
Process Exercise control
Process Systolic blood pressure measured
Outcome Systolic blood pressure <140 mmHg¹
Process LDL cholesterol measured
Outcome LDL cholesterol <2.5 mmol/l¹
Process Advice physical activity
Process Diet control
Process Counseling about diet
Process Registration of alcohol intake
Process Patients with LDL cholesterol >-- 2.5 mmol/l with statin prescription 
Process Waist circumference measured
Process Prescription antiplatelet drugs¹
Process Fasting glucose measured
Process Comprehensive risk assessment *
*  Positive score when there is a record of: blood pressure, BMI, waist circumference, fasting 
glucose measurement, LDL cholesterol measurement, smoking behavior, alcohol intake,  
advice and control of diet and physical exercise in the past 12 months.
¹ Primary outcome
  
  Measures of effectiveness
The effect evaluation aims to determine the effectiveness of the program 
on primary performance indicators for CVRM and to determine the 
potential impact of the program on other indicators for CVRM, self-
reported goal attainment in the intervention group, and unintended 
consequences.
Primary outcomes have been selected from the 20 quality indicators for 
established CVD21, which were developed by DCGP (Table 1), and are:
 1.   The percentage of patients in the practice with known established 
CVD who have systolic blood pressure below  
140 mmHg.
 2.   The percentage of patients in the practice with known established 
CVD who have LDL cholesterol below 2.5 mmol/l.
 3.   The percentage of patients in the practice with known established 
CVD with a record that aspirin, an alternative anti-platelet therapy, 
or an anticoagulant has been prescribed.
Data concerning indicators are extracted from medical records and will 
be available at patient level so that linkage to other measures (resource 
use, patient characteristics) can be made at patient level.
  Secondary outcomes consist of the 17 remaining indicators used 
and include: measurement of systolic blood pressure, measurement of 
LDL-cholesterol, prescription of statin, smoking status, stop smoking 
advice, measurement of body mass index (BMI), BMI <25 kg/m2, 
measurement of waist circumference, fasting glucose measurement, 
influenza vaccination, registration of alcohol intake, control and advice 
for exercise and diet, and comprehensive risk assessment (Table 1). 
Furthermore, secondary outcomes are measured in interviews with the 
contact person of the practice and contain perceived goal attainment 
regarding the improvement plans, which is measured on a Likert scale, 
and unintended consequences as result of participating in the practice 
accreditation program.
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and practice characteristics22,29 (e.g., availability of nurses, delegation 
of medical tasks to assistance, practice size). Only factors emerging 
from previous research are considered to avoid overcorrection in 
the primary analysis. A logistic regression model will be constructed 
for each outcome to analyze these outcomes in relation to group 
(intervention, control) and measurement moment (baseline, follow-up). 
Identified differences between the groups at baseline will be included 
in this analysis. Random coefficients will be included to allow for the 
clustering of data within practices. Each of the secondary outcomes 
(clinical and organizational indicators) will also be analyzed in this way. 
Finally, if an internally consistent scale can be constructed (reflected 
by high reliability coefficients of the combined score), we will develop 
an aggregated measure of outcome, and use this in a similar random 
coefficients linear regression analysis.
  To identify the effectiveness of this program on attainment of 
practice-defined goals and its perceived unintended consequences, the 
second key objective, a descriptive analysis will be performed aimed at 
determining what proportion of self-defined goals for improvement was 
achieved by the practices and straightforward listing of the GP views on 
unintended consequences of the practice accreditation program.
  
  Economic analysis
The economic analysis, the third key objective, aims to determine the 
efficiency of the program in the observed period regarding the primary 
outcomes. The economic evaluation also investigates the relationship 
between costs, performance indicators, and accreditation. The economic 
evaluation provides incremental cost-effectiveness ratios: incremental 
cost per percentage patients gained with systolic blood pressure below 
140 mmHg; incremental cost per percentage patients gained with LDL 
cholesterol <2.5 mmol/l; incremental cost per percentage patient gained 
with aspirin, an alternative anti-platelet therapy or an anti-coagulant.
For the economic analysis, costs analyses will be based on the 
competing health production processes respectively, including and 
excluding resources attributed to accreditation. Specific unit-costs 
include, for example medical care (contacts in primary care practice, 
tests, treatments, etc.) and improvement related costs (accreditation 
tariff, time for audit, planning and implementing improvement, exposure 
to other relevant quality improvement, etc.). Units of resources are 
monetary valued on the basis of prevailing Dutch guidelines30 or national 
CVZ tariffs. The analysis aims to provide incremental cost-effectiveness 
ratios (ICERs). The ICERs will be computed, and uncertainty will be 
determined using the bootstrap method to account for skewness in 
  Measures of costs
In follow-up measurements items of use of healthcare will be 
extracted from the medical records with a retrospective three-month 
observation period. These items include number of contacts in the 
practice (face to face, telephone, email), use of various types of 
cardiovascular medication, use of hospital care or other care providers 
for cardiovascular diagnosis or therapy. Additional information will be 
collected with patient questionnaires, particularly on other healthcare 
use (e.g., home care) and productivity losses, using a one-month 
retrospective observation period. Also, at follow-up in both groups, time 
and other resources of practice teams spent on quality improvement 
in the total period of 18 months will be documented. Data-collection on 
performance indicators will be done in the follow-up measurement by 
medical record audit.
  Other measures
1.   Exposure to other quality improvement activities: both study groups 
report on their exposure to relevant professional education and 
practice improvement activities (e.g., training for practice nurses).  
This will be measured in semi-structured telephone interviews.
2.   Potential confounders: at follow up, potential confounders will be 
measured. These include patient characteristics, particularly patient 
age, gender and multi-morbidity. Furthermore, data on practice 
characteristics will be collected. These include practice size, physician 
workload, volume of assistance in the practice, delegation of medical 
tasks to assistants, and involvement of practice nurses in chronic 
care. These practice characteristics have shown to be associated with 
better chronic disease management in Dutch primary care practices.22 
3.   Patient reported outcomes: at follow up, patients receive 
questionnaires that include items on demographic characteristics, 
labor activities and healthcare use. Furthermore the EQ-5D (five  
items and VAS scale) will be added to measure health outcome.23  
To measure chronic care delivery, the Patient Assessment of Chronic 
Illness Care (PACIC) will be used.24 Questionnaires for physical 
exercise (RAPA, nine items),25 and the Treatment Self-Regulation 
Questionnaire (TSRQ)26 to measure the motivation for being physically 
active will be included.
  Statistical methods
The study groups will be compared at baseline regarding known 
determinants of cardiovascular care and its improvement. These include 
patient factors27,28 (e.g., age, multi-morbidity, ethnicity at practice level) 
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We expected that the accreditation and improvement program will 
have an effect of 5% to 10% absolute change, which is the median value 
of effect sizes in a comprehensive review of 235 studies on quality 
improvement.14 Other assumptions were a power = 0.80, alpha = 0.05,  
and ICC = 0.05. Given the sample of 30 patients per practice per 
indicator, we aimed to include 31 practices in each group. Allowing for 
dropout, we aim to include 35 practices in each group (n = 70 practices 
in total). This number is feasible, given the recruitment rate for the 
accreditation in 2006.
  Time frame of the study
The study is planned from September 2008 until September 2012. In 
months 1 to 18, practices are recruited and included in the project and 
go through the accreditation procedure. The baseline data collection 
will take place in these months. During months 3 to 42, practices (in 
the intervention group) work on improving their management of CVD, 
practices in the control group on improvements in other areas. In months 
18 to 42, follow-up measurements in intervention and control practices 
are planned. During months 43 to 48, data will be analyzed and reported.
DISCUSSION
The sample of participating primary care practices in this study is 
composed of volunteers for the practice accreditation program and 
therefore not nationally representative for primary care practices in the 
country. This reflects current practice, in which practice accreditation is 
a voluntary activity. It implies that study results cannot be generalized 
to the (currently hypothetical) situation of obligatory accreditation. 
Furthermore, we only collect data on CVRM; therefore, we cannot make 
statements about the effects of the program on other chronic illnesses.
Because both intervention and control groups start with accreditation, 
this project cannot pick up nonspecific effects of the practice 
accreditation program. For example, we expect that practices prepare for 
accreditation by improving their practice (e.g., involve a practice nurse). 
We intend to compare the groups with other, independent samples of 
practices that provide data on cardiovascular care to get an impression 
of the representativeness of our sample of practices.
  With the results of this study, we hope to make a contribution 
with regard to further development and adjustment of the practice 
accreditation program. Previous research32 has shown that the program 
is time-consuming for participating practices. Furthermore, it costs 
the underlying parameter distributions. Uncertainty will be presented 
in a Bayesian fashion using cost-effectiveness acceptability curves 
(CEAC’s) that are able to evaluate efficiency by using different thresholds 
for the ICER (varying the willingness to pay for a percentage patients 
gained for each of the primary outcomes). Uncertainty in deterministic 
parameters will be examined with sensitivity analysis based on the range 
of extremes.
  Process evaluation
The process evaluation, the fourth key objective, aims to explore what 
factors and mechanisms are associated with change (or absence 
of change) of performance on CVRM indicators. Semi-structured 
telephone interviews will be held with primary care physician or the 
quality coordinator of the practice after data collection for follow-
up measurement is concluded. Topics of this interview are: practice 
characteristics; feedback reports; composing improvement plans; 
and reasons to participate in and experiences with the practice 
accreditation program. We want to explore if specific elements of the 
practice accreditation program are the cause of change in CVRM. 
All interviews will be conducted by the same person and will be 
audiorecorded. Interviews will be transcribed verbatim. Two researchers 
will independently review the transcripts. Data analysis will be done 
according to the framework approach.31 Topics in the interviews will 
be used as coding frame. Software package Atlas ti. will be applied 
to analyze qualitative data. The primary analysis of the interview data 
aims to identify determinants of (change of) practice as perceived by 
participants.
  Sample size
In the practices in the practice accreditation program up to 2006 (n 
= 139), the following median values at practice level were found on 
indicators referring to patients with CVD: 53% for acceptable blood 
pressure levels; 36% for acceptable cholesterol levels; and 38% for use 
of anticoagulents (unpublished data at IQ healthcare, 2005 and 2006). 
These data suggest that the current scores on the primary outcomes are 
in the range of 35% to 55%, which imply that substantial improvement 
is possible in many practices. The proposed study has been powered 
to detect a difference of 10% (from 55% to 65%), not yet taking control 
for baseline values into account because of uncertainty regarding the 
correlation between baseline and follow-up measures.
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ABSTRACT
 Background
Accreditation of healthcare organizations is a widely used method to 
assess and improve quality of healthcare. Our aim was to determine the 
effectiveness of improvement plans in practice accreditation of primary 
care practices, focusing on cardiovascular risk management (CVRM). 
 Method
A two-arm cluster randomized controlled trial with a block design was 
conducted with measurements at baseline and follow-up. Primary care 
practices allocated to the intervention group (n=22) were instructed to 
focus improvement plans during the intervention period on CVRM, while 
practices in the control group (n=23) could focus on any domain except 
on CVRM and diabetes mellitus. Primary outcomes were systolic blood 
pressure <140 mmHg,  LDL cholesterol <2.5 mmol/l and prescription of 
antiplatelet drugs. Secondary outcomes were 17 indicators of CVRM 
and physician’s perceived goal attainment for the chosen improvement 
project.
 Results
No effect was found on the primary outcomes. Blood pressure targets 
were reached in 39.8% of patients in the intervention and 38.7% of 
patients in the control group; cholesterol target levels were reached 
in 44.5% and 49.0% respectively; antiplatelet drugs were prescribed in 
82.7% in both groups. Six secondary outcomes improved: smoking status, 
exercise control, diet control, registration of alcohol intake, measurement 
of waist circumference, and fasting glucose. Participants’ perceived goal 
attainment was high in both arms: mean scores of 7.9 and 8.2 on the 
10-point scale.
 Conclusions
The focus of improvement plans on CVRM in the practice accreditation 
program led to some improvements of CVRM, but not on the primary 
outcomes. 
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METHODS
 Trial design
The study design was a two-arm cluster randomized controlled trial with 
a block design, taking primary care practices as units of clustering, with 
measurements at baseline and at follow-up in independent samples of 
patients. The study protocol was published elsewhere.13 The trial was 
registered at clinicaltrials.gov nr NCT00791362, http://www.clinicaltrials.
gov/ct2/show/ NCT00791362?term=NCT00791362&rank=1
 Ethical approval and informed consent
The Medical Ethics committee Arnhem-Nijmegen waived approval for this 
trial after assessing the study protocol (file number 2008/258). For the 
baseline-measurement mandatory information on indicators for patients 
with established CVD was used collected by practices on behalf of the 
practice accreditation program. At follow-up patients were requested 
informed consent in writing for permission to audit their medical records. 
The privacy of the participating patients was protected, and all data was 
coded and processed anonymously. 
 Participants
 Primary care practices
Primary care practices were recruited from practices in the Netherlands 
who had applied to start the practice accreditation program. After 
baseline data collection practices were randomized to study arms. 
Participating practices were randomized to a group which was instructed 
to improve CVRM (intervention arm) or to a group which was instructed 
to postpone improvement in CVRM or diabetes mellitus (DM) (control 
arm) until the intervention period was finished. Practices with a clear 
preference for a specific improvement plan were excluded from 
participation in the study.
 All practices received a minimum of 4 hours support by outreach 
consultants for free. 
 Practices were recruited between September 2008 and April 
2010. The date of receiving accreditation was the starting point of the 
intervention. Data concerning follow-up measurement were collected 
from February 2010 until May 2012, over the course of 12 months after  
the starting point of the intervention. 
 Patients 
The study focused on patients with established atherosclerosis-related 
cardiovascular disease, as defined by prevailing clinical guidelines and 
INTRODUCTION 
Accreditation of healthcare organizations is a widely used method to 
assess and improve the quality of healthcare. Most accreditation systems 
assess and rate the performance of organizations and service by 
evaluating their progress and appraising their compliance with standards, 
using mechanisms such as self-assessment surveys, data review and 
structured visits by surveyors.1 Although the terms accreditation and 
certification are often used interchangeably, accreditation usually applies 
to healthcare organizations, while certification applies to practitioners 
and organizations.2 In many countries accreditation is also emerging in 
primary care.3 In the Netherlands, primary care practice accreditation 
is a voluntary activity comprising of an extensive audit, which covers 
clinical and organizational domains, followed by structured planning of 
improvements and formal review by an external assessor.4 The program 
was initiated by the Dutch College of General Practitioners (DCGP) and 
is delivered by an independent organization (NPA). Improvement of 
professional performance and practice organization are prominent in the 
Dutch program.5-7  
 Rigorous evaluations of the effectiveness of practice 
accreditation are rare.8 Effects of accreditation on clinical performance, 
organizational processes and financial status are inconsistent and 
most studies focus on hospital care.9 A study of practice accreditation 
in German primary care practices showed that it improved aspects 
of practice organization, but this study did not measure the effect on 
clinical processes or outcomes.10 Given the role of audit and feedback 
in practice accreditation, research on this strategy may provide clues to 
the potential impact. A Cochrane review with 150 trials found that audit 
and feedback had a median effect of 4% improvement on aspects of 
professional performance, with substantial heterogeneity of effect sizes 
across studies. Audit and feedback combined with target setting and 
action planning, which is done in the Dutch practice accreditation, had 
11% effect of measures of professional performance.11 The Dutch practice 
accreditation model was an innovative approach of accreditation, 
because of its focus on learning and improving. In the Netherlands the 
majority of cardiovascular disease (CVD) patients receive necessary 
cardiovascular risk management in primary care practices.12 In this 
paper we report on a study, which aimed to assess the effectiveness of 
improvement plans in practice accreditation of primary care practices, 
focused on cardiovascular risk management (CVRM). 
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 Outcomes
Primary results were selected from the 20 quality indicators for 
established CVD,15 which were developed by the DCGP: the percentage 
of patients with known established CVD with systolic blood pressure 
below 140 mmHg, the percentage of patients with known established 
CVD with a LDL cholesterol level below 2.5 mmol/l, and the percentage 
of patients with known established CVD with a record that aspirin, 
an alternative anti-platelet therapy or an anti coagulant has been 
prescribed. Secondary outcomes consisted of the 17 remaining indicators 
and included: measurement of systolic blood pressure, measurement 
of LDL-cholesterol, prescription of statin, smoking status, patient is a 
smoker, stop smoking advice, measurement of Body Mass Index, Body 
Mass Index <25 kg/m², measurement of waist circumference, fasting 
glucose measurement, influenza vaccination, registration of alcohol 
intake, control and advice for exercise and diet and comprehensive risk 
assessment. The indicators consist of process indicators, which give an 
indication of the progress of processes in an organization and outcome 
indicators, which give an indication of the outcome of care.
 Medical data extraction was performed using a standardized 
procedure and documented for each included patient.
Another secondary outcome was the perceived goal attainment in the 
chosen improvement plans. This was documented in interviews with 
general practitioners or nurses on a likert-scale. 
 Sample size
In the practices who voluntarily applied the practice accreditation 
program up to 2006 (n=139) the following median values at practice 
level were found on indicators referring to patients with CVD: 53% for 
acceptable blood pressure levels; 36% for acceptable cholesterol levels; 
and 38% for use of anti coagulants (unpublished data, 2006). These data 
suggest that the scores on the primary outcomes are in the range of 36 
to 53%, which imply that substantial improvement is possible in many 
practices. The proposed study was powered to detect a difference of 
10% on all primary outcomes. We expected the practice accreditation 
program had an effect of 5% to 10% absolute change, which is the 
median value of effect sizes in a comprehensive review of 235 studies on 
quality improvement.7 Other assumptions were a power=0.80, alpha=0.05, 
and ICC=0.05.21 Given the sample of 30 patients per practice per 
indicator, we aimed to include 31 practices in each group. Allowing for 
drop-out, we aimed at 35 practices in each group. 
recorded in patients’ medical records,14, 15 including angina pectoris (K74), 
acute myocardial infarction (K75), other chronic ischemic heart diseases 
(K76), transient ischemic attack (K89), ischemic stroke (K90.3), peripheral 
arterial disease (K92.1) and aneurysma aortae (K99.1). Patients had to be  
in treatment for established CVD for a minimum period of 12 months. 
Patient selection from electronic medical records was based on 
corresponding diagnostic International Classification of Primary Care 
codes (ICPC-codes), an international classification system that is widely 
used in the Netherlands.16
 The practice accreditation program
The practice accreditation program is a service, which has been offered 
since 2005. Practices have to comply to some minimum standards in 
order to be eligible for participation.17 It is a comprehensive program 
including elements of clinical performance, practice organization and 
patient experiences. The program focuses strongly on chronic illness 
care, particularly DM, asthma, COPD, and CVD.
 The practice accreditation program comprises, firstly, of a 
comprehensive audit (using validated performance indicators on a 
randomly selected sample of 40 patients per clinical domain) and written 
feedback to the practice, which covers a range of clinical domains (CVRM, 
DM, asthma and COPD), practice management, and patient experiences. 
The feedback, which consists of a comparison with benchmarks of 
other primary care practices, is discussed with a trained observer in 
a feedback consultation with the whole practice team and helps to 
identify substandard performance domains. The second obligatory 
component, the planning of improvements in the practice according to 
the principles of quality management, are based on this feedback. The 
practice team may chose to rely on a trained consultant to develop an 
improvement plan. Practices which perform the procedure as planned 
are all accredited, so accreditation does not imply that a certain minimum 
score on performance indicators has been obtained. In the practice 
accreditation program validated instruments are used: VIP,18 clinical 
indicators19 and Europep.18,20 Practices could claim an allowance for the 
costs of the accreditation program from health insurance companies. 
Furthermore they received a certification for the time period of one year 
which demonstrates (to the public) their involvement in continuous quality 
improvement.  Every year the practice will be audited and every year new 
improvement plans have to be formulated which have to be approved by 
the auditor. The prolongation of the accreditation depends on having met 
the objectives of the improvement plans.
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Figure 1. Flow Diagram
Enrolment
Allocation
Follow-up
Allocated to intervention group 
(n=22)
Received allocated intervention 
(n=21, 799 patients)
Did not receive allocated 
intervention (had 
second thoughts about 
randomization(n=1)
Allocated to control group (n=23)
Received allocated intervention 
(n=22, 886 patients)
Did not receive allocated 
intervention (had 
second thoughts about 
randomization(n=1)
Lost to follow-up 
(not willing to 
participate in follow-
up measurement) 
(n=1)
Lost to follow-
up (no adequate 
infrastructure to 
participate in follow-
up measurement) 
(n=1)
Analysis
Analysed  
(n=20, 952 patients)
Excluded  (n=30)
Declined to 
participate (n=24)
Other reasons (n=6)
Non responders 
(n=261)
Analysed  
(n=21, 719 patients)
 Randomization
General practices were the unit of randomization. A computer list of 
random numbers was generated and used to randomly allocate practices 
to equally sized intervention group or control group by an independent 
statistician. This was done in a randomized block design in blocks of four 
practices based only on time period in order of enrolment. 
 Blinding
General practitioners were aware of the allocated arm as the intervention 
consisted of making and implementing their own improvement plans. 
Data collectors were blinded to allocation. Blinding of patients was 
unnecessary as only medical records were assessed.
 Statistical methods
Descriptive data were analyzed using the SPSS 16.0 software package 
(Chicago, Illinois, USA). All indicators (all dichotomous measures) were 
included in a two-level logistic regression, taking into account the 
hierarchical structure of our study (patients nested within practices).  
In the logistic model covariates on the practice level that were taken into 
account included practice located in deprived area, availability of nurses 
for CVRM-related tasks and practice type (solo, duo, group). Patient’s 
co-morbidity, age and sex were also included in the regression models. 
The analysis was performed in the SAS 9.2 package with procedure 
PROC GLIMMIX. We used a logistic regression model with a binomial 
distribution, a logit link function, a random intercept, and all other 
variables fixed. 
 Perceived goal attainment of participants was analyzed in a  
one-level regression model.
 Results
336 Practices applied for the practice accreditation program in the 
recruitment period and were invited to participate in the study. 45 
Practices were willing to participate in the study (Figure 1). A total of 
22 practices was allocated to the intervention group en 23 practices  
to the control group. For follow-up measurement data on 20 practices 
were available in the intervention arm and data on 21 practices in the 
control arm.
Assessed for 
eligibility (n=336)
Randomized 
(n=45 )
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Table 2 presents characteristics of patients in the study population.  
At baseline 799 patients were included in the intervention group and 886 
patients were included in the control group. At follow-up measurement 
952 patients were included in the intervention group and 719 in the 
control group. In both study groups most common co-morbidity was 
diabetes and most common cardiovascular history was angina pectoris.
Table 2. Characteristics of Patient Population, Intervention versus Control group
Intervention Control 
T0 (n=799) T1 (n=952) T0 (n=886) T1 (n=719)
Age (years) 69.41  
(sd 11.65)
69.42 ( 
sd 10.04)
68.88  
(sd 12.22)
68.02  
(sd 10.29
% Female 37.0 32.6 39.1 33.7
Diabetes (%) 23.2 16.9 25.2 22.8
COPD (%) 10.5 10.2 10.7 11.5
Astma (%) 5.6 6.4 4.0 6.5
Angina Pectoris 37.8 33.3 35.7 31.8
Myocardial Infarction 31.1 31.1 27.7 28.1
Other chronic ischemic 
heart diseases
9.4 10.7 12.1 17.1
TIA 14.3 14.8 15.2 13.6
Ischemic stroke 5.0 10.8 8.4 8.9
Peripheral arterial 
disease, claudicatio 
intermittens
8.8 11.0 14.3 13.8
Aneurysma Aortae 4.8 5.3 5.0 7.9
Table 1 presents the characteristics of practices in the intervention and 
the control arm. In the intervention arm 57.1% of practices were solo 
practices, 19.0% were duo practices and 23.8% were group practices.  
For control arm practices this was 36.4%, 36.4% and 27.3% respectively. 
Of practices in the intervention group 6.3% participated in a care group 
with focus on CVRM, for control arm practices this was 35.0%. 
Table 1. Characteristics of Practice Population, Intervention vs. Control group
Intervention Control
T0 T1 T0 T1
Number of practices
21 20 22 21 
Number of patients 799 952 886 719
Practice Size (mean) 4417 4487 3559 3559
Solo practice 57.1% 36.4%
Duo practice 19.0% 36.4%
Group practice 23.8% 27.3%
FTE general practitioners 2.0 (SD 1.5) 1.7 (SD 0.8)
FTE practice assistants 2.5 (SD 1.9) 2.1 (SD 1.3)
FTE nurse practitioners 0.8 (SD 0.6) 0.7 (SD 0.5)
FTE nurses 3.3 (SD 2.4) 2.8 (SD 1.7)
Training practices 84.0% 60.0%
Participation in care Group* 
with focus on CVRM
6.3% 35.0%
*  Regional organizations that have contracts with health insurers to coordinate CVRM-related 
care in a particular region with the objective to improve quality of care.
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Table 3.  Record of indicators for cardiovascular risk management in electronic  
medical records
In
te
rv
en
tio
ng
ro
up
C
on
tr
ol
g
ro
up
Ty
p
e 
of
 
in
d
ic
at
or
Ba
se
lin
e 
T0
 (n
=7
99
)
Fo
llo
w
-u
p 
T1
 
(n
=9
52
)
C
ha
ng
e 
%
Ba
se
lin
e 
T0
 (n
=8
86
)
Fo
llo
w
-u
p 
T1
 (n
=7
19
)
C
ha
ng
e 
%
Be
tw
ee
n 
G
ro
up
 
ch
an
ge
 %
 
O
ut
co
m
e
S
ys
to
lic
 b
lo
od
 p
re
ss
ur
e 
<1
40
 m
m
H
g
29
7/
58
8 
(5
0
.5
)
28
3/
71
2 
(3
9.
8)
-1
0
.7
34
2/
67
6 
(5
0
.6
)
22
5/
58
1 
(3
8.
7)
-1
1.9
1.2
P
ro
ce
ss
S
ys
to
lic
 b
lo
od
 p
re
ss
ur
e 
m
ea
su
re
d
58
8/
79
6 
(7
3.
9)
71
2/
94
8 
(7
5.
1)
+1
.2
67
6/
88
6 
(7
6.
3)
58
1/
71
6 
(8
1.1
)
+4
.8
-3
.6
O
ut
co
m
e
LD
L 
ch
ol
es
te
ro
l  
<2
.5
 m
m
ol
/l
17
4/
38
2 
(4
5.
6)
23
2/
52
1 
(4
4.
5)
-1
.1
21
5/
44
8 
(4
8)
21
7/
44
3 
(4
9)
+1
.0
-2
.1
P
ro
ce
ss
LD
L 
ch
ol
es
te
ro
l 
m
ea
su
re
d
38
4/
79
3 
(4
8.
4)
52
1/
93
7 
(5
5.
6)
+7
.2
44
8/
88
4 
(5
0
.7
)
44
3/
71
6 
(6
1.9
)
+1
1.2
-3
.0
P
ro
ce
ss
P
at
ie
nt
s 
w
ith
 L
D
L 
ch
ol
es
te
ro
l > -
-2
.5
 m
m
ol
/l
 
w
ith
 s
ta
tin
 p
re
sc
ri
p
tio
n 
13
7/
20
7 
(6
6.
2)
20
0
/2
89
 
(6
9.
2)
+3
.0
14
6/
23
3 
(6
2.
7)
17
6/
22
5 
(7
8.
2)
+1
5.
5
-1
2.
5
P
ro
ce
ss
P
re
sc
ri
p
tio
n 
an
tip
la
te
le
t 
d
ru
g
s
67
1/
79
6 
(8
4.
3)
78
7/
95
2 
(8
2.
7)
-1
.6
75
1/
88
5 
(8
4.
9)
59
3/
71
7 
(8
2.
7)
-2
.2
-0
.6
P
ro
ce
ss
S
m
ok
in
g
 s
ta
tu
s 
29
3/
79
6 
(3
6.
8)
60
9/
95
1 
(6
4)
+2
7.
2
43
6/
88
2 
(4
9.
4)
45
7/
71
9 
(6
3.
6)
+1
4.
2*
*
13
.0
O
ut
co
m
e
P
at
ie
nt
 is
 a
 s
m
ok
er
93
/2
92
 
(3
1.9
)
13
4/
60
9 
(2
2)
-9
.9
13
6/
43
6 
(3
1.2
)
12
3/
45
7 
(2
6.
9)
-4
.3
5.
6
P
ro
ce
ss
S
to
p
 s
m
ok
in
g
 a
d
vi
ce
 
58
/9
3 
(6
2.
4)
69
/1
33
 (
51
.9
)
-1
0
.5
67
/1
34
 
(5
0
)
65
/1
18
 (
55
.1)
+5
.1
-1
5.
6
P
ro
ce
ss
Ex
er
ci
se
 c
on
tr
ol
22
0
/7
98
 
(2
7.6
)
35
7/
95
1 
(3
7.
5)
+9
.9
26
4/
88
5 
(2
9.
8)
23
4/
71
5 
(3
2.
7)
+2
.9
**
7.0
P
ro
ce
ss
A
d
vi
ce
 p
hy
si
ca
l a
ct
iv
it
y
15
5/
79
8 
(1
9.
4)
19
8/
95
1 
(2
0
.8
)
+1
.4
19
1/
88
4 
(2
1.6
)
18
2/
71
4 
(2
5.
5)
+3
.9
-2
.5
 Primary outcomes
None of the primary outcomes showed significant improvements  
(Table 3). Patients with a systolic blood pressure <140 mmHg decreased 
in the study arm (from 50.5% to 39.8%) as well as the control arm 
(from 50.6% to 38.7%). Patients with LDL cholesterol <2.5 mmol/l hardly 
changed. Patients with a prescription of antiplatelet drugs decreased in 
the intervention group from 84.3% to 82.7% and in the control group from 
84.9% to 82.7%.
 Secondary outcomes
Of the 17 secondary outcomes, six showed significant improvements as 
a result of the intervention. These were, patients with known smoking 
status (27.2% and 14.2% change respectively; p=<0.0001); registration 
of physical exercise (9.9% and 2.9% change respectively; p=0.0042); 
registration of diet control (3.6% and 0.9% change respectively; 
p=0.0258); registration of alcohol intake (16.0% and 6.1% change 
respectively; p=0.0007); measurement of waist circumference (5.8% and 
5.6% change respectively; p=0.0346) and measurement of fasting glucose 
(10.1% and 1.8% change respectively; p=0.0360). The other 11 secondary 
outcomes did not show significant changes. 
 Perceived goal attainment 
The objectives of the chosen improvement plans on CVRM mainly 
concerned the establishment of a CVRM-consultation hour, the 
identification of patients eligible for CVRM and the improvement of 
registration in electronic medical records. The participants’ perceived 
goal attainment on plans concerning chronic care management was 
documented for 30 practices. The findings suggest that goals were 
largely perceived to be met (Table 4). In the intervention arm the mean 
score for goal achievement was 7.9 (SD 1.2) and in the control group the 
mean score was 8.2 (SD=1.2). There was no significant difference between 
the study arms (p=0.45) which implies CVRM related goals were achieved 
to the same extent as goals focusing on other domains of chronic care.
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Table 4. Perceived goal attainment on plans concerning chronic care management1 
Intervention a (N=14) Control b  (N=16)
Min 6 6
Max 10 10
Mean 7.9 8.2
SD 1.2 1.2
 
1 Measured on a Likert scale (1-10)
a Plans concerning CVRM
b Plans concerning chronic care management other than CVRM 
DISCUSSION
The Dutch accreditation program for primary care practices is strongly 
focused on learning and improving healthcare delivery, using a 
comprehensive audit and feedback procedure that is largely focused 
on the management of chronic diseases. We found that this program 
improved some aspects of professional performance concerning CVRM 
in the practices who focused their improvement plans on CVRM, but not 
on the primary outcomes. The participants largely perceived to achieve 
chosen goals of their improvement projects . 
Although accreditation schemes have been evaluated in observational 
studies, this is one of the first controlled evaluations of this method  
to enhance quality of healthcare. A notable exception is a controlled 
study in German primary care practices,10 which also reported positive 
effects, however, this German accreditation program focused on organi-
zational domains rather than clinical processes. If we compare our 
primary outcomes with the results of trials of audit and feedback  
(a key component of the Dutch practice accreditation), we found effects 
at lower end of the range of effect sizes. The effects on a few secondary 
outcomes were only slightly higher than other studies of audit and 
feedback, combined with target setting and action planning, have found. 
So, this study did not provide evidence that the context of practice 
accreditation had an added value to the effectiveness of the audit and 
feedback.
 A possible explanation for the lack of stronger effects is the 
impact of patient related factors on the outcomes, such as poor 
compliance with treatment22 and patients’ comorbidity. Furthermore,  
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data collection from their electronic medical record. Selection bias may 
also be the effect of the fact that randomization only occurred in order  
of time of enrolment due to feasibility problems.
 Randomization determined the focus on CVRM for the 
improvement plans in the first year of the cycle, ideally the outcome 
of feedback determines the focus of the plans. Furthermore this might 
explain why invited practices declined to participate. In this study 
practices could establish their own goals for improvement plans without 
limitations or guidance. If plans would be more focused on improvement 
of outcome measures, the effects might have been larger.
 It was not feasible to assess outcomes on patient level such 
as death, myocardial infarction or stroke, however it would have been 
interesting to examine if the accreditation program is of influence on 
these outcomes.
 We have failed to mention the covariates included in this study 
with registration of this trials. However, the covariates were discussed  
in the published studyprotocol.13
 Generalizability
General practices in this study all voluntarily applied for the practice 
accreditation program. This could imply that practices included in this 
study have a more than average affinity with quality of care and have 
higher baseline measurements and therefore have less to improve. 
Furthermore the practice accreditation program was initiated in 2005, 
practices included in this study are the early adaptors26 among general 
practices in the Netherlands, especially taking into account the program  
is voluntary, and for that reason more eager to initiate improvement.  
A substantial number of practices in our study are training practices.  
Of these practices it is to be expected they are more open to 
innovations. On the other hand they may have felt pressure to 
participate.
 The results of our study can be compared to a large 
observational study in European primary care (EPA-Cardio), which 
provided data on CHD on the basis of validated quality indicators in eight 
European countries, including the Netherlands.27 In Dutch practices in 
EPA-cardio 28.9% of patients had a systolic blood pressure below 140 
mmHg, which is lower than in our study at both baseline and follow-up 
measurement. In addition, 43.0% of patients in EPA-cardio had a LDL 
cholesterol level below 2.5 mmol/l which was comparable to our sample. 
Anti-platelet drugs were prescribed in 82.8% of patients which was also 
comparable to the results of our study. So, accrediting practices in our 
study are comparable to other practices in the Netherlands. 
a substantial part of practices in the intervention arm were solo 
practices. Group practices might have more defined processes to 
address quality issues. In the follow-up measurement the number 
of patients with diabetes decreased. A smaller contribution of this 
otherwise relatively well treated sub group23 will lead to lower overall 
scores. 
 A number of secondary outcomes improved more in the 
intervention arm. Assuming participating in the accreditation program 
induces better monitoring of patients and improvement of registration 
behavior in general, we would expect all secondary outcomes to 
improve and not only the six outcomes as demonstrated in this study. 
 Practices in the control arm also showed improvements on 
the measures of CVRM quality at follow up. This might be explained 
by increased attention on CVRM in integrated care groups, increased 
awareness for quality of care in general in addition to improvement 
plans and furthermore increased awareness of registration behavior  
in general when participating in an accreditation program.
 Strengths and weakness of the study
To our knowledge this is one of the first trials of an accreditation 
program in primary care. The performance indicators in the program 
were carefully developed.24, 25 Data in this study were manually collected 
from electronic medical support systems. The sample size calculated 
was 30 patients per practice. However, practices participating in the 
practice accreditation were required to collect data on 40 patients 
which gives more body of evidence to the baseline-measurement. In 
the analysis baseline-measurements were included in the model which 
amplifies the power and therefore compensates for the calculated 
number of 35 clusters per group that was not achieved. 
 Follow-up of the same cohort of patients would have been more 
efficient but was not feasible. We measured aspects of clinical process 
and outcomes on patients as an indicator of change in clinicians, who 
remained the same throughout the study. The different samples were 
taken into account in the data-analysis approach, resulting in somewhat 
reduced accuracy compared to following up the same cohort of 
patients. 
 The control group in this study also showed improvements. 
This could be the effect of contamination as practices in the control 
group also participated in the Dutch accreditation program. A different 
study design might have demonstrated a larger effect, but this was not 
feasible. Another limitation of the study is the risk of selection bias in 
the follow-up measurement as patients had to give informed consent for 
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outcomes did not show improvements, participating practices in our 
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they may help to optimize the effectiveness of the program.
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Chapter 4
Determinants of change 
in a practice accreditation 
program in primary care:  
a qualitative study
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ABSTRACT
 Background
Practice accreditation is a widely used method to assess and improve 
the quality of healthcare services. In the Netherlands, a practice 
accreditation program was implemented in primary medical care. 
We aimed to identify determinants of change related to the practice 
accreditation program, building on the experiences of primary care 
professionals who had participated in an accreditation program.
 Methods
An interview study was done to document the experiences of 
33 participating primary care professionals and used to identify 
determinants of outcomes. The Consolidated Framework for 
Implementation Research (CFIR) was used as framework for the 
qualitative analysis. 
 
 Results
After analyzing 23 interviews saturation was reached. The practice 
accreditation program is based on structured quality improvement, 
but only some of its elements were identified as determinants of 
change. Factors that were perceived to facilitate implementation of the 
program were: designating one person responsible for the program, 
ensuring clear lines of communication within the whole practice team 
and having affinity with or stimulate enthusiasm for improving quality 
of care. Contextual factors such as participation in a care group and 
being connected to the general practitioner educational institute were 
important for actual change. The accreditation program was perceived 
to have positive effects on team climate and commitment to quality of 
care in the practice team. The perception was that patient care was not 
directly influenced by the accreditation program. Receiving a certificate 
for completing the accreditation program seemed to have little added 
value to participants.
 Conclusions
Practice accreditation may have positive outcomes on quality of care, 
but not all planned elements may contribute to its outcomes. Both 
factors in the accreditation process and in the context were perceived 
as determinants of quality improvement. The challenge is to build on 
facilitating factors, while reducing the elements of accreditation that 
do not contribute to its impact. 
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identify relevant factors. The Consolidated Framework for Implementation 
Research (CFIR) was used as framework for analysis.9 
 Setting 
The primary care practice accreditation program in the Netherlands has 
been offered on a voluntary basis since 2005. Practices have to comply 
to few minimum standards in order to be eligible for participation.10 The 
practice accreditation program comprises, firstly, of a comprehensive 
audit (using validated performance indicators) and written feedback to 
the practice, which covers a range of clinical domains (cardiovascular 
risk management (CVRM), diabetes mellitus (DM), asthma and COPD, 
practice management, and patient experiences. The feedback, which 
consists of a comparison with benchmarks of other primary care 
practices, is discussed with a trained observer in a feedback consultation 
with the whole practice team and helps to identify substandard 
performance domains. The second obligatory component, the planning 
of improvements in the practice according to the principles of quality 
management, is based on this feedback. The practice team may 
chose to rely on a trained consultant to develop an improvement plan. 
Participants who perform the procedure as planned are all accredited, 
so accreditation does not imply that a certain minimum score on 
performance indicators has been obtained. In the practice accreditation 
program validated instruments are used: VIP,11 clinical indicators7 and 
Europep.12 Participants receive a certification for the time period of one 
year which demonstrates (to the public) their involvement in continuous 
quality improvement. Every year the practice will be audited and every 
year new improvement plans have to be formulated which have to be 
approved by the auditor. The prolongation of the accreditation depends 
on having met the objectives of the improvement plans.
 Participants
Participants in the study were team members of the primary care 
practice with a coordinating role in the implementation of the practice 
accreditation program in the primary care practice.
 Interviews 
Semi-structured interviews with one team member per practice were 
conducted. All interviews were held by one person (EN), a health scientist 
and physiotherapist. All practices included in the cluster randomized 
trial8 were approached to participate in the interviews. An interview guide 
was used and was adjusted during the process of interviewing based 
on interim reviewing of the results. Interviews (by telephone due to 
feasibility) lasted approximately half an hour. 
INTRODUCTION
Accreditation and certification are widely used methods to assess and 
improve healthcare services. These are complex interventions, which 
typically comprise an audit of a healthcare provider, an assessment 
of performance, followed by formal allowance of accreditation or 
certification. Accreditation programmes can have positive effects on 
quality and safety of clinical care and organizational performance.1 
Worldwide, accreditation focuses on promoting continuous 
improvements, applying standards and providing feedback.2 Given the 
opportunity costs involved, it is important to know which components 
and contextual factors contribute to the outcomes of accreditation on 
quality and outcomes of healthcare. However, little is known about this.
 In the Netherlands, primary care practice accreditation is a 
voluntary activity comprising a comprehensive audit, which covers 
clinical and organizational domains, followed by structured planning of 
improvements and formal review by an external assessor.3 The program 
was initiated by the Dutch College of General Practitioners (DCGP) and 
is delivered by an independent organization (Netherlands Institute for 
Accreditation in Healthcare, NPA). While accreditation may serve several 
purposes, improvement of professional performance and practice 
organization are prominent among these in the Dutch program.4-6 
Previous research with respect to the Dutch practice accreditation 
program showed that general practitioners (GPs) were willing to assess 
their practice in order to improve the quality of care. Furthermore the 
practice accreditation program is used to obtain understanding of the 
practice organization in order to enhance the quality of care in the 
practice.7 
 The aim of this study was to identify and map out determinants 
of change related to the practice accreditation program, building on the 
experiences of primary care professionals who had participated in the 
accreditation program. 
METHODS
 Study design 
A qualitative study was conducted, which was linked to a cluster 
randomized trial of the practice accreditation program in the Netherlands.8 
All participating practices participated in the practice accreditation 
program and all were invited for the qualitative study. We used semi-
structured interviews with participating primary care professionals to 
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RESULTS
All participating practices were invited for the interview study. Eight 
practices declined to participate in the study due to lack of time or 
sickness among staff. Interviews were done with 33 individuals in the 
year 2012. Interviews lasted from 17 minutes until 46 minutes. Table 1 
shows characteristics of the interviewed participants. After analyzing 
data of 23 interviews, saturation was reached. Eight interviews were 
analyzed and coded by all three authors, 15 interviews were coded by 
two of the authors (JvL, EN). The findings were reported regarding the 
five domains of CFIR and were supported by verbatim quotations from 
interviews. 
Table 1 Characteristics of interview participants
Team member 22 (96%) GP
1 (4%) Practice assistant
Type of practice 10 (44%) Solo practices
7 (30%) Duo practices
6 (26%) Group practices
Female 10 (44%)
GP training practices 20 (87%)
Participating in care group concerning CVRM 3 (13%)
The interview guides were developed on the basis of literature7 
and during several core-group meetings. Topics that guided the 
development of the interview were: reasons to participate in the 
practice accreditation program, consequences of participating in 
the program, preparation and implementation of improvement plans, 
incentives for quality improvement, dealing with feedback and the 
significance of participating in the program. 
 The study was undertaken to identify determinants of change 
related to the practice accreditation program, building on the 
experiences of primary care professionals who had participated in the 
accreditation program in primary care, therefore a qualitative method 
was appropriate.
 Data analysis 
All interviews were audio-taped and transcribed verbatim. Interviews 
were repeatedly read and analyzed in an iterative approach by three 
researchers, who had three rounds of separate analysis of interviews 
followed by collaborative interpretation and consensus. Interview data 
were analyzed until saturation was reached. A stepwise analytical 
approach was used.13 We provisionally coded all statements referring 
to program components or contextual factors which appeared to be 
determinants of change. In a second stage, the codes were linked to 
the logical steps in practice accreditation (Figure 1). We then used the 
CFIR framework, which provides constructs from multiple domains for 
identifying potential influences on implementation of interventions,9 
in a deductive analysis. The CFIR constructs are organized into five 
major domains and, as applies to this study, are: characteristics of the 
practice accreditation program (evidence strength and quality, relative 
advantage, adaptability, complexity, design quality and packaging, 
cost); the outer setting (patient needs and resources, cosmopolitanism, 
peer pressure, external policies and incentives); the inner setting; the 
process used to implement the program; characteristics of individuals 
involved (Appendix 1).9
 Ethical approval and informed consent
The Medical Ethics committee Arnhem-Nijmegen waived approval for 
this trial after assessing the study protocol (file number 2008/258). 
All participants consented to recording of the interviews. All data was 
coded and processed anonymously. 
 P
R
A
C
TI
C
E 
A
C
C
R
ED
IT
AT
IO
N
 T
O
 IM
P
R
O
V
E 
C
A
R
D
IO
VA
S
C
U
LA
R
 R
IS
K
 M
A
N
A
G
EM
EN
T 
IN
 G
EN
ER
A
L 
P
R
A
C
TI
C
E
75
74
C
H
A
P
TE
R
 4
Figure 1 Steps in the practice accreditation program
Practice 
accreditation 
program
On-site visit 
of assessor
Audit
Outcome
Registration 
and
preparation
Implemen-
tation 
improvement 
plans
Improvement 
plans
Added value Expectations
Connection to 
primary process 
Improvement
plans
Intrinsic
motivation 
Patient
surveys 
Dealing with 
feedback 
reports
Value of the 
certificatet
Consultant Input 
improvement 
plans 
-  feedback 
report (audit)
-  patient 
surveys (audit)
- care group
-  GP’s own 
ideas
-  ideas practice 
assistants
-  patient 
complaints
Practice characteristics
-  education level team members
-  one team member  responsible 
-  perceived workload in  
the practice
Extrinsic 
motivation 
Financial 
incentives
Positive 
effects
Negative
effects
Netherlands Institute 
for Accreditation in 
Healthcare:
- changes in program
-  provision of uniform 
information
Intervention:
- Website 
- Working book
- Assessor
External factors:
-  Affiliation chronic 
care group
-  Participation other 
accreditation 
program
- Intervision 
-  National 
developments 
-  Participation in 
research
 Views on intervention characteristics
 Intervention source
The practice accreditation program was externally developed by the 
DCGP.14 Elements of the program corresponded with existing work 
processes, which was perceived as beneficial for implementation of  
the program.
 Adaptability
The adaptability of an intervention is the degree to which the intervention 
can be tailored to the needs of the organization. A core component in 
the practice accreditation program is developing improvement plans 
on four chronic conditions mostly treated in general practice. These 
plans are tailor-made, using the feedback reports to guide their focus, 
and therefore should be consistent with the needs of the practice. The 
program did provide additional support for developing and implementing 
improvement plans, which is important in applying elements of quality 
improvement. However, some participants experienced there was no 
possibility to implement their own priorities using improvement plans. 
‘What we disliked was that we were obliged to make a plan on the four most 
common chronic diseases, you have to do this, you have to do that. When 
you indicate you have other priorities for the improvement plans, you still 
have to implement a plan on topics they have made mandatory. That felt 
annoying sometimes.’ (respondent 13)
 Complexity
The first step in the practice accreditation program is collecting patient 
related data on four chronic diseases. Many participants experienced 
this as the most time-consuming and difficult step of the program. 
Furthermore, other elements of the program such as developing 
improvement plans and implementing these plans were experienced as 
a heavy burden as these are supplementary tasks in addition to daily 
practice. 
 Design quality and packaging
The intervention consisted of a workbook, a supporting website and 
practices were obliged to contract a trained consultant to assist the 
practice through all steps of the program. Another component is the 
practice visit of an assessor to assess improvement plans and minimum 
standards. Practices in this study were in general not content with the 
supporting website which was found unclear and slow. Experiences 
with the assistance of the consultant varied. Furthermore there was a 
lack of consistency in assessment methods of assessors which caused 
confusion on how to interpret and execute the program. 
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 Cost
All respondents expressed their dissatisfaction with the high costs of the 
intervention. Furthermore they questioned the benefits of the program,  
in particular in relation to the costs.
 Views on the outer setting
 Patient needs and resources
In the practice accreditation program participants are obliged to 
conduct a patient satisfaction survey. Based on these outcomes several 
participants defined an aim for their improvement plans so needs of 
patients can be met. ‘We used results from the patient survey to inspire 
us in choosing a topic for the improvement plans for this year. There were 
especially complaints regarding privacy.’ (respondent 26) 
 However, participants perceived that patient care was not directly 
influenced by the accreditation program as the program had no direct 
influence on patient-caregiver interactions.
 Cosmopolitanism 
All practices in the study were affiliated with a chronic care group. In 
addition to the practice accreditation program, participants in the study 
mentioned participation in a chronic care group as a contextual factor 
that positively influenced the quality of the care they provided. Some 
of the practices were, as training practices, connected to an institute 
for vocational training of GPs. Peer review meetings for GPs working in 
training practices appeared to be of a positive influence on their attitude 
towards quality improvement.
 External policy and incentives 
The most important extrinsic reasons to participate in the program 
were a financial stimulus for GP training practices and the requirement 
of insurance companies to demonstrate how quality is managed within 
the practice. Participation in research projects, nationally organized 
projects (on registration behavior) and participation in other certifications 
programs all provided a positive influence on implementation of the 
program. 
 Views on the inner setting 
 Structural characteristics
In small practice organizations, lines of communication are clear which is 
beneficial for the implementation of the practice accreditation program. 
However in solo-practices all tasks concerning the program have to 
be performed by one person. Furthermore, when a practice loses 
staff members due to illness or resignation, there is no priority for the 
program and it also implies the loss of knowledge about the program.
‘Well, when you lose staff members because of resignation or illness, 
it causes major problems. First priority is to keep the practice running 
and then there is no time left to spend on tasks concerning the practice 
accreditation program.’ (respondent 46)
 The age of general practitioners was mentioned as a factor 
associated with the enthusiasm with which the program was accepted 
for implementation. ‘I think it’s a generational thing. I have the feeling 
older GPs consider it more difficult to work according to the practice 
accreditation program than younger GPs.’ (respondent 15)
 Networks and communication
The practice accreditation program requires the involvement of the 
whole team. Therefore it is advised to organize structural team meetings 
to evaluate the progress of improvement plans. Participants experienced 
implementation of the program as more effective when indeed all 
members of the team were involved and processes were structurally 
evaluated in team meetings. 
 Culture
The majority of participants in this study had affinity with improving the 
quality of care they provide, prior to participating in the program, which 
benefits implementation. Furthermore participants mentioned that the 
motivation and education level of team members was of influence in 
the implementation of the program. ‘I think we have team members with 
a critical attitude. All our assistants have a bachelors degree, which is 
uncommon.’ (respondent 34)
 Implementation climate
The degree of motivation regarding implementation of the program may 
be dependent on the function of the staff members. Some GP assistants 
experienced the program as a burden while practice nurses had no 
difficulties implementing the program. Furthermore, in some practices 
not all GPs found the program beneficial and were therefore less 
motivated to implement the program.
 Views on the characteristics of individuals
 Knowledge and beliefs about the intervention
Participants started with the program while it provides support when 
improving quality of care in the practice: ‘We wanted to be more 
conscious of the quality of care we provide and we wanted to reveal our 
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blind spots. The most important reason to participate in the program was 
to improve the quality of care we provide.’ (respondent 24)
 Self-efficacy 
The program provided tools to work systematically: ‘I often started new 
things (new procedures) without completing them. The advantage of the 
accreditation program is that it forces me to complement the circles to 
implement new approaches in a constructive manner.’ (respondent 22)
 Individual stage of change 
In the initial stages of the program participants required more assistance 
from the consultant than in later stages of the program. They then 
became more accustomed to working according to a quality cycle and 
the program was more integrated in daily practice.
 
 Other personal attributes
Some participants were motivated to participate in the practice 
accreditation program because they were also employed in another 
function relating to quality of care.
 Views on the process of change
 Planning
Most participants made no preparations before they volunteered to 
participate in the program. The practice accreditation program consists 
of various elements (Figure 1). Practices in the program started with 
collecting patient related data to four chronic diseases (COPD, DM, 
CVRM, Asthma). Particularly this element was very time-consuming and 
led to barriers for some participants due to computer related problems.
‘I’m no computer expert, I need help with that and I think that also applies 
to some of my colleagues’. (Respondent 38)
 Based on the data on four chronic diseases practices receive 
a feedback report with benchmarks which provides insight into their 
medical practice. This information was considered to be important 
however it had little influence on improvement plans. A possible reason 
is it is difficult to adequately reflect on the outcomes. ‘It (the feedback 
report) shows the benefits of my efforts and indicates in what areas I 
should plan improvements. It is very difficult to reflect on the feedback 
reports sufficiently. I have to spend time to study it, to think about it and 
reflect on it. You should be able to discuss it with your team. The rush 
of daily practice leaves no time for this and that is very unfortunate.’ 
(Respondent 44)
However, some participants considered the feedback report of minor 
importance. ‘No, we do not look into it that much. This is our practice and 
we manage it our own way.’ (Respondent 29)
 Another element of the practice accreditation program was 
the formulation of improvement plans. These plans were in general 
drafted and implemented by all team members. The practice consultant 
provided useful feedback on the plans in the first year of the program. 
However, only to a certain extent the subject of improvement plans can 
be determined. ‘I have to come up with three new plans for this year. You 
have to be careful you don’t make up things only because the auditor is 
coming.’(Respondent 45)
 Visitation of an assessor is the next element of the practice 
accreditation program. During this visit the assessor audits the practice. 
Results of the audit seem to depend on which assessor visits the 
practice. ‘I have noticed over time that the assessors all have different 
backgrounds. They assess the practice in a non-similar manner. The 
things that are important differ for various assessors.’ (Respondent 34)
 Engaging
Some of the partners of the GPs were member of the practice team. 
This appeared to be a highly stimulating factor in implementation of 
the program. ‘As the manager I have the time to perform accreditation-
related tasks. So I took the initiative, otherwise it would not have been 
a success. We talk about it over dinner, so to speak, so the reflection 
process is already started. And then at one point I nag that he really has 
to write those plans, and then he picks up the voice recorder and begins.’ 
(Respondent 29)
 When starting with the program some participants expanded 
responsibilities of other team members for the purpose of guiding the 
implementation of the program. ‘One of our assistants had just finished 
a management training, that was our benefit. We appointed her as 
coordinator of the practice accreditation program.’ (Respondent 40)
 
 Executing
Every year the practice is audited by an auditor who assesses the 
objectives of implemented improvement plans and approves new 
improvement plans. This annual visit is for most participants an 
important motivator for continuous quality improvement and to keep 
implementation of improvement plans on the practice agenda. 
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 Reflecting and Evaluating
Quantitative feedback about the progress of implementation of the 
program was provided by feedback reports at the start of the program. 
It is required for practices to define their improvement plans with a 
measurable goal. After a year they have to provide evidence that goals 
have been achieved. Furthermore team meetings were regularly held, as 
required by the practice accreditation program, to monitor progress of 
implementation. 
 As a result of participation in the program, team members 
were more motivated in performing their work and their responsibility 
increased as a consequence of participation in the program. Overall 
a better team spirit emerged. ‘Very often issues are not mentioned 
because it is difficult to give one another feedback. Now we succeeded 
in establishing a safe work environment where we can provide each other 
feedback in a constructive manner.’ (respondent 40)
DISCUSSION
The aim of this study was to identify determinants of change related 
to the practice accreditation program, building on the experiences of 
primary care professionals who had participated in the accreditation 
program in primary care. The presence of a team member who has the 
specific responsibility for the program appeared to be a stimulating 
factor. The accreditation program had positive effects on team climate 
and caused more sense of responsibility for quality of care among all 
team members. The perception was that patient care was not directly 
influenced by the accreditation program. Audit and feedback is a crucial 
element of the accreditation program, however choices for improvement 
plans were rarely based on feedback reports. Receiving a certificate  
for completing the accreditation program seemed to have little value  
to participants.
As shown in a Cochrane review15 audit and feedback leads to variable 
and overall modest improvements in professional practice. The 
effectiveness seems to depend on baseline performance and on how 
feedback is exactly provided. Knowledge gaps remain regarding when 
audit and feedback will work best and why.16 Feedback is more effective 
when accompanied by both explicit goals and an action plan. However, 
results in this study show that feedback is not necessarily used when 
making improvement plans, because practices have ideas in advance on 
what to improve regardless of the outcome of feedback. Furthermore, 
external factors, such as participation in chronic care groups, appear 
to have a more important impact on the implementation of new or 
improved procedures in the practice than audit and feedback. As shown 
in this study, participants experienced that patient care was not directly 
influenced by the accreditation program, it is therefore recommended 
that improvement plans should be focussed more on improvement of 
outcome measures.
 In this study staff responsibility for quality was identified as an 
important implementation facilitator, which was also demonstrated in 
a previous study.17 Similar to previous studies in hospital-settings,18 this 
study in primary care demonstrates contrasting professional attitudes 
towards accreditation programs; a possible explanation for this may be 
age of the professional.19 The program results in better organizational 
performance and it provides a guide to external stakeholders illustrating 
how quality is managed within the practice. However critical perspectives 
are that the program is bureaucratic, time consuming and adds little 
value to patient care because of its focus on administrative processes. 
Furthermore there is a perceived lack of consistency among assessors. 
 As a response to this and other evaluations, the Netherlands 
Institute for Accreditation in Healthcare has adjusted the practice 
accreditation program to make implementation more feasible 
and flexible. Data collection has been spread over different years, 
improvement plans can be documented in a more flexible way, and 
the use of external advisors is optional. New evaluation is required to 
examine the impact of these changes on feasibility and outcomes.
Strengths and limitations of the study 
The strength of this study lies in the qualitative approach which gives us 
more information on the working elements of the practice accreditation 
program. The CFIR framework was used to organize the data in this 
study. All domains described in the CFIR were represented in the results. 
As the CFIR framework was only used in the last stage of coding, the 
risk of overlooking material that does not fit in the constructs, was small. 
General practices in this study all voluntarily applied for the practice 
accreditation program and subsequently they voluntarily participated in 
this study. This could imply that participants included in this study had 
a more than average affinity with quality of care and were motivated to 
change. Therefore it is recommended to conduct further research in 
the late majority population. In this study only the quality coordinators 
of the practices were approached for participation. A focus group 
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study with all team members of the practice could have resulted in 
additional outcomes to provide more understanding of mechanisms of 
action regarding implementation of the program. Furthermore, the data 
collection method we choose might have been inadequate as with face-
to-face interviews more in-depth and nuanced data can be collected. 
This study contributes to the body of knowledge on determinants of 
outcome of a practice accreditation program implemented in general 
practice. Perceived determinants in this study do not imply these are 
already proven and they have to be further explored in future research. 
However, the results of this study provide feasible, ready to use 
suggestions, like designating one responsible team member, to facilitate 
the implementation of a practice accreditation program and therefore 
can be relevant for general practice teams, practice managers and 
policymakers.
 Consistent with results from this study, previous research has 
shown that accreditation results in improved teamwork, improved 
access to care, increased awareness of patient safety, improved 
practice systems and care processes and improved quality of care.19 
Nevertheless, not all planned elements of accreditation appeared 
to contribute to its outcomes, so there may be room for improving 
efficiency of the program. As shown in this study, elements that were 
perceived to facilitate implementation of the program were; designating 
one person responsible for the program, ensuring clear lines of 
communication within the whole practice team and having affinity with 
or stimulate enthusiasm for improving quality of care. Furthermore 
contextual factors such as participation in a care group and being 
connected to the GP educational institute were important for practice 
change. The importance of the elucidation of contextual factors has 
been shown in previous research. Reporting contextual information is a 
way to provide information needed to foster health care systems,20 and 
it is therefore recommended to explore contextual information in future 
accreditation research. 
 Across the world, practice accreditation is an established strategy 
for assessing and improving healthcare practices. Nevertheless, there 
remains a need for better insight into the factors and processes related 
to its impact in order to optimize existing accreditation programs. 
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Appendix 1
Topic/Description Short description
I. INTERVENTION CHARACTERISTICS
A.  Intervention 
source
Perception of key stakeholders about whether the intervention is 
externally or internally developed.
B.  Evidence 
Strength  
& Quality
Stakeholders’ perceptions of the quality and validity of evidence 
supporting the belief that the intervention will have desired outcomes.
C.  Relative  
Advantage
Stakeholders’ perception of the advantage of implementing the 
intervention versus an alternative solution.
D. Adaptability The degree to which an intervention can be adapted, tailored, refined, 
or reinvented to meet local needs.
E. Trialability The ability to test the intervention on a small scale in the organization, 
and to be able to reverse course (undo implementation) if warranted.
F. Complexity Perceived difficulty of implementation, reflected by duration, scope, 
radicalness, disruptiveness, centrality, and intricacy and number of 
steps required to implement.
G.  Design Quality  
and Packaging
Perceived excellence in how the intervention is bundled, presented, 
and assembled.
H. Cost Costs of the intervention and costs associated with implementing that 
intervention including investment, supply, and opportunity costs.
II. OUTER SETTING
A.  Patient Needs  
& Resources
The extent to which patient needs, as well as barriers and facilitators 
to meet those needs are accurately known and prioritized by the 
organization. 
B. Cosmopolitanism The degree to which an organization is networked with other external 
organizations.
C. Peer Pressure Mimetic or competitive pressure to implement an intervention; 
typically because most or other key peer or competing organizations 
have already implemented or in a bid for a competitive edge.
D.  External Policy  
& Incentives
A broad construct that includes external strategies to spread 
interventions including policy and regulations (governmental or other 
central entity), external mandates, recommendations and guidelines, 
pay-for-performance, collaboratives, and public or benchmark 
reporting.
III. INNER SETTING
A.  Structural 
Characteristics
The social architecture, age, maturity, and size of an organization.
B.  Networks & 
Communications
The nature and quality of webs of social networks and the nature and 
quality of formal and informal communications within an organization.
C. Culture Norms, values, and basic assumptions of a given organization.
D.  Implementation 
Climate
The absorptive capacity for change, shared receptivity of involved 
individuals to an intervention and the extent to which use of that 
intervention will be rewarded, supported, and expected within their 
organization.
1.  Tension for 
Change
The degree to which stakeholders perceive the current situation as 
intolerable or needing change.
2. Compatibility The degree of tangible fit between meaning and values attached 
to the intervention by involved individuals, how those align with 
individuals’ own norms, values, and perceived risks and needs, and 
how the intervention fits with existing workflows and systems.
3. Relative Priority Individuals’ shared perception of the importance of the 
implementation within the organization.
4.  Organizational 
Incentives  
& Rewards
Extrinsic incentives such as goal-sharing awards, performance 
reviews, promotions, and raises in salary and less tangible incentives 
such as increased stature or respect.
5.  Goals and 
Feedback
The degree to which goals are clearly communicated, acted upon, 
and fed back to staff and alignment of that feedback with goals.
6. Learning Climate A climate in which: a) leaders express their own fallibility and need 
for team members’ assistance and input; b) team members feel that 
they are essential, valued, and knowledgeable partners in the change 
process; c) individuals feel psychologically safe to try new methods; 
and d) there is sufficient time and space for reflective thinking and 
evaluation.
E.  Readiness for 
Implementation
Tangible and immediate indicators of organizational commitment to 
its decision to implement an intervention.
1.  Leadership 
Engagement
Commitment, involvement, and accountability of leaders and 
managers with the implementation.
2.  Available 
Resources
The level of resources dedicated for implementation and on-going 
operations including money, training, education, physical space, and 
time.
3.  Access to 
knowledge and 
information
Ease of access to digestible information and knowledge about the 
intervention and how to incorporate it into work tasks.
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IV. CHARACTERISTICS OF INDIVIDUALS
A.  Knowledge & 
Beliefs about the 
Intervention
Individuals’ attitudes toward and value placed on the intervention 
as well as familiarity with facts, truths, and principles related to the 
intervention.
B. Self-efficacy Individual belief in their own capabilities to execute courses of action 
to achieve implementation goals.
C.  Individual Stage  
of Change
Characterization of the phase an individual is in, as he or she 
progresses toward skilled, enthusiastic, and sustained use of the 
intervention.
D.  Individual 
Identification 
with Organization
A broad construct related to how individuals perceive the 
organization and their relationship and degree of commitment with 
that organization.
E.  Other Personal 
Attributes
A broad construct to include other personal traits such as tolerance 
of ambiguity, intellectual ability, motivation, values, competence, 
capacity, and learning style.
V. PROCESS
A. Planning The degree to which a scheme or method of behavior and tasks 
for implementing an intervention are developed in advance and the 
quality of those schemes or methods.
B. Engaging Attracting and involving appropriate individuals in the implementation 
and use of the intervention through a combined strategy of social 
marketing, education, role modeling, training, and other similar 
activities.
1. Opinion Leaders Individuals in an organization who have formal or informal influence 
on the attitudes and beliefs of their colleagues with respect to 
implementing the intervention.
2.  Formally 
appointed 
internal 
implementation 
leaders
Individuals from within the organization who have been formally 
appointed with responsibility for implementing an intervention as 
coordinator, project manager, team leader, or other similar role.
3. Champions “Individuals who dedicate themselves to supporting, marketing, and 
‘driving through’ an [implementation]”, overcoming indifference or 
resistance that the intervention may provoke in an organization.
4.  External Change 
Agents
Individuals who are affiliated with an outside entity who formally 
influence or facilitate intervention decisions in a desirable direction.
C. Executing Carrying out or accomplishing the implementation according to plan.
D.  Reflecting & 
Evaluating
Quantitative and qualitative feedback about the progress and quality 
of implementation accompanied with regular personal and team 
debriefing about progress and experience.
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Chapter 5
Comorbidity complicates 
cardiovascular treatment: 
is diabetes the exception?
E. Nouwens
J. van Lieshout
M. Wensing
The Netherlands Journal of Medicine 2012;70(7): 298-305.
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ABSTRACT
 Background
Many patients with cardiovascular disease do not attain the targets 
for health-related lifestyle and preventive treatment recommended in 
practice guidelines. The aim of this study was to assess the impact of 
diabetes (DM) and chronic obstructive pulmonary disease (COPD) on the 
quality of cardiovascular risk management in patients with established 
cardiovascular diseases (CVD).
 Methods and Results
Patients with established CVD were randomly selected in primary care 
practices using recorded diagnoses. Structured case forms were used to 
review data on 20 performance indicators concerning CVD from medical 
records. Descriptive and multilevel regression analyses were conducted.
In 45 primary care practices with 106 physicians in the Netherlands, 1614 
medical records of patients with CVD (37.9% women) were reviewed. A 
total of 1076 (66.7%) patients had recorded CVD only (reference group); 
7.8% had CVD and COPD; 22.4% had CVD and DM; 3.1% patients had CVD, 
COPD and DM. Compared with the reference group, patients with CVD 
and DM yielded higher scores on 17 of 20 indicators; patients with CVD, 
DM and COPD on 14 indicators; and patients with CVD and COPD on 
three indicators. Of the patients with CVD and DM, fewer patients had 
LDL-cholesterol levels over 2.5 mmol/l (OR=0.36; 95% CI 0.26-0.50), more 
had antiplatelet drugs prescribed (OR=1.72; 95% CI 1.17-2.54), and more 
had systolic blood pressure measurement (OR=4.12; 95% CI 2.80-6.06).
 Conclusions
This study showed that DM but not COPD was associated with more 
comprehensive cardiovascular risk management. This finding adds to 
cumulating evidence that presence of DM is associated with better 
preventive treatment of cardiovascular risk.
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MATERIALS AND METHODS
 Design
This study was based on the baseline measurement in a cluster 
randomised trial no. NCT00791362, which was executed from September 
2008 until February 2011. The trial aimed to determine the effectiveness 
and efficiency of a national accreditation and improvement program 
(NHG-Praktijkaccreditering®) for primary care practice, focusing 
on patients with established CVD. The national accreditation and 
improvement program was a new strategy for quality improvement in 
Dutch primary care. It consists of a set of implementation interventions 
including: audit and feedback, outreach visits by trained facilitators and 
planning improvements according to the quality management principles. 
The Arnhem-Nijmegen ethics committee waived approval for this trial. 
Data were collected by audit of electronic medical records of primary 
care patients in the Netherlands.
 Study population
We recruited patients with established CVD, namely angina pectoris, 
acute myocardial infarction, transient ischaemic attack (TIA), ischaemic 
stroke, peripheral arterial disease, aortic aneurysm and other chronic 
ischaemic heart diseases. Selection of patients with these conditions 
was based on corresponding diagnostic codes (ICPC K74, K75, K89, 
K90.3, K92.1, K99.1 and K76). Patients were classified as having DM or 
COPD if the corresponding diagnostic codes (T90 for DM, R95 for COPD) 
were recorded in their medical record. Patients were recruited from 45 
primary care practices involving 106 family physicians in the Netherlands 
who agreed to participate in the study. All primary care practices which 
voluntarily enrolled in the Dutch national accreditation program (NHG-
Praktijkaccreditering®) from December 2008 until March 2010 were 
invited by letter to participate in the study. All primary care practices 
used electronic medical records, which is common in the Netherlands, 
and International Classification of Primary Care codes (ICPC codes),  
a worldwide system to label conditions in primary care.20
 Measurements
In each practice 40 patients with established CVD were randomly 
sampled from the practice register. Data collection, related to the 
last 12 months, was based on quality indicators for established CVD21 
(developed by the Dutch College of Family Physicians), which included: 
systolic blood pressure in mmHg measured in the practice, LDL 
cholesterol in mmol/l, prescription of statin and antiplatelet drugs, 
INTRODUCTION
Cardiovascular disease (CVD) remains an important cause of death 
and disability in the world. In the United States, 33.6% of all deaths are 
caused by CVD.1 Similar numbers were found in the Netherlands where 
one in three individuals dies of CVD (Netherlands Heart Foundation).2 
Many activities have been developed to prevent CVD in public health 
and in primary care.3,4 Despite these activities and a range of practice 
guidelines,5,6 many individuals receive suboptimal cardiovascular risk 
management. Many cardiovascular disease patients do not attain the 
lifestyle, risk factor and therapeutic targets that are recommended.6,7 
One reason may be the presence of comorbidity in CVD patients, which 
can complicate treatment.8-10 The prevalence of comorbidity in patients 
with cardiovascular risk is high, especially in patients over the age of 
65 years.11 Practice guidelines tend to ignore comorbidity, although 
adherence to a guideline for one disease may have a negative effect in 
treatment of a co-existing disease.10 Nevertheless, studies on guideline 
adherence concerning patients with comorbidity have remained 
inconclusive and whether higher guideline adherence results in better 
health outcomes in patients with comorbidity is as yet unclear. On the 
one hand, many multi-morbid patients receive multiple drugs which may 
compromise adherence and safety of treatment.12 Research has also 
suggested that these patients have a poorer functional status or quality 
of life, a higher mortality risk and greater use of health services.13 On 
the other hand, some studies have in fact shown a positive association 
between the number of medical conditions and guideline adherence.14-17 
For instance, a Dutch survey demonstrated that patients with chronic 
heart failure and diabetes mellitus (DM) received treatment that was 
more consistent with guideline recommendations than patients with 
chronic heart failure but no DM.18 Furthermore, type of comorbid 
conditions may also be of influence on guideline adherence.9,19
The aim of this study was to assess the impact of DM and chronic 
obstructive pulmonary disease (COPD) on measures of cardiovascular 
risk management in patients with established CVD. Given the 
commonalities in the preventive treatment of the three conditions, which 
is illustrated by overlapping quality indicators, we expected comorbidity 
to be associated with higher scores on these measures.
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RESULTS
Of the 336 practices invited to participate in this study, 45 entered the 
study, representing 106 family physicians. In 45 practices a random 
sample of 1614 patients with established CVD and possibly DM and/or 
COPD as comorbidity was recruited.
Table 1 presents characteristics of the study population. More men 
(62.1%) were included in the sample. The mean age was 69.5 years (SD 
11.8). A total of 1076 (66.7%) patients had CVD only; 126 (7.8%) had CVD 
and COPD; 362 (22.4%) had CVD and DM; and 50 (3.1%) patients had CVD, 
COPD and DM. 
Table 1. Characteristics of the study population (N=1614)
CVD (%) CVD+COPD 
(%)
CVD+DM 
(%)
CVD+DM 
+COPD (%)
Total 
scores (%)
Men 665 (61.8) 90 (71.4) 212 (58.6) 36 (72) 1003 (62.1)
Women 411 (38.2) 36 (28.6) 150 (41.4) 14 (28) 611 (37.9)
Total 1076 (66.7) 126 (7.8) 362 (22.4) 50 (3.1) 1614
Mean age in 
years (SD)
68.7 (12.2) 71.3 (9.6) 70.9 (10.9) 70.1 (11.4) 69.5 (11.8) 
Table 2 describes the cardiovascular diseases. The most common 
cardiovascular history was angina pectoris (37.4% of patients) followed 
by myocardial infarction (30%). Of patients with multiple cardiovascular 
disorders (n=247) 37.2% had coronary heart disease only (K74, K75, K76), 
31.6% had coronary heart disease and peripheral arterial disease or 
aortic aneurysm (K92.1, K99.1) and 22.3% had coronary heart disease 
and TIA or ischaemic stroke (K89, K90.3). Table 3 shows that in audited 
records, recording was best for blood pressure measurement (75.9%), 
influenza vaccination (76.3%) and prescription of antiplatelet drugs 
(84.8%) and worst for risk assessment (4.8%). Goals for outcome 
measurement BMI (<25 kg/m2) were achieved in 16.9% of patients whose 
BMI was measured. Systolic blood pressure was <140 mmHg in 60.2%  
of patients with a record of BP, and LDL-cholesterol levels were below  
2.5 mmol/l in 46.8% of patients with a record of LDL cholesterol.
smoking status, stop smoking advice, body mass index in kg/m2, waist 
circumference ever measured, fasting glucose measurement measured 
in the past five years, influenza vaccination, registration of alcohol intake 
and control and advice on exercise and diet. This set of 20 indicators 
was complemented by information on age, sex and the presence of 
comorbidity (COPD and DM). Paper-based abstraction forms were used 
to collect data. Data were manually abstracted out of electronic medical 
records from January 2009 until May 2010. The starting point in this 
study was indicators related to established CVD21 but when considering 
indicators for all three chronic illnesses,21-23 seven indicators were 
commonly shared. These indicators were: exercise control, influenza 
vaccination, measurement of BMI, BMI <25 kg/m2, smoking status, patient 
is a smoker and stop smoking advice. Eight indicators concerned both 
established CVD and DM. These indicators were: systolic blood pressure 
measurement, systolic blood pressure <140 mmHg, LDL-cholesterol 
measurement, LDL cholesterol <2.5 mmol/l, advice on physical activity, 
diet control, counselling about diet and registration of alcohol intake. 
Five indicators related to established CVD only (measurement of waist 
circumference, prescription of antiplatelet drugs, fasting glucose 
measurement, patients with LDL cholesterol >--2.5 mmol/l with statin 
prescription and comprehensive risk assessment).
 Statistical analysis
Data were analysed using the SPSS 16.0 software package (Chicago, 
Illinois, USA). Outcome measures were all indicators as described above. 
All indicators (all dichotomous outcomes) were included in a two-level 
logistic regression, taking into account the hierarchical structure of 
our study (patients nested within practices). Multilevel analysis was 
performed in the SAS 9.2 package with procedure PROC GLIMMIX. We 
performed a logistic model (with a binomial distribution and a logit link 
function) with a random intercept and all other variables (group, age 
and sex) fixed. Only patient variables were included in the model. In the 
multilevel regression analysis four groups were taken into account. The 
first group, the reference group, consisted of patients with CVD only, the 
second group were patients with CVD and COPD, the third group were 
patients with CVD and DM, the fourth group were patients with CVD, DM 
and COPD.
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Indicators 
shared across 
CVD/DM
Process Systolic blood 
pressure 
measured
755 (70.2) 90 (71.4) 329 
(90.9)
48 (96) 1222 
(75.9)
Outcome Systolic blood 
pressure <140 
mmHg
464 (61.5) 50 (55.6) 196 
(59.6)
26 (54.2) 736 
(60.2)
Process LDL cholesterol 
measured
446 (41.4) 54 (42.9) 267 
(73.8)
38 (76) 805 
(50)
Outcome LDL cholesterol 
<2.5 mmol/l
170 (38.1) 20 (37.0) 166 
(62.2)
21 (55.3) 377 
(46.8)
Process Advice physical 
activity
150 (13.9) 19 (15.1) 142 
(39.2)
16 (32) 327 
(20.3)
Process Diet control 137 (12.7) 17 (13.5) 216 
(59.7)
28 (56) 398 
(24.7)
Process Counseling 
about diet
158 (14.7) 14 (11.1) 197 
(54.4)
26 (52) 395 
(24.5)
Process Registration of 
alcohol intake
245 (22.8) 31 (24.6) 183 
(50.6)
27 (54) 486 
(30.2)
Indicators CVD 
only
Process Patients with 
LDL cholesterol 
>--2.5 mmol/l 
with statin 
prescription 
170 (61.6) 23 (67.6) 73 (72.3) 7 (41.2) 273 
(63.8)
Process Waist 
circumference 
measured
103 (9.6) 12 (9.5) 87 (24) 16 (32) 218 
(13.7)
Process Prescription 
antiplatelet 
drugs
896 
(83.6)
101 (80.2) 325 
(89.8)
44 (88) 1366 
(84.8)
Process Fasting glucose 
measured
644 (59.9) 76 (60.3) 328 
(90.6)
46 (92) 1094 
(68)
Process Comprehensive 
risk assessment 
*
27 (2.5) 2 (1.6) 41 (11.3) 7 (14) 77 
(4.8)
*  positive score when there is a record of: blood pressure, BMI, waist circumference, fasting 
glucose measurement, LDL cholesterol measurement, smoking behavior, alcohol intake, advice 
and control of diet and physical exercise in the past 12 months.
Table 2. Type of cardiovascular disease
ICPC CVD 
(%)
CVD+
COPD 
(%)
CVD+DM 
(%)
CVD+DM+
COPD (%)
Total 
scores (%)
Angina Pectoris K74 401 
(37.5)
51 
(40.8)
123 
(34.5)
23 
(46)
598 
(37.4)
Myocardial Infarction K75 324 
(30.3)
44 
(35.2)
98 
(27.5)
15 
(30)
481 
(30)
Other chronic  
ischemic heart dis-
eases
K76 108 
(10.1)
8 
(6.4)
47 
(13.2)
6 
(12)
169 
(10.6)
TIA K89 175 
(16.4)
17 
(13.6)
48 
(13.4)
2 
(4)
242 
(15.1)
Ischemic stroke K90.3 77 
(7.2)
4 
(3.2)
23 
(6.4)
3 
(6)
107 
(6.7)
Peripheral arterial 
disease, claudicatio 
intermittens
K92.1 104 
(9.7)
17 
(13.6)
68 
(19)
9 
(18)
198 
(12.4)
Aneurysma Aortae K99.1 56 
(5.2)
13 
(10.4)
10 
(2.8)
3 
(6)
82 
(5.1)
TIA = transient ischaemic attack.
Table 3.   Record of indicators for cardiovascular risk management in electronic  
medical records 
Type of 
indicator
CVD (%) CVD+COPD 
(%) 
CVD+DM
(%)
CVD+DM+
COPD (%) 
Total  
(%)
Indicators 
commonly 
shared across 
CVD/COPD/DM
Process Smoking status 359 (33.4) 62 (49.2) 212 (58.6) 35 (70) 668 
(41.5)
Outcome Patient is a 
smoker
110 (30.6) 36 (58.1) 43 (20.2) 18 (51.4) 207 
(41.6)
Process Stop smoking 
advice 
 60 (54.5) 22 (61.1) 26 (60.5) 12 (66.7) 119 
(54.8)
Process BMI measured 191 (17.8) 29 (23) 189 (52.2) 29 (58) 438 
(27.2)
Outcome BMI <25 kg/m² 38 (19.9) 6 (20.7) 26 (13.8) 4 (13.8) 74 
(16.9)
Process Influenza 
vaccination
784 (72.9) 106 (84.1) 301 (83.1) 39 (78) 1230 
(76.3)
Process Exercise control 209 (19.4) 25 (19.8) 191 (52.8) 25 (50) 450 
(27.9)
Type of 
indicator
CVD (%) CVD+COPD 
(%) 
CVD+DM
(%)
CVD+DM+
COPD (%) 
Total  
(%)
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4
 Indicator scores
 Indicators shared across conditions
Of the seven indicators that are relevant for each of the conditions, 
three to five yielded higher scores in patients with DM and/or COPD 
in addition to CVD (Table 4). Smoking status was better registered for 
all patients with comorbidity compared with patients with CVD only. In 
the group of patients with CVD and COPD and in patients with CVD, 
DM and COPD more smokers were present (odds ratio (OR)=4.13; 95% 
confidence interval (CI) 2.26-7.54; OR=2.61; 95% CI 1.23-5.54). Patients 
with CVD and DM and patients with CVD, DM and COPD had more 
recordings of BMI (OR=7.09; 95% CI 5.24-9.60; OR=7.97; 95% CI 4.16-
15.30) and control of exercise (OR=6.26; 95% CI 4.69-8.35; OR=5.72; 95% 
CI 3.06-10.68). More patients with CVD and DM and patients with CVD 
and COPD received influenza vaccinations (OR=1.84; 95% CI 1.30-2.59; 
OR=1.99; 95% CI 1.15-3.44) than patients with CVD only. No differences 
between groups were identified regarding the process measurement 
‘stop smoking advice’.
 More patients with CVD and DM had a BMI over 25 kg/m2 
(OR=2.05; 95% CI 1.15-3.65). On the practice level, intra-class coefficient 
(ICC) scores ranged from 0.038 for ‘patient is a smoker’ to 0.261 for 
‘BMI measured’.
 Indicators shared across CVD and DM
Of eight indicators shared across CVD and DM all but one (systolic 
blood pressure <140 mmHg) yielded higher scores in patients with 
DM (with or without COPD). In patients with CVD and COPD, indicator 
scores were the same as in patients with CVD only. Patients with 
CVD and DM and patients with CVD, DM and COPD were more likely 
to have blood pressure measurement (OR=4.12; 95% CI 2.80-6.06; 
OR=10.56; 95% CI 2.53-44.09), LDL-cholesterol measurement (OR=4.03; 
95% CI 3.08-5.28; OR=4.82; 95% CI 2.47-9.39), advice (OR=8.26; 95% CI 
6.20-11.00; OR=7.32; 95% CI 3.96-13.56) and control (OR=12.04; 95% CI 
8.94-16.21; OR=10.92; 95% CI 5.86-20.35) on diet, advice about physical 
activity (OR=4.38; 95% CI, 3.29-5.84; OR=3.21; 95% CI 1.68-6.14) and 
registration of alcohol intake (OR=4.18; 95% CI 3.17-5.51; OR=5.32; 95% CI 
2.85-9.93) compared with patients with CVD only. No differences were 
found between groups regarding systolic blood pressure ≤140 mmHg. 
Patients with CVD and DM and patients with CVD, DM and COPD were 
less likely to have a LDL-cholesterol level >--2.5 mmol/l (OR=0.36; 95% CI 
0.26-0.50; OR=0.49; 95% CI 0.25-0.96). On the practice level, ICC scores 
ranged from 0.021 for ‘systolic blood pressure <140 mmHg’ to 0.159 for 
‘registration of alcohol intake’.
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DISCUSSION
In line with our expectations, we found evidence that comorbidity was 
associated with more comprehensive cardiovascular risk management. 
However, this only applied to DM and not to COPD. This trend applied 
to indicators that were shared across the conditions, but remarkably 
also to indicators that were only related to CVD. This study adds to the 
cumulating research evidence that the presence of DM is associated with 
better preventive treatment for other diseases.17,18,24 Our findings should  
be interpreted in the context of the sample of primary care practices, 
which may be the early majority with respect to quality improvement as 
they had voluntarily joined an accreditation program.
 A plausible explanation for our findings seems to be that disease 
management programs for diabetes care have been well established on 
a nationwide basis in Dutch primary care in recent years. Evidence found 
that these programs have positive effects on the quality of care.25 We 
suggest that similar programs might explain similar findings from studies 
in other countries.17,24 In the Netherlands, disease management programs 
are governed by so-called ‘care groups’. This is an organization of 50 
to 100 primary care practices which is responsible for the coordination 
and provision of contracted care in a particular region. Since 2010 
all care groups in the Netherlands have a bundled payment contract 
for the diabetes care program; so 100% national coverage has been 
achieved.26 So far, few care groups have focused on COPD or CVD in the 
Netherlands. The impact of disease management is based on a number of 
mechanisms. One component of care in disease management programs is 
that clinical activities and clinical parameters are registered in electronic 
medical records, which use this information to provide computer 
generated reminders. This implies that more such activities can be found 
in a chart audit. 
 DM and CVD are concordant conditions while they represent 
parts of the same pathophysiological risk profile and are more likely 
to be the focus of the same disease management plan. Discordant 
conditions, in contrast, are not directly related in management or 
pathogenesis.27 COPD and CVD are less concordant conditions than 
DM and CVD.19,28 Our findings illustrate that the management of DM and 
CVD has more in common than the management of COPD and CVD. This 
could even apply to the indicators concerning CVD only. For instance, 
better prescription of antiplatelet drugs might be explained by the fact 
that the recommendation for antiplatelet drugs for diabetes patients 
with established CVD is mentioned in the diabetes guideline. This is not 
recommended for diabetes patients without established CVD.29,30 
 Indicators for CVD only
Of five indicators that are only relevant for CVD, three to five yielded 
higher scores in patients with DM (with or without COPD). No such 
differences were found in patients with CVD and COPD. Patients with 
CVD and DM and patients with CVD, DM and COPD were more likely 
to have a record of waist circumference (OR=4.83; 95% CI 3.33-7.02; 
OR=6.07; 95% CI 2.93-12.56), fasting glucose measurement (OR=7.40; 
95% CI 4.99-10.98; OR=9.41; 95% CI 3.30-26.84) and a comprehensive 
risk assessment (OR=6.99; 95% CI 3.98-12.27; OR=7.15; 95% CI 2.56-
20.02) than patients with CVD only. Antiplatelet drugs were more 
often prescribed to patients with CVD and DM (OR=1.72; 95% CI 1.17-
2.54) than to patients with CVD only. Patients with CVD and DM with 
LDL-cholesterol levels above 2.5 mmol/l were more likely to receive a 
statin (OR=2.13; 95% CI 1.24-3.67). Increasing patient age was positively 
correlated with prescribing antiplatelet drugs (OR=1.03; 95% CI 1.01-
1.04) and receiving influenza vaccination (OR=1.05; 95% CI 1.04-1.06). 
Recording of blood pressure measurement was positively correlated 
with increasing age as well (OR=1.02; 95% CI 1.01-1.03); however, with 
increasing age blood pressure targets were less often achieved. 
Increasing age was negatively correlated with a record of smoking 
behaviour (OR=0.97; 95% CI 0.96-0.98), advice on physical activity 
(OR=0.99; 95% CI 0.97-1.00), dietary advice (OR=0.98; 95% CI 0.97-0.99) 
and control (OR=0.99; 95% CI 0.98-1.00), record of waist circumference 
(OR=0.98; 95% CI 0.96-0.99) and statin prescription for patients with 
an LDL-cholesterol level >--2.5 mmol/l (OR=0.96; 95% CI 0.94-0.98). With 
increasing age, more patients had a BMI below 25 kg/m2 (OR=0.94; 
95% CI 0.91-0.96) and of the patients whose smoking behaviour was 
registered, less patients smoked (OR=0.95; 95% CI 0.93-0.96). On 
the practice level, ICC scores ranged from 0.055 for ‘prescription of 
antiplatelet drugs’ to 0.372 for ‘comprehensive risk assessment’. Female 
gender was positively correlated with prescription of antiplatelet 
drugs (OR=1.99; 95% CI 1.49-2.64) and the registration of alcohol intake 
(OR=1.49; 95% CI 1.16-1.90).
 No differences regarding gender were found for the remaining 
indicators.
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specific improvement plan could not participate in the study while 
participating practices were randomized to a group which started with 
an improvement plan on cardiovascular risk management or to a group 
that did not. This also accounted for practices that participated in 
ongoing improvement programs due to regional developments in disease 
management, which makes the assessment of the true participation 
rate of practices in this study unattainable. The sampling of patients 
in this study was based on ICPC codes allocated to patients by family 
physicians. However, some cardiovascular diseases, for example TIA, 
are more difficult to diagnose, while diagnosis is made based on the 
anamnesis.36 This does not seem to be a large problem as 12% of the 
patients had only TIA as cardiovascular diagnosis. In this study we only 
assessed COPD and DM as comorbidities of influence on preventive 
cardiovascular care while these are common in patients with established 
CVD.37,38 Furthermore we only considered patient characteristics in this 
study while practice characteristics could also be of influence on the 
outcomes. Further research should consider the influence of other 
concordant and discordant comorbidities and practice characteristics on 
cardiovascular risk management.
 At the time of the study, disease management programs for 
DM were well established in primary care practices, unlike disease 
management programs for CVD and COPD. The results of this study 
illustrate the influence of these programs on the quality of care. Currently 
ongoing initiatives aim to implement disease management programs 
for CVD and COPD in primary care. It would be relevant to repeat this 
study when disease management programs for CVD and COPD are 
well established. As many components of preventive care for patients 
with CVD and DM are shared, it may be efficient to integrate these 
components in a comprehensive care program. This would reduce the 
burden for both caregivers and patients and open up time for other 
important clinical tasks.
A third determinant of our findings is that CVD patients visiting the 
practice because of their structured DM care are being considered 
not just DM related but more broadly as cardiometabolic risk, which 
can be seen as an integral primary care approach. For instance, waist 
circumference and risk for developing DM are related.29 Although not 
an indicator for DM in the Dutch national accreditation program (NHG-
Praktijkaccreditering®), in many DM care groups in the Netherlands 
waist circumference is measured routinely. The same applies to fasting 
glucose measurement, which is not defined as a quality indicator 
for DM, but is used to diagnose DM and to monitor glucose levels in 
patients with DM.29 When considering comprehensive risk assessment, 
all items are recommended preventive care in diabetes patients.
 While most performance indicators yielded higher scores in 
patients with comorbidity, no differences were found between patient 
groups for ‘systolic blood pressure ≤140 mmHg’, which is a proxy health 
outcome. More smokers were represented in the group of patients with 
CVD and COPD and patients with CVD, DM and COPD. While smoking is 
the most important cause of COPD, most COPD patients smoke or have 
a history of smoking.31 The decreasing numbers of patients who smoke 
with increasing age could be the consequence of the fatal effects of 
smoking.
 For the proxy outcome indicator ‘LDL cholesterol <2.5 mmol/l’ 
targets were more often attained in patients with CVD and DM and 
patients with CVD, DM and COPD than in patients with CVD only. 
Previous research shows that many patients with CVD do not attain 
therapeutic targets set in guidelines for CVD.6,32,33 Higher target 
attainment for LDL-cholesterol levels in patients with CVD and DM may 
be related to better prescription of statins in this group of patients, 
which may be related to the sample of primary care practices included 
in this study.
 Overall, the results of this study showed room for improvement 
in preventive care in patients with established CVD, even in this 
sample of primary care practices. This is in line with results from 
other studies.6,7,34 Improvements can be made especially on lifestyle 
counseling in patients with established CVD with or without COPD, while 
results on these items are disappointing. Primary care has an important 
role to play in effective health promotion and disease prevention.35
This study had some limitations. Primary care practices participating in 
this study were enrolled in a national implementation and accreditation 
program. It seems likely that they were better organized and staffed 
than average. Primary care practices with a clear preference for a 
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Chapter 6
Shifting cardiovascular 
care to nurses results in 
structured chronic care
E. Nouwens
J. van Lieshout
P. van den Hombergh
M. Laurant
M. Wensing
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ABSTRACT
 Objective
To explore nurse involvement in cardiovascular risk management (CVRM) 
in primary care and how this involvement was associated with the degree 
of structured chronic illness care.
 Study design
A cross-sectional observational study in seven European countries.
 Methods
Five aspects of nurse involvement in CVRM and 35 specific components 
of structured chronic illness care were documented in 202 primary care 
practices from Austria, Belgium, Germany, the Netherlands, Slovenia, 
Spain and Switzerland. An overall measure for chronic care management 
with a range from 0 to 5 was constructed derived from elements of the 
Chronic Care Model (CCM). Random coefficient regression modelling was 
used to explore associations.
 Results
A majority of practices involved nurses for organization of CVRM in 
administrative tasks (82.2 %), risk factor monitoring (78.5%) and patient 
education (57.1%). Fewer practices involved nurses in defining protocol 
and the organization for CVRM (45%) or diagnosis and treatment (34.6%). 
With an increasing number of tasks taken up by nurses, overall median 
adoption of CCM increased from 2.7 (95% CI 1.5-3.6) to 4.2 (95% CI 3.8-4.1). 
When the number of nurse tasks increased by one, the adoption of CCM 
increased with 0.13 (p<0.05; 95% CI 0.03-0.22). Some practices with low 
nurse involvement had high adoption of CCM, while variation of adoption 
of CCM across practices reduced substantially with an increasing level of 
nurse involvement.
 Conclusions
Nurses were involved in the delivery of CVRM at varying degree. Higher 
involvement of nurses was associated with higher degree of structured 
chronic illness care with less variation. 
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Box 1. Elements of the Chronic Care Model 8
Community resources and policies
- Provider organizations are linked to community-based resources, for example, 
exercise programmes, self-
- help groups, and senior centers. 
Healthcare Organization
- Chronic care is seen as a priority, otherwise innovation will not take place.
- Reimbursement of the healthcare organization has a major impact on chronic care 
improvements.
- Chronic care quality needs to be rewarded by purchasers and insurers to sustain 
improvements.
Self-management support
- Patients themselves become the principal caregivers. They learn to manage their 
illnesses and they control lifestyle issues themselves.
- Self-management support involves collaboratively helping patients and their 
families acquire the skills and confidence to manage their chronic illness, providing 
self-management tools, and routinely assessing problems and accomplishments.
Delivery system design
- Planned management of chronic conditions is separated from acute care.
- Non-physicians support patient self-management, arrange for routine periodic 
tasks, and ensure appropriate follow-up.
- Planned visits are an important feature of practice redesign.
Decision support
-  Evidence-based clinical practice guidelines provide standards for optimal chronic 
care and should be integrated into daily practice through reminders.
- Specialist expertise is available and does not always require full specialty referral.
- Guidelines are reinforced by educational sessions for practice teams.
Clinical information systems
- Registries, a central feature of the chronic care model, are lists of all patients
        with a particular chronic condition on an organization’s or physician’s panel.
- Reminder systems help primary care teams comply with practice guidelines.
- The system provides feedback to physicians to show how each professional is 
performing on chronic illness measures.
- Registries are used to plan individual patient care and the population-based care.
INTRODUCTION
In primary care across the world clinical tasks have been shifted from 
physicians to nurses at varying degree. Re-allocation of such tasks from 
family physicians (FP’s) to nurses has been found to be associated with 
improved, or at least equivalent, quality and outcomes of chronic disease 
care.1-5 The degree of re-allocation of tasks varies across countries 
as a result of policy and organizational and legal factors.6 In addition, 
the absence of robust evidence on the impact in natural settings (as 
opposed to controlled trials and demonstration projects) is an issue in 
re-allocation of clinical tasks to non-physicians. 
 Better structuring of (primary) health care for patients with 
chronic diseases is expected to result in better outcomes for patients 
and societies,7 if it integrates all domains (Box 1) specified by the 
Chronic Care Model (CCM).8 Allocation of tasks to nurses may contribute 
to implementation of structured chronic care by increasing capacity 
and competence in specific areas, such as coordination and patient 
education, compared to healthcare delivered by physicians only.2, 9 
 Cardiovascular disease (CVD) remains an important cause of 
death and disability in the world. Many activities have been developed 
to prevent CVD in public health and in primary care.10, 11 Substitution of 
tasks from physicians to nurses can be applied in cardiovascular risk 
management (CVRM).12, 13 Nurse managed disease management programs 
concerning CVD improved lifestyle, risk factor control, use of medications 
and quality of life.13 These positive effects are based on the clinical 
knowledge and skills of nurses,14 but potentially also on their contribution 
to teamwork and practice organization.
 This study aimed to explore the potential contribution of task 
allocation to nurses in primary care on the implementation of structured 
chronic care in primary care for patients with cardiovascular conditions. 
The study focused on primary care practices in a number of countries 
in order to get robust estimates in real clinical practice settings across 
various health care systems.
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Practice size was based on patient list size when available, otherwise 
on yearly attending patient numbers. While our definition of ‘nurse’ in 
this study included nurse practitioners and (advanced) practice nurses, 
results of these professionals on the five specific CVRM tasks were 
combined.
Box 2.  Items of adoption of Chronic Care Model based on five domains of  
Chronic Care Model
Health care organization 
1.     Does the practice have a procedure for the management of patient information in 
relation to detailed examination results and the documentation of measures that 
were taken (for example, blood examinations)?
2.     Does the practice have a procedure for the management of patient information in 
relation to the review of detailed examination results by the doctor (in terms of outgoing 
needs)?
3.     Does the practice use a system for reviewing medication prescribed to individual 
patients on a regular basis?
4.     Does the practice produce an annual report?
5.     Does the practice produce a quality report?
6.     Has the practice undertaken at least one clinical audit in the last 12 months?
7.     Does the practice have a critical incident register?
Delivery system design
      Practice-led contact for patient groups
1.    Does the practice use a system for recalling patients with cardiovascular diseases?
2.    Does the practice use a system for recalling patients with diabetes?
3.    Does the practice use a system for recalling patients with asthma/chronic obstructive 
pulmonary disease?
4.    Does the practice use a system for recalling patients with hypertension?
     Practice-led contact for prevention
1.    Does the practice use a system for recalling populations at risk for preventive care 
regarding cardiovascular diseases?
2.    Does the practice use a system for recalling populations at risk for preventive care 
regarding influenza?
3.    Does the practice use a system for recalling populations at risk for preventive care 
regarding cervical screening?
4.    Does the practice use a system for recalling populations at risk for preventive care 
regarding breast cancer screening?
     Attendance rates for preventive activities
1.    Does the practice have the attendance rate for cervical screening?
2.    Does the practice have the attendance rate for influenza vaccination?
3.    Does the practice have the attendance rate for breast cancer screening?
     Preventive procedures
1.    Does the practice have a procedure for prevention of pressure sores?
2.    Does the practice have a procedure for prevention of osteoporosis?
3.    Does the practice have a procedure for using folic acid by women who are pregnant  
or want to get pregnant?
4.    Does the practice have a procedure for smoking cessation (for example, with the  
minimal intervention strategy)?
METHODS
 Design and study population
This study was based on secondary analysis of data from the European 
Practice Assessment of Cardiovascular risk management project (EPA 
Cardio project), an observational study on CVRM in 315 primary care 
practices in 10 countries in 2008-2009.15 Briefly, EPA Cardio focused on 
coronary heart disease patients, high risk patients, and healthy adults. 
Multiple measurement instruments were used, including chart reviews, 
patient surveys, and validated questionnaires on practice characteristics16 
completed by FP’s in the practices. For the present study, we included 
data from 202 practices in 7 countries: Austria, Belgium, Germany, the 
Netherlands, Slovenia, Spain and Switzerland. Data from the remaining 
three countries were excluded from this analysis because the required 
data on involvement on tasks concerning CVRM was missing.
 Measures
For this study we used data from the FP questionnaires. Specifically, data 
on practice characteristics (practice size, full time equivalent FP, full time 
equivalent nurse) and diversity of tasks of FP’s and nurses. In this paper, 
‘nurses’ included nurse practitioners and (advanced) practice nurses. The 
nurses included in this study all performed clinical tasks in primary care 
practices. Nurse and FP involvement on five specific tasks concerning 
CVRM was measured; 1. administrative tasks, recalls and recording 
(enrolling and selecting patients for periodic checkups, managing 
patient records, archiving laboratory results and mail); 2. monitoring risk 
factors (periodic monitoring of blood pressure, smoking status, weight, 
cholesterol etc); 3. patient education and counselling (counselling and 
control of diet and physical activity); 4. defining protocol and organization 
of cardiovascular care (drafting protocols based on guidelines for 
CVD care, coordination of CVD consulting hours); and 5. diagnosis, risk 
assessment and medical treatment (determining risk profile, periodic 
check up for CVD patients, discussing medication). These five tasks 
are based on a list of tasks of practice nurses17 modified by the EPA 
core group on the basis of consensus. These items were measured on 
a dichotomous answering scale (yes/no). In addition, for each practice 
adoption of CCM was calculated using 35 items (Box 2).18 This is a score 
based on the five practice related domains derived from the CCM19:  
1. health care organization (7 items); 2. delivery system design (15 items);  
3. decision support (3 items); 4. clinical information systems (6 items); 
and 5. self-management support (4 items). This score was measured on a 
scale of 0 to 5 with equal weight for each domain. A higher score means 
more structured chronic illness care.
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94.1% of practices employed a nurse, Switzerland 85.7% and Belgium 
33.3%. Overall, 89.6% (N=177) of practices employed a nurse. The number 
of FP tasks varied from 3.9 in Slovenia to 4.9 in Spain. Number of nurse 
tasks varied from 1.5 in Belgium to 4.8 in Spain. The nurse/FP ratio was 
1.4 (SD 0.7) on average with the least nurses per FP in Belgium (mean 
0.4, SD 0.7) and the most in Germany (mean 1.9, SD 1.0). The adoption 
of CCM was highest for practices in Spain and lowest for practices in 
Switzerland. 
Table 1. Characteristics of participating practices (N=202)
Practice 
size in 
number of 
patients 
Nurse/
Family 
physician 
ratio
Practices 
with   
nurse
Number 
of family 
physician 
tasks
(range 0-5)
Number of 
nurse tasks 
(range 0-5)
Adoption 
of Chronic 
Care Model 
(range 0-5)
Austria 
(n=31)
2943 
(1307)
1.8 (0.5) 100% 4.5 (0.8) 1.9 (0.6) 2.8 (0.6) 
Belgium 
(n=24)
2884 
(2192)
0.4 (0.7) 33.3% 4.7 (0.6) 1.5 (1.8) 3.3 (0.6)
Germany 
(n=21)
4060 
(1772)
1.9 (1.0) 100% 4.2 (1.1) 3.6 (1.1) 3.2 (0.6)
Netherlands 
(n=35)
3169 
(1200)
1.2 (0.6) 100% 4.1 (1.1) 3.9 (1.1) 3.7 (0.5)
Slovenia 
(n=34)
2075  
(813)
1.4 (0.6) 94.1% 3.9 (0.7) 2.9 (1.1) 2.8 (0.8)
Spain (n=36) 23761 (11619)
1.4 (0.3) 100% 4.9 (0.5) 4.8 (0.5) 4.2 (0.2)
Switzerland 
(n=21)
3514 
(2462)
1.4 (0.6) 85.7% 4.2 (0.7) 1.7 (1.3) 2.3 (0.7)
Total 
(n=202)
6906 
(9695)
1.4 (0.7) 89.6% 4.4 (0.9) 3.2 (1.5) 3.3 (0.8)
Mean figures per practice with standard deviation between brackets.
Nurse involvement
Considering nurse involvement in specific tasks, table 2 shows nurses 
were mostly involved in CVRM-related administrative tasks, recalls and 
recording (82.2%) and least involved in diagnosis, risk assessment and 
medical treatment (34.6%). FP involvement was highest in diagnosis, risk 
assessment and medical treatment (99%) and lowest in administrative 
tasks, recalls and recording (68%). For administrative tasks, recalls and 
recording; monitoring risk factors; and patient education and counselling, 
most percentages of nurse involvement were above 50%. 
Decision support
1.    Do the practice doctors have direct access to medical guidelines (either on paper  
or electronic) in their treatment rooms?
2.    Do the practice doctors have direct access to (peer-reviewed) medical journals  
(either on paper or electronic)?
3.    Do the practice doctors have direct access to literature data banks such as Medline/
Pubmed or Cochrane?
Clinical information systems
1.    Do you have internet access?
2.    Do you have e-mail access in the practice?
3.    Are the computers with internet access outfitted with anti-virus software?
4.    Is the access to the practice computers protected, in that a user name and password 
have to be entered?
5.    Does the practice use a computer-supported patient file system?
6.    Is the computer used for creating medication prescriptions?
Self-management support
1.    Are there information leaflets about cardiovascular disease (for example, coronary  
heart disease [CHD], stroke, hypertension, and stop smoking) available at the practice for 
patients to take home or read in the practice?
2.    Does the practice have an up-to-date directory of prevention activities/organizations 
available locally (for example, gyms, walking group, and weight-watchers)?
3.    Do you offer regularly written information on lifestyle?
4.    Do you regularly offer advice about websites for education on health risks or healthy 
lifestyle?
 Data-analysis
Data analysis consisted of both descriptive and analytical methods. 
Random coefficient linear regression modelling was used to explore 
the effect of nurse involvement on structured illness care (adoption of 
CCM). The influence of number of FP tasks and nurse tasks, nurse/FP 
ratio and practice size on the adoption of CCM was also explored in the 
regression model. Two-level models were specified with practices nested 
in countries. Data analysis was performed using the SPSS 16.0 software 
package (Chicago, Illinois, USA). 
RESULTS
 Study population
Table 1 shows practice characteristics of practices in the seven countries. 
The number of included primary care practices ranged from 21 in 
Switzerland and Germany to 36 in Spain. Spain had the largest practice 
size and Slovenia had the smallest practice size. In Austria, Germany, the 
Netherlands and Spain, all practices had a nurse employed. In Slovenia 
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For the tasks defining protocol and organization of cardiovascular 
care and diagnosis, risk assessment and medical treatment most 
percentages of nurse involvement were below 50%. Considerable 
variation between countries was found on involvement in specific tasks 
of both nurses and FP’s.
 Relation nurse involvement with structured 
 chronic illness care
Figure 1 illustrates the number of nurse tasks related to the adoption  
of CCM. When more tasks were allocated to nurses the mean adoption 
of CCM was higher. 
Figure 1. Adoption of Chronic Care Model related to the number of nurse tasks 
*,  extreme value; о, outlier; end of the upper tail, 95th percentile value; end of the lower tail,  
5th percentile value; upper limit of the box, 75th percentile value; lower limit of the box,  
25th percentile value; horizontal line through box, median value. 
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for the adoption of CCM. This variable was normally distributed. Results 
show that the number of nurse tasks had a positive effect on the adoption 
of CCM. When the number of nurse tasks increased with one, the adoption 
of CCM increased with 0.13 (p<0.05; 95% CI 0.03-0.22). The regression 
model used in this analysis explained 19% of the variance on the adoption 
of CCM.
Table 4. Impact of nurse and physician involvement on adoption of Chronic Care Model
Adoption of Chronic Care Model
Ba 95% CI
Fixed Effects
Number of family physician tasks -0.06 -0.17 0.05
Number of nurse tasks 0.13b 0.03 0.22
Nurse/family physician ratio 0.12 -0.03 0.27
Random Effects
Level-two variance (country) 0.26 (S.E. 0.04) 0.07 0.95
Level-one variance (practice) 0.34 (S.E. 0.17) 0.27 0.43
a   unstandardized b-weight
b   p<0.05
DISCUSSION
Nurses were involved in the delivery of CVRM in this sample of European 
primary care practices, but at varying degree. In a vast majority of 
practices nurses were involved in administrative tasks, recalls and 
recording and they were least involved in diagnosis, risk assessment 
and medical treatment of cardiovascular care. Involvement of nurses in 
more aspects of CVRM was associated with better structured chronic 
illness care, but some practices with limited nurse involvement, related to 
administrative tasks only, also provided well structured chronic illness care. 
 The variation of nurse involvement in the delivery of CVRM 
in this study may have several determinants. Re-allocation of tasks 
concerning CVRM could differ between types of nurses although previous 
research has shown that mid-level providers, with different educational 
backgrounds, perform similar tasks.20 Level of training could influence 
the outcomes, as well as level of experience of nurses,21 which were not 
Table 3 shows that the mean adoption of CCM in practices without nurse 
involvement was 2.6 (SD 1.3, 95% CI 1.5-3.6) and in practices with nurse 
involvement on all tasks the mean adoption of CCM was 4.0 (SD 0.5, 
95% CI 3.8-4.1). Practices without nurse involvement on CVRM related 
tasks showed a minimum adoption of CCM of 0.5 and a maximum 
adoption of CCM of 4.4. For practices with nurse involvement on all 
CVRM related tasks this was 2.4 and 4.7 respectively. Of nurses with 
only one CVRM related task the vast majority had administrative tasks 
(Appendix 1). Nurses with two tasks mostly had administrative tasks 
combined with monitoring risk factors. When nurses had three or four 
tasks, combination of tasks varied more. The mean adoption of CCM was 
lowest for administrative tasks (3.3, SD 0.9)  and highest for diagnosis, 
risk assessment and medical treatment (mean 4.0, SD 0.7). For further 
explanation see Appendix 1.
 Visual inspection of figure 1 suggests that with increasing 
involvement of nurses, the variation on the adoption of CCM decreased. 
Low scores on the adoption of CCM were absent when nurses had more 
tasks. However, some practices without nurse involvement had high 
adoption of CCM. 
Table 3.  Association between number of nurse tasks and adoption  
of Chronic Care Model
Adoption of Chronic Care Model
Number of nurse tasks (N) min max Median Mean (SD) 95% CI
0 (8) 0.5 4.4 2.7 2.6 (1.3) 1.5-3.6
1 (15) 1.1 4.3 2.3 2.5 (0.8) 2.0-2.9
2 (42) 1.4 4.7 2.9 2.9 (0.7) 2.7-3.1
3 (30) 1.3 4.3 3.0 3.1 (0.8) 2.8-3.4
4 (31) 1.3 4.7 3.4 3.4 (0.7) 3.2-3.7
5 (51) 2.4 4.7 4.2 4.0 (0.5) 3.8-4.1
Adoption of Chronic Care Model score 0 to 5, higher score equals more chronic care 
management; N is number of family practices
Table 4 shows the results of the regression model. Number of tasks of 
FP and nurse, nurse/FP ratio and practice size were taken into account. 
Practice size showed no effect on the adoption of CCM (P=0.19). In the 
analysis 155 cases were included. The degree of skewness was explored 
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participating practices are better organized concerning cardiovascular 
care management. Participating countries have differences in the health 
care organization which may have caused bias as well as differences in 
interpretation of the questionnaire. In this study, only tasks concerning 
CVRM were considered. An inventory of tasks considering other chronic 
conditions such as diabetes mellitus or COPD could have changed 
the picture.
 The effect of nurse involvement related to CVRM on the 
organization of chronic illness care is positive but modest. Tasks of 
nurses on CVRM are predominantly administrative or contain the 
monitoring of risk factors and are less focused on organizational tasks. 
A meta analyses related to diabetes care shows that team change is a 
key ingredient for improving chronic disease management on patient 
outcomes, providing larger reductions in HbA1c values than other 
quality improvement strategies evaluated.27 Furthermore, extending the 
role of nurses in the organization of chronic illness care could result 
in cost-effectiveness28 and higher patient satisfaction.29 Another study 
investigating the clinical effectiveness of practice nurses acting as 
substitutes for FP’s in CVRM found that practice nurses achieved equal 
or better results than FP’s.30 When nurses would be more responsible  
for the organization of chronic illness care in general on top of the tasks 
that are directly patient related, the adoption of CCM could generally 
become higher. 
 This study quantified the role of nurses in the organization of 
CVRM in primary care practices across Europe. More nurse involvement 
in CVRM was associated with better structured chronic illness care in 
primary health care. To optimally utilize the added value of nurses in 
primary care, nurses should be engaged in all aspects of CVRM related 
care, provided that their level of education is adequate. In general more 
responsibility for the organization of chronic illness care might eventuate 
in higher job satisfaction for all staff members. 
 While our study has an observational design it is not possible 
to determine effectiveness regarding patient outcomes. Nevertheless 
our results are of importance for decision makers because of two main 
reasons: firstly, the study is focused on a natural setting (rather than a 
controlled trial or demonstration project) and secondly, the inclusion 
of various health systems provides a degree of control of confounding 
contextual factors, thus contributing to more robust results. Our main 
finding is that the level of nurse involvement in CVRM matters for 
implementation of structured chronic care rather than the mere 
presence of a nurse.
taken into account in this study. The definition of nurse which is applied 
in this study could also be of influence on the outcomes. ‘Nurses’ in this 
study included nurse practitioners and (advanced) practice nurses. Nurses 
responsibility for chronic disease management may vary from practice to 
practice, dependent on the willingness of FP’s to delegate tasks.22 Of the 
practices in our study with low nurse involvement (less than 2 tasks on 
CVRM; N=23) and with high adoption of CCM (>3.5) none employed other 
nonclinical staff members performing administrative tasks or other CVRM-
related tasks. Overall, nurse involvement in CVRM was mixed, but limited in 
the sample of practices. 
 The results of our study showed that well structured chronic care 
is possible in practices with little nurse involvement. With maximum nurse 
involvement there is on average better chronic care with less variation in 
the adoption of CCM. Successfully organizing chronic illness care may well 
be dependent on elements of care not accounted for in this study. Practice 
characteristics like team size and workload could affect the organization 
of chronic illness care.18 Furthermore, it could also be that better organized 
practices are more likely to employ and retain nurses to manage chronic 
patients as the working climate for nurses is expected to be better in 
these practices thus providing higher job satisfaction for nurses. Practice 
size could be of influence on the organization of chronic illness care while 
evidence shows that in larger patient populations more clinical tasks are 
substituted by other health care providers.23 However, our study suggests 
practice size has no significant influence on the adoption of CCM. 
 Countries with strong primary care systems are expected to 
manage chronic conditions more effectively.24, 25 Initiatives for improving 
the management of chronic conditions are in different stages of 
development in the participating countries. Austria and Belgium are in an 
early stage of development.24 Furthermore, in some countries initiatives 
to improve management of chronic conditions are introduced nationally 
(for instance in Germany), in other countries (as in the Netherlands) this is 
handled through local or regional projects. This may imply that the location 
of practices entered in this study can be of influence. All German practices 
included in this study employed nurses with clinical tasks (monitoring 
risk factors, for example periodic monitoring of blood pressure, smoking 
status, weight, cholesterol etc). This indicates selection bias while 
previous research indicates that German nurses were mainly involved in 
administrative tasks like arranging appointments for patients, answering 
telephone calls and preparing and providing the patient files.26 
 Our findings should be interpreted with caution as our study had 
a number of limitations. Practices have volunteered to participate in this 
study. This convenience sample may cause bias while it is possible that 
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Appendix 1.  Impact of nurse involvement on adoption of the Chronic Care Model
Adoption of Chronic Care Model
Number of nurse tasks (N) min max Mean (SD) 95% CI Median
0 (8) 0.5 4.4 2.6 (1.3) 1.5-3.6 2.7
1 (15) 1.1 4.3 2.5 (0.8) 2.0-2.9 2.3
Defining protocol and organization of cardiovascular 
care (1) 3.45
Administrative tasks, recalls and recording (14) 1.1 4.3 2.4 (0.8) 1.9-2.8 2.4
2 (42) 1.4 4.7 2.9 (0.7) 2.7-3.1 2.9
Defining protocol and organization of cardiovascular 
care (4) 2.6
4.7 3.5 (1.0) 1.9-5.1 3.3
Monitoring risk factors (39) 1.4 4.7 3.0 (0.7) 2.7-3.2 3.0
Patient education and counselling (4) 1.9 3.8 2.7 (0.9) 1.3-4.0 2.5
Administrative tasks, recalls and recording (37) 1.4 4.3 2.8 (0.6) 2.6-3.0 2.9
3 (30) 1.3 4.3 3.1 (0.8) 2.8-3.4 3.0
Defining protocol and organization of cardiovascular 
care (9) 1.3
4.2 3.2 (0.9) 2.5-3.9 2.9
Diagnosis, risk assessment and medical treatment (3) 2.7 4.0 3.4 (0.6) 1.8-5.0 3.4
Monitoring risk factors (29) 1.8 4.3 3.2 (0.8) 2.9-3.5 3.0
Patient education and counselling (23) 1.3 4.3 3.0 (0.9) 2.7-3.4 3.0
Administrative tasks, recalls and recording (26) 1.3 4.3 3.0 (0.8) 2.7-3.4 3.0
4 (31) 1.3 4.7 3.4 (0.7) 3.2-3.7 3.4
Defining protocol and organization of cardiovascular 
care (21) 1.8
4.7 3.5 (0.7) 3.1-3.8 3.4
Diagnosis, risk assessment and medical treatment (12) 1.3 4.2 3.3 (0.9) 2.7-3.9 3.5
Monitoring risk factors (31) 1.3 4.7 3.4 (0.7) 3.2-3.7 3.4
Patient education and counselling (31) 1.3 4.7 3.4 (0.7) 3.2-3.7 3.4
Administrative tasks, recalls and recording (29) 1.3 4.7 3.5 (0.7) 3.2-3.7 3.4
5 (51) 2.4 4.7 4.0 (0.5) 3.8-4.1 4.2
Specific tasks (number of practices with nurses with 
specific tasks)
Administrative tasks, recalls and recording (157) 1.1 4.7 3.3 (0.9) 3.2-3.4 3.3
Monitoring risk factors (150) 1.3 4.7 3.4 (0.8) 3.3-3.6 3.5
Patient education and counselling (109) 1.3 4.7 3.6 (0.8) 3.4-3.7 3.8
Defining protocol and organization of cardiovascular 
care (86) 1.3
4.7 3.7 (0.7) 3.6-3.9 4.0
Diagnosis, risk assessment and medical treatment 
(66) 1.3
4.7 3.8 (0.7) 3.7-4.0 4.0
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Chapter 7
Consistency of performance 
indicators for cardiovascular 
risk management across 
procedures and panels
Jan van Lieshout
Elvira Nouwens
Margriet Bouma
Cor Spreeuwenberg
Michel Wensing
Quality & Safety in Health Care 2010;19:e31.
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ABSTRACT
 Introduction 
Delphi procedures are frequently used to develop performance 
indicators, but little is known about the validity of this method. We 
aimed to examine the consistency of indicator selection across different 
procedures and across different panels.
 Methods 
Analysis of three indicator set development procedures: the EPA Cardio 
project, which used international GP panels; the UniRap project, a Dutch 
GP indicator project; and the Vitale Vaten project, which used a national 
multidisciplinary health professional panel and a stakeholder panel.
 Results 
With respect to clinical indicators, consistency between procedures 
varied according to the origin of the indicators. In Vitale Vaten the 
multidisciplinary panel of health professionals validated 63% from the 
international EPA Cardio indicators again. From the UniRap GP set only 
13% was rated valid again. Considering organizational indicators, 27 
indicators were rated in both EPA Cardio and Vitale Vaten. In the Vitale 
Vaten project 17 indicators (63%) were validated, including eight of the 
nine indicators validated in EPA Cardio. Consistency between panels was 
moderate, giving a decisive role to the health professional panel, being 
the most critical. 
 Conclusion 
The consistency of selected performance indicators varied across 
procedures and panels. Further research is needed to identify underlying 
determinants of this variation.
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METHOD
This paper is based on the analysis of the Vitale Vaten project, partly 
in relation to Epa Cardio and UniRap, projects in which performance 
indicators for CVRM were selected. The relationship between the 
projects and the comparisons made in this study is illustrated in the 
figure supplement. 
Figure supplement. The EPA Cardio and Vitale Vaten procedures.
INTRODUCTION
Indicators for assessing quality and outcomes of healthcare delivery have 
been developed in many healthcare systems and countries. Indicators 
provide healthcare professionals formative feedback to enhance learning 
and improvement of clinical practice.1 They can also be used to create 
transparency on quality of care. Indicators should be valid and reliable, 
feasible, and effective with respect to their aims.2 This implies that 
indicators should be developed and evaluated systematically. Some 
methods for indicator development, such as the Delphi-procedure, have 
been adopted across the world.3
 Nevertheless, many questions remain concerning indicator 
quality and appropriate development methods. This paper addresses 
the consistency of panel evaluations of indicators, using data from three 
indicator development projects in cardiovascular risk management (CVRM).
 The importance of the quality of care for patients with 
cardiovascular diseases (CVD) and those at high risk remains undisputed: 
the incidence of CVD is high worldwide with high morbidity, mortality, 
and costs. Many countries have launched large programmes to improve 
CVRM.4 In The Netherlands, a multidisciplinary clinical guideline for 
CVRM was published in 2006.5 In 2009 a platform of stakeholder 
organizations (Platform Vitale Vaten) issued a multidisciplinary guideline 
with recommendations on the organization, delivery and process of 
care (‘care standard’),6 largely based on Wagner’s chronic care model.7 
Simultaneously, a set of multidisciplinary quality indicators covering clinical 
and organizational aspects was developed, using a Delphi procedure with 
two panels: healthcare professionals and other stakeholders.
 Consistency and confirmability are criteria mentioned to add to 
the reliability of indicator development procedures.8 Though widely used 
in medical science, the Delphi procedure itself is still being studied and 
compared with other methods of indicator development.9-12 Previously 
published Delphi procedures with different panels show variable effects 
and amounts of agreement between panels, challenging consistency.13-16 
It has been shown that healthcare providers especially have a decisive 
role in multidisciplinary procedures, depending on the influence of a 
single panel in a multipanel procedure. In a procedure with different 
panels, an indicator is usually validated when validated by all panels. This 
methodology leads to a core set of generally supported indicators but 
may be too rigid.
 We aimed to examine the consistency of indicator selection across 
different procedures. We assessed the results of consecutive validation 
ratings and compared the results of two Delphi procedures with different 
panels. Furthermore, we examined consistency across health professional 
and a stakeholder panels.
175 indicators
27
organisational 
indicators
52 
organisational 
indicators:
38 from 
guideline
9 from DCGP 
vision
5 additional
Uniform 
Reporting 
Project 
(UniRap) set 
(23 clinical 
indicators)
EPA Cardio set 
9 organisational 
indicators
17 indicators
29 indicators
EPA Cardio 
set
35 clinical 
indicators
2 indicators
22 indicators
Clinical indicators
Organisational indicators
Vitale Vaten set 
(clinical)
Vitale Vaten set
(organizational)
Arrows show comparisons 
for analysis of consistency 
between procedures; panel 
ratings in orange arrows 
are analyzed to assess 
consistency between panels.
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nuances. Various stakeholder organizations provided comments on draft 
sets, leading to revisions and a final set that was approved by the Dutch 
professional GP organizations.
 Vitale Vaten project
In the Vitale Vaten project, indicators for CVRM were selected in a  
two-round Delphi procedure, involving multidisciplinary panels of 
health professionals and stakeholders from The Netherlands. Table 2 
presents the panel’s composition. As this project has not been published 
elsewhere, it will be described in more detail.
Table 2. Panel composition in the Vitale Vaten procedure
Health care professional panel Stakeholder panel
3 General practitioners 3 Members of patient organizations
2 Internists 2 Representatives of health Insurance companies
2 Cardiologists 2 Platform members
1 Neurologist 1 Dutch Heart Foundation
1 Vascular surgeon 1 Dutch diabetes federation
1 Pharmacist 1 Health department
1 Medical psychologist 1 Health inspectorate
1 Nurse practitioner vascular care 1 DCGP, prevention specialist
1 Dietician 1  Expertise centre on quality review in healthcare and 
welfare
1 Manager primary care centre 1  The Netherland Organization for Health Research and 
Development
1 Physiotherapist 1 Director integrated Care department
All participants were related to the Platform Vitale Vaten, an initiative 
of the Dutch Heart Association and many national stakeholders to 
improve CVRM. A major activity of the Platform was the development 
of a so-called ‘care standard,’ recommendations on the organization 
of CVRM, complementary to the multidisciplinary clinical guideline of 
which key elements were included in the care standard. Simultaneously, 
performance indicators were developed. The board of the Platform 
recruited and motivated participants for the indicator selection 
procedure. All correspondence was via email.
Table 1 presents some project features.
Table 1. Characteristics of the EPA Cardio, Vitale Vaten and UniRap project
EPA Cardio Vitale Vaten UniRap
Procedure Two-round Delphi 
procedure
Clinical indicators:
One-round scoring
Organizational 
indicators:
Two-round Delphi 
procedure
Successive discussion 
rounds
Number of 
panels and 
composition
9 GP panels A multidisciplinary 
health professional 
panel and a 
stakeholder panel
Experts, 
representatives of GP 
information technology 
user organizations, 
final approval by 
professional GP 
organizations
Setting 9 countries in Europe 
(Austria, Belgium, 
Finland, France, 
Germany, The 
Netherlands, Slovenia, 
UK, Switzerland)
The Netherlands The Netherlands
 EPA cardio project
The EPA Cardio project is described elsewhere.17 In summary, GP panels 
from nine European countries (total n=101) rated 202 indicators for CVRM 
in primary care in two Delphi rounds. This resulted in a set of 35 clinical 
and nine organizational indicators, including primary prevention and risk 
management in patients with established CVD or diabetes.
 UniRap project
A Dutch College of General Practitioners (DCGP) working group 
developed indicators for the Uniform Reporting Project (UniRap), as 
part of a project to create one national indicator set for GP care.18 The 
UniRap indicator set consisted of 17 indicators on established CVD and 
six concept indicators on primary prevention of CVD. The goal of UniRap 
was to provide indicators that met the criteria of content validity based 
on the CVRM guideline, and were feasible: GPs should be able to deliver 
the data from their medical record system for internal and external use. 
A set of indicators was discussed in an expert group and, in order to 
make them feasible, with representatives of GP information technology 
user organizations. Consequently, these indicators had little room for 
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Table 3. Response rates in the Vitale Vaten two-round Delphi procedure
Number of participants (%)
Health care professionals n=15 Stakeholders n=15
Round 1 10 (67) 5 (33)
Round 2 11 (73) 9 (60)
 
 Analysis
To examine the consistency of indicator selection procedures we 
assessed the results on the clinical indicators from the Vitale Vaten 
project. As previously developed sets were the startingpoint, the 
percentages of indicators validated reflected agreement and were taken 
as a measure for consistency.
 In addition, we compared the validity rating results of the list of 
27 organizational indicators rated in both EPA Cardio and Vitale Vaten.
To examine consistency of indicator selection across panels, we 
compared the results from the health professional and stakeholder 
panels scoring the organizational indicators in Vitale Vaten.
RESULTS
 Consistency across indicator selection procedures
Table 4 focuses on the Vitale Vaten set of clinical indicators. The panel 
selected 25 indicators, including three out of 23 from the UniRap 
indicators (13%) and 22 out of 35 from the EPA Cardio set (63%). 
Table 4.  Clinical indicators selected by a multidisciplinary panel of health professionals  
by origin of the indicators
Number Number (%) of indicators rated valid 
by multidisciplinary panel 
of health care professionals 
Uniform Reporting Project set, 
the Netherlands
23 3 (13)
International EPA Cardio set 35 22 (63)
Total 58 25 (43)
The initial list of 58 clinical indicators presented in this project comprised 
two previously developed sets: the 35 EPA Cardio clinical indicators, and 
the 23 UniRap indicators. Clinical indicators were presented in the first 
Delphi round only.
 The 74 organizational indicators presented in the first round of 
the Vitale Vaten project came from three sources. The 27 indicators on 
organization presented in the original EPA Cardio list were all included. 
Furthermore, 38 indicators were formulated on the basis of the draft 
version of the care standard and nine on the basis of the DCGP’s vision 
on care. Finally, five additional indicators were formulated based on 
comments in the first Delphi round.
 Participants assessed the necessity of the clinical indicators, 
defined as ‘necessary to deliver and record in the patient’s medical 
record.’ Organizational indicators were assessed regarding clarity 
(‘expressed in clear, precise and unambiguous language’) and necessity 
in the first round. Here, panelists had room to formulate comments 
and additional indicators. The panelists received feedback on the first-
round necessity results and scored the organizational indicators in the 
second round regarding necessity and feasibility (‘availability of data 
on a consistent, comparable and reliable basis’). Necessity, clarity and 
feasibility were defined exactly the same as in EPA Cardio. All scores 
were on a scale from 1 to 9.
Table 3 shows the response rates of the panels. Because two out of 
five responding stakeholders did not score the clinical indicators, this 
selection was based on the results of the health professional panel only. 
Clinical indicators were validated when they had a median necessity 
score of 7, 8 or 9 with agreement, meaning that 80% of respondents 
scored 7 or higher.
 Organizational indicators were validated if the second-round 
necessity score in both panels met the criteria as described for clinical 
indicators. Furthermore, both panels should rate the indicators feasible 
without disagreement. Indicators were rated feasible when the median 
score was 7, 8 or 9; less than one-third of the scores had to be 1, 2 or 3 in 
order to conclude that there was no disagreement. There was no preset 
maximum number of indicators.
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Clinical indicators Origin
18 For patients with CVD (CHD, stroke, TIA, or PVD) there is a record of 
their cholesterol (general/total, HDL and LDL) at least once in the last 
15 months.
EPA Cardio
19 All patients with CVD (CHD, stroke, TIA, or PVD)  should have their sys-
tolic blood pressure controlled to < 140.
EPA Cardio
20 All patients with CVD (CHD, stroke, TIA, or PVD) are offered a statin. EPA Cardio
21 For patients who have had an Myocardial Infarction there is a record 
that a beta blocker has been offered (unless a contraindication or 
side-effects is recorded).
EPA Cardio
22 CVD risk assessment includes age. EPA Cardio
23 CVD risk assessment includes gender. EPA Cardio
24 CVD risk assessment includes diabetes status. EPA Cardio
25 For patients with diabetes there is a record that specific advice about 
lifestyle was offered at least once in the last 5 years.
EPA Cardio
CHD: coronary heart disease; CVD: cardiovascular disease; PVD: peripheral vascular disease; 
TIA: transient ischaemic attack.
Table 6 focuses on the Vitale Vaten set of organizational indicators. 
In general, 46 out of 79 indicators were selected. From the list of 27 
indicators also presented in EPA Cardio, the Vitale Vaten panels validated 
17 indicators (63%). In EPA Cardio, nine indicators from this list were 
selected; eight indicators were validated in both procedures. 
Table 6.  Organizational indicators selected by panels of healthcare professionals and 
stakeholders by origin of the indicators
Number Number (%) of indicators rated valid
Health care 
professional panel
Stakeholder 
panel
Both 
panels
Indicators formulated 
on the basis of the 
care standard
38 22 (58) 32 (84) 22 (58)
International EPA 
Cardio set
27 17 (63) 18 (67) 17 (63)
Indicators formulated 
on the basis of the 
DCGP’s vision on care
9 5 (56) 7 (78) 5 (56)
Added after round 1 5 2 (40) 2 (40) 2 (40)
Total 79 46 (58) 59 (75) 46 (58)
Table 5 presents the clinical indicators selected in Vitale Vaten.
Table 5. Vitale Vaten set of clinical indicators
Clinical indicators Origin
1 Percentage of patients with established CVD with a record of smoking 
status.
UniRap
2 Percentage of patients with established CVD with anticoagulant or 
anti-platelet drugs prescribed.
UniRap
3 Percentage of patients with established CVD in the practice popula-
tion at the end of the reporting period (denominator is the practice 
population)
UniRap
4 For patients with CVD (chd, stroke, TIA, or PVD) there is a record of 
smoking status in the past 15 months except those who never smoked.
EPA Cardio
5 For patients with diabetes there is a record of blood pressure at least 
once in the last 15 months.
EPA Cardio
6 For patients prescribed antihypertensive medication for diagnosed 
hypertension there is a record of blood pressure at least once in the 
last 15 months.
EPA Cardio
7 For patients with established CVD (CHD, stroke, TIA, or PVD) there is a 
record of blood pressure at least once in the last 15 months.
EPA Cardio
8 For patients with diabetes there is a record of their cholesterol (gener-
al/total, HDL and LDL) at least once in the last 15 months.
EPA Cardio
9 For patients with CVD (CHD, stroke, TIA, or PVD), there is a record that 
anti-platelet therapy (aspirin, clopidogrel or equivalent) at least 75 mg 
daily has been offered unless contraindicated.
EPA Cardio
10 CVD risk assessment includes smoking status. EPA Cardio
11 CVD risk assessment includes blood pressure. EPA Cardio
12 CVD risk assessment includes personal history of diabetes. EPA Cardio
13 For patients with CVD Blood Plasma Glucose is tested at diagnosis. EPA Cardio
14 For patients with diabetes there is a record of smoking status in the 
past 15 months except for those who have never smoked whose smok-
ing status should be recorded at least once.
EPA Cardio
15 For patients with diabetes there is a record of their weight or Body 
Mass Index at least once in the last 15 months.
EPA Cardio
16 For patients with CVD (chd, stroke, TIA, or pvd) there is a record of their 
weight or Body Mass Index at least once in the last 15 months.
EPA Cardio
17 For patients with diabetes there is a record that diet advice has been 
offered at least once in the last 15 months.
EPA Cardio
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EPA
set
Vitale 
Vaten set
6.  Nurses should take part in education about CVD risk factors (e.g. 
diet, exercise, smoking) in schools
7.  General practitioners should take part in local/community 
campaigns or actions on CVD risk prevention (e.g. stop smoking 
campaigns, fun-runs etc)
8.  Nurses should take part in local/community campaigns or actions 
on CVD risk prevention (e.g. stop smoking campaigns, fun runs etc)
Information
1.  The medical record should contain a summary list of major medical 
problems
V V
2.  The medical record should contain details of current actual 
prescribed medication
V V
3.  The medical record should contain information about intolerances 
and contraindications to medication
V V
4.  Information leaflets about CVD (e.g. CHD, stroke, hypertension, 
stopping smoking etc) should be available at the practice for 
patients to take home or read in the practice
V
5.  Advice to patients about CVD risk factors/lifestyle should be 
based on using validated assessment tools (e.g. food frequency 
questionnaire, international physical activity questionnaire, etc)
6.  A CVD risk assessment tool should be integrated with the patient 
medical record system (e.g. so that the CVD event risk score is 
entered directly in to the patient’s medical record)
V
7.  CVD risk advice (e.g. about modifiable risk factors such as diet 
and exercise) should be integrated with the patient medical record 
system
V
8.  Smoking status should be clearly identifiable on the paper and/or 
electronic record 
V V
9.  The diagnosis of hypertension should be clearly identifiable on the 
paper and / or electronic record
V V
10.  The diagnosis of diabetes should be clearly identifiable on the 
paper and / or electronic record
V V
11.  The diagnosis of CVD should be clearly identifiable on the paper 
and / or electronic record
V V
12. The practice has an up-to-date directory of prevention activities/
organizations available locally (e.g. gyms, walking group, weight-
watchers etc)
V
Quality and safety
1.  The practice should have a team meeting about quality 
improvement relating to CVD at least once in the last 15 months
CHD: coronary heart disease; CVD: cardiovascular disease; PVD: peripheral vascular disease; 
TIA: transient ischaemic attack; v = rated valid.
Table 7 shows these indicators with the results from EPA Cardio and 
Vitale Vaten. On the web, we present all organizational indicators 
validated in Vitale Vaten, ordered by origin.
Table 7.   Results of EPA Cardio and Vitale Vaten considering the list of 27 organizational 
indicators presented in both procedures. 
EPA
set
Vitale 
Vaten set
Infrastructure
1.  The practice should have a system for offering all patients with 
chronic illness (e.g. established CVD: CHD, stroke, TIA, or PVD – see 
glossary), a check-up/review at least once in the last 15 months
V
2.  Patients who smoke and are recorded as being motivated to stop 
should be offered at least one follow-up consultation within 3 
months
V V
3.  For all patients who are obese (Body Mass Index >30kg/m2) there 
should be a record that they have been offered at least one follow-
up consultation within the last 15 months 
V
4.  All practices should use an electronic disease classification system 
that can be used to create registers of patients with established 
CVD (CHD, stroke, TIA or PVD: see glossary) e.g. International 
classification of Primary Care, READ Codes
V
5.  All practices should use an electronic disease classification system 
that can be used to create registers of patients at risk of CVD 
(hypertensives, etc) e.g. International classification of Primary Care, 
READ Codes
V
6.  All patients at high risk (eg. chronic respiratory disease, established 
CVD (CHD, stroke, TIA, or PVD – see glossary), chronic heart 
disease, chronic renal failure, diabetes, immunosuprression of 
any cause, residents of nursing homes etc, anyone aged >65) 
should be offered flu vaccination in the preceding flu season (e.g. 1 
September to 31 March or 1 September to 31 December)
V
People
1.  All GPs should attend at least one training/continuing medical 
education event on CVD  within the last 5 years
2.  At least one general practitioner per practice should attend >-- one 
training/continuing medical education event on CVD within the last 
15 months
3.  All nurses should attend at least one training/continuing medical 
education event on CVD within the last 5 years
4.  At least one nurse per practice should attend at least one training/
continuing medical education event on CVD  within the last 15 
months
V
5.  General practitioners should take part in education about CVD risk 
factors (e.g. diet, exercise, smoking) in schools
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ensured that indicators were excluded if not assessed highly necessary 
in all countries. The reasonable consistency between EPA Cardio and 
Vitale Vaten may also reflect the fact that CVRM mostly is a primary 
care activity, so the perspectives of health professionals from other 
backgrounds may not have changed much, compared with GPs only.
 UniRap indicators were not very successful in Vitale Vaten, 
showing little consistency between procedures. Explanations may be 
that they were specifically for general practice or that development 
was very much driven by the possibility of registering the indicators 
in GP information systems with computerized extraction. Additionally, 
EPA Cardio indicators were formulated with nuances in contrast to the 
UniRap indicators, formulated in terms of measurability in electronic 
patient records. Furthermore, new insights in the prevailing guideline, 
reflected in the UniRap clinical indicators, may not been well known or 
accepted yet. Finally, UniRap indicators focus more on (proxy) outcome, 
a choice that is always debatable.
 Regarding the organizational indicators rated in EPA Cardio and 
Vitale Vaten, consistency between procedures was high. Eight out of  
17 indicators validated in Vitale Vaten were in the EPA Cardio set of nine 
indicators. As expected, the two-panel procedure was more liberal: it is 
of course more difficult to have understanding in nine country panels. 
Surprisingly, the one indicator from the EPA Cardio set not validated in 
Vitale Vaten was about offering flu vaccination to high-risk patients, a 
longexisting practice. The health professional panel did not agree on 
necessity.
 The high consistency between health professionals and 
stakeholders regarding their selection of organizational indicators may 
reflect active involvement of all participants in the Platform Vitale Vaten. 
Consistency varied noticeably with the origin of the indicators. Many 
indicators validated by stakeholders, but not by health professionals, 
were derived directly from the care standard text. These indicators 
considered innovations such as an individual treatment dossier, and 
an explicitly appointed central care giver. The stakeholders validated 
all these seven indicators about the dossier. This gave the health 
professionals a decisive role, in agreement with previous studies.14,16 
Probably, results would have changed with a central question about 
concordance between indicators and recommendations instead of 
necessity.
 There are several explanations for the results concerning 
innovative issues. We assume that the presence of supportive evidence 
may be an important motivation for the necessity rating. As opposed 
to the enormous amount of clinical evidence in CVRM, evidence on 
 Consistency across health professionals  
 and stakeholders
Table 6 also shows the results of the two Vitale Vaten panels separately. 
The stakeholder panel selected 59 out of the 79 indicators (75%), while 
the health professional panel selected 46 indicators (58%), all included in 
the stakeholder set.
DISCUSSION
 Main findings
This study showed, first, that clinical and organizational indicators for 
CVRM, selected by international panels of general practitioners (EPA 
Cardio), were reasonably well validated by a multidisciplinary panel of 
health professionals in one country (Vitale Vaten). Conversely, indicators 
previously selected by a national GP working group (UniRap) were not 
validated.
 Second, the study showed high consistency between health 
professionals and stakeholders (Vitale Vaten) regarding organizational 
indicators. Health professionals were most critical in their selection.
 Interpretation
Several studies compared different consensus procedures showing 
consistency;19-22 other studies focused on quantifying the results of 
Delphi rounds, for instance assessing the result of each round.23-25 
Research on Delphi procedures with different panels shows variable 
results depending on the validation criteria. Hardy et al accepted 
indicators when validated by at least one panel.13 In EPA Cardio, nine 
national GP panels validated 30-61% of the indicators.17 In a procedure 
with 11 different stakeholders panels rating indicators on primary mental 
healthcare services, agreement within panels was very high but low 
between panels.14 Indicators had to be validated by all panels, effectively 
giving physicians most influence. Comparing the results of healthcare 
managers and family physicians rating indicators of quality of primary 
care in the UK managers gave significantly higher ratings.16 In summary, 
the inclusion criteria in a multipanel Delphi procedure determine the final 
set, often giving a decisive role to the most critical panel.
 We can only speculate on the factors underlying the variable 
consistency of Delphi procedures regarding clinical indicators. 
Considering the EPA Cardio indicators, low consistency might be 
expected, due to the international perspective on general practice only. 
On the other hand, EPA Cardio was rigorous, because the procedure 
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organizational aspects is sparse, and new concepts obviously lack 
evidence, as developments and opinions precede research evidence. 
This may be a reason for panelists to reject these indicators. On the other 
hand, similar concepts used in diabetes care are evaluated positively.26,27 
Our results show that healthcare professionals are yet not willing to 
accept indicators on important elements of the chronic care model 
as the basis for patient empowerment, supporting self management 
and clarifying central care givers’ tasks in CVRM. Competition between 
indicators cannot explain the results: all indicators were rated separately 
without a maximum. Anyhow, results suggest that a Delphi procedure 
with health professionals is less suitable to select indicators concerning 
innovative organizational concepts. Other methods may be more 
appropriate, like expert meetings. On the other hand, as the Vitale Vaten 
projects show, stakeholders seem less suitable to rate clinical indicators.
 Strengths and weaknesses
Clinical indicators presented in Vitale Vaten were the result of former 
selection procedures (EPA Cardio and UniRap), and a list of organization 
indicators was presented identically formulated in identical procedures 
(Vitale Vaten and EPA Cardio). These are the strengths of this study. 
Nevertheless, the study should be regarded explorative and further 
research into underlying factors for consistency of Delphi procedures  
is needed. A limitation was that the response rates were not maximal,  
in particular of the stakeholders.
 The stakeholders were selected because they represented 
different organizations. However, some panelists were also healthcare 
professionals. This ‘cross over’ may have increased consistency between 
panels.
CONCLUSION
The consistency of Delphi procedures to select indicators was mixed. 
Several factors related to the procedures and the panel’s composition 
could influence this. Regarding CVRM, a large number of international 
indicators (EPA Cardio) were validated again. This finding supports 
the view that rigorous international indicator selection procedures are 
valuable. A limitation, however, seems to be that these tend to exclude 
indicators reflecting healthcare delivery innovations. Another challenge is 
to involve stakeholders meaningfully, as we found that they did not assess 
clinical indicators and that their assessments of organizational indicators 
largely reflected those of health professionals.
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Chapter 8
General discussion
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In this chapter we firstly present an overview of the main findings of the 
studies described in this thesis. We will secondly discuss the results and 
then discuss implications for practice and future research.
MAIN FINDINGS 
 Section 1 
 Accreditation in general practice
Practices who implemented improvement plans with a focus on 
cardiovascular risk management (CVRM) improved some aspects of 
professional performance concerning CVRM, but not on the primary 
outcomes. Data from the randomized clinical trial presented in this 
thesis showed that none of our primary outcomes showed significant 
improvements. These primary outcome measures were: systolic blood 
pressure <140 mmHg,  LDL cholesterol <2.5 mmol/l, and prescription 
of antiplatelet drugs. Of the 17 secondary outcomes, six showed 
significant improvements as a result of the intervention. These were: 
patients with known smoking status; registration of physical exercise; 
registration of diet control; registration of alcohol intake; measurement 
of waist circumference and measurement of fasting glucose. Practices 
in the control arm also showed improvements on the measures of 
CVRM quality at follow up. Participants in both intervention and control 
group largely perceived to achieve chosen goals of their improvement 
projects. The process evaluation linked to this trial showed that the 
presence of a team member who has the specific responsibility for the 
program appeared to be a stimulating factor. Furthermore the practice 
accreditation program had positive effects on team climate and caused 
more sense of responsibility for quality of care among all team members. 
The perception was that patient care was not directly influenced by the 
accreditation program. Audit and feedback is a crucial element of the 
accreditation program, however choices for improvement plans were 
rarely based on feedback reports. Receiving a certificate for completing 
the accreditation program seemed to have little added value to 
participants.
 Section 2 
  Contextual factors of influence on cardiovascular risk 
management in general practice  
Comorbidity was associated with more comprehensive CVRM. However, 
this only applied to DM and not to COPD. This trend applied to quality of 
care indicators that were shared across the conditions, but remarkably 
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large positive effects and a quarter had negative or no effect. If we 
compare our primary outcomes with the results of this review, we found 
effects at lower end of the range of effect sizes. The effects on a few of 
our secondary outcomes were only slightly higher than those found in 
other studies of audit and feedback combined with target setting and 
action planning. 
 Financial incentives may have the ability to enhance 
implementation of the practice accreditation program. In the 
Netherlands, a pay-for-performance study was performed, to assess 
changes in performance. This study showed that clinical care 
indicators, concerning diabetes, COPD, asthma and cardiovascular risk 
management improved, as well as patient experience.4 In the United 
Kingdom, in 2004 the NHS implemented the Quality and Outcomes 
Framework, in which financial incentives, linked to achievements on a 
comprehensive set of indicators, are aimed to improve primary care. 
This large pay-for-performance-program brings about high costs, a 
quarter of the income of general practitioners (GPs) are tied to measures 
of their performance.5 Research on pay for performance shows it can 
be effective, however effects are sometimes short-term.6 Furthermore, 
quality of care may decline when an incentive is removed.7     
Consistent with results from our process evaluation, previous research 
has shown that accreditation results in improved teamwork, increased 
awareness of patient safety, improved practice systems and care 
processes and improved quality of care.8 A qualitative study in Australia 
also identified factors that contribute to effective implementation of 
accreditation programs. This study shows that effective programs 
were more likely to be collaborative and valid and to use relevant 
standards; with healthcare professionals and organizations embracing 
accreditation as a legitimate quality and safety tool; and accreditation 
appropriately aligned with other regulatory initiatives and supported by 
relevant incentives.9 Our process evaluation confirmed this last item as 
it showed contextual factors such as participation in a care group and 
being connected to the GP educational institute were also important 
for practice change. We can only speculate what element has been 
more important. Therefore, it is important in future research to gain 
better insight into the factors and processes related to the impact of 
accreditation programs in order to optimize existing programs.
 
also to indicators that were only related to CVD. The presence of DM is 
associated with better preventive treatment for other diseases. 
Secondary analysis of data from an international study showed that 
nurses were involved in the delivery of CVRM at varying degree. In a vast 
majority of practices nurses were involved in administrative tasks, recalls 
and recording and they were least involved in diagnosis, risk assessment 
and medical treatment of cardiovascular care. Involvement of nurses in 
more aspects of CVRM was associated with better structured chronic 
illness care. The degree of nurse involvement matters for implementation 
of structured care, rather than the mere presence of a nurse.
 A study on performance indicators for CVRM showed that 
indicator development partly depends on the panel composition. There 
was high consistency between health professionals and stakeholders 
regarding organizational indicators. However, health professionals were 
most critical in their selection.
DISCUSSION OF THE MAIN FINDINGS
 Section 1
 Accreditation in general practice
Although accreditation schemes have been evaluated in observational 
studies, this is one of the first controlled evaluations of this method 
to enhance quality of healthcare. The results of our study can be 
compared to a large observational study in European primary care (EPA 
Cardio), which provided data on coronary heart diseases on the basis 
of validated quality indicators in eight European countries, including the 
Netherlands.1 In Dutch practices in EPA Cardio 28.9% of patients had 
a systolic blood pressure below 140 mmHg, which is lower than in our 
study at both baseline and follow-up measurement. In addition, 43.0% of 
patients in EPA cardio had a LDL cholesterol level below 2.5 mmol/l which 
was comparable to our sample. Antiplatelet drugs were prescribed in 
82.8% of patients which was also comparable to the results of our study. 
So, the practices in our study are largely comparable to other practices 
in the Netherlands.
 A controlled study in German general practices2 also reported 
positive effects, however, this German accreditation program focused 
on organizational factors rather than clinical processes. As shown 
in a Cochrane review3 audit and feedback (a key component of the 
Dutch practice accreditation) leads to variable and overall modest 
improvements in professional practice. It leads to a median 4.3% 
absolute improvement, a quarter of interventions in this review had  
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In our study on task shift of CVRM related care to nurses the effects 
on the organization of chronic illness care were positive but modest. 
Substitution of physicians by nurses is an appealing strategy due 
to its potential to address workforce shortages, to reduce cost and 
decrease workload.21,22 Furthermore, extending the role of nurses in 
the organization of chronic illness care could result in higher patients 
satisfaction,23 lowered overall mortality and lowered hospital admissions.24
 Substitution of care to nurses can result in good quality of 
provided healthcare. Trained nurses appeared to be better than 
physicians at lowering systolic blood pressure, however there is 
insufficient evidence to conclude that nurse-led care leads to better 
outcomes of other clinical parameters than physician-led care.25 Another 
study investigating the clinical effectiveness of practice nurses acting 
as substitutes for GPs in CVRM found that practice nurses achieved 
equal or better results than GPs.26 Patients’ perspectives on their care 
are highly associated with factors related to nurses and GPs employed in 
the practice. Moreover, nurses can contribute to clinical processes and 
outcomes in general practice.27
 In our study, the effect of nurse involvement related to CVRM 
on the organization of chronic illness care was positive but modest. 
In the Netherlands at the time of the study, clinical tasks of nurses on 
CVRM were predominantly administrative or contain the monitoring of 
risk factors and are less focused on organizational tasks, however this 
is rapidly changing which is reflected by the competence profile of 
practice nurses.28 To optimally utilize the added value of nurses in general 
practice, nurses should be engaged in all aspects of CVRM related care.
 The contextual factors presented in this study are only a small 
representation of possible contextual factors that can be of influence 
on health care delivery in general practice. The importance of the 
elucidation of contextual factors has been shown in previous research. 
Reporting contextual information is a way to provide information needed 
to foster health care systems,29 and it provides more insight in barriers 
and facilitators when implementing quality improvement initiatives. 
Contextual factors at the practice level including practice characteristics 
and factors related to experiences of patients and clinicians, at 
organizational level, at external environment level and motivation for 
implementation of interventions are important factors for practice 
change. It is recommended to further explore contextual factors in future 
research, using research methods designed to incorporate relevant 
context. 
 Section 2 
  Contextual factors of influence on cardiovascular  
risk management in general practice  
Adherence to clinical practice guidelines, which aim to improve the 
quality of cardiovascular prevention is often suboptimal.10,11 Many 
cardiovascular disease patients do not attain the lifestyle, risk factor 
and therapeutic targets that are recommended in these guidelines.12,13 
As outlined in this thesis, contextual factors can be of influence on 
guideline adherence. 
 In addition to other studies,14-16 our observational study on how 
comorbidity complicates treatment showed that comorbidity was 
associated with more comprehensive cardiovascular risk management 
for patient with DM as comorbidity. However, the degree of concordance 
of the comorbid conditions influences the guideline adherence.17 Our 
study also showed there was room for improvement in preventive 
care in patients with established CVD. This is in line with results 
from other studies12,13,18 which also showed that many patients with 
CVD do not achieve the lifestyle, risk factor and therapeutic targets 
for cardiovascular disease prevention. Improvements can be made 
especially on lifestyle counseling in patients with established CVD with 
or without COPD.  
 Other patient-related factors can influence guideline adherence. 
A study among GPs in Austria showed patients’ lack of awareness 
accounted for about 70% of non-adherence to guidelines. In about 
30% of the quality indicators not fulfilled, non-adherence was due to 
other reasons like adverse drug events or patients not willing to take 
a recommended drug. This indicates the necessity to improve patient 
involvement in their treatment.19 Additionally, a study in the Netherlands 
showed that according to GPs mostly patient related barriers obstruct 
guideline adherence. The involvement of patients in the process of 
guideline development as well as in the actual decision making process 
could improve the applicability of guideline recommendations in daily 
practice.20
 The organization of care is another contextual factor that can 
influence health care delivery. A specific model to organize chronic 
illness care is by disease management programs. At the time of our 
study, disease management programs for diabetes mellitus (DM) were 
well established in general practices, unlike disease management 
programs for CVD and COPD. The results of this study illustrate the 
influence of these programs on the quality of care. Currently ongoing 
initiatives aim to implement disease management programs for CVD 
and COPD in general practice. 
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accreditation program has the ability to stimulate general practices to 
improve health care delivery. As a response to intermediate results of our 
study and other evaluations, the Netherlands Institute for Accreditation 
in Healthcare has adjusted the practice accreditation program in 2011 
to make implementation more feasible and flexible. Data collection on 
chronic illness care has been spread over different years, improvement 
plans can be documented in a more flexible way, and the use of practice 
consultants to guide participants through the accreditation program is 
optional. New evaluations are required to examine the impact of these 
changes on feasibility and to assess whether outcomes do improve in 
the new program.
 The practice accreditation program aims to enhance the quality of 
care provided to patients. However, participants in our study perceived 
that patient care was not directly influenced by the practice accreditation 
program. The patient-caregiver contact did not seem to change as a 
result of participation in the program. To improve patient outcomes we 
recommend that improvement plans focus more on improvement of 
outcome measures. Furthermore, for accreditation to be effective the 
minimum standards required have to challenge participants.32 It can 
be noted that the Dutch College of General Practitioners will offer an 
individual certification program for GPs from 2015, which will complement 
the practice accreditation program. This individual certification 
program, which includes audits that overlap with those in the practice 
accreditation, may be perceived as closer to individual performance and 
outcomes of patient care.
 Information technology can be supportive for the implementation 
of a quality improvement initiative like the practice accreditation 
program. In the Netherlands there are many different electronic medical 
record systems in general practice, which are tailored to the demands of 
the practice accreditation program at varying degree. Moreover, optimal 
use of these systems requires proper computer skills, which is often 
lacking in practice team members. When used efficiently, electronic 
medical record systems can be a very helpful tool in organizing chronic 
health care and support the quality of provided care.33 
 In this study we focused on patients with established 
cardiovascular diseases. Many of these patients visit a specialist 
once a year for an annual control consultation, in addition to the care 
provided in the general practice. There is often a lack of clarity who has 
primary responsibility of providing recommended care to the patient. 
To overcome this problem, enhanced collaboration and coordination 
between different health care professionals and their patients is needed.
METHODOLOGICAL ISSUES
General practices in this study all voluntarily applied for the practice 
accreditation program. This reflects current practice, in which practice 
accreditation is a voluntary activity. This could imply that practices 
included in this study have a relatively high affinity with quality of care. 
Furthermore the practice accreditation program was initiated in 2005, 
practices included in this study were the early adaptors30 among general 
practices in the Netherlands and for that reason might be more eager 
to initiate quality improvement. A substantial number of practices in our 
study were training practices. Of these practices it is to be expected they 
are more open to innovations. Furthermore at time of the study there 
were incentives for training practices to apply to the program as it was 
stimulated by the GP educational institutes by means of staff support.
 Additionally, a substantial part of practices in the intervention 
arm were single-handed practices. We did not stratify for solo or group 
practices. Group practices might have more defined processes to 
address quality issues. 
 The differences between various panels in their selection of 
performance indicators for CVRM suggested that chosen measures 
should be interpreted with care. Nevertheless, the primary outcomes  
of the trial are widely regarded as important.31 
 Practices in the control group in this study also showed 
improvements on CVRM related care. This could be the effect of 
contamination as practices in the control group also participated in the 
Dutch accreditation program and therefore were also working on quality 
improvement, which may have benefited CVRM related care. A different 
study design might have demonstrated a larger effect of practice 
accreditation, however an RCT where randomization would determine 
which practices should start with the practice accreditation program  
was not feasible.
IMPLICATIONS FOR PRACTICE AND FUTURE RESEARCH 
The practice accreditation program for general practices encourages 
practice teams to use a planned and cyclic approach to learning and 
improving their performance. Our results on focusing improvement 
plans on CVRM showed no significant changes to the primary outcomes 
of care, however, a large number of indicators on lifestyle advice 
showed improvement. Thus, audit and feedback in combination with 
improvement plans, which is the most important element of the practice 
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practice accreditation program of general practices, focusing on CVRM.  
Primary care practices allocated to the intervention group (n=22) were 
instructed to focus improvement plans during the intervention period 
on CVRM, while practices in the control group (n=23) could focus on 
any domain except on CVRM and diabetes mellitus. Primary outcomes 
were systolic blood pressure <140 mmHg,  LDL cholesterol <2.5 mmol/l 
and prescription of antiplatelet drugs. Secondary outcomes were 17 
indicators of CVRM and physician’s perceived goal attainment for the 
chosen improvement project. There were measurements at baseline and 
follow-up in independent samples of patients. 
 No effect was found on the primary outcomes. Blood pressure 
targets were reached in 39.8% of patients in the intervention and 38.7% 
of patients in the control group; cholesterol target levels were reached 
in 44.5% and 49.0% respectively; antiplatelet drugs were prescribed in 
82.7% in both groups. Six secondary outcomes improved: smoking status, 
exercise control, diet control, registration of alcohol intake, measurement 
of waist circumference, and fasting glucose. Participants’ perceived goal 
attainment was high in both arms: mean scores of 7.9 and 8.2 on the 
10-point scale.
 We found that this program improved some aspects of 
professional performance concerning CVRM in the practices who 
focused their improvement plans on CVRM, but not on the primary 
outcomes. The participants largely perceived to achieve chosen goals  
of their improvement projects . 
 Chapter 4
The aim of the study presented in this chapter was to identify 
determinants of change related to the practice accreditation program, 
building on the experiences of primary care professionals who had 
participated in the accreditation program. We performed an interview 
study to document the experiences of 33 participating primary care 
professionals and used to identify determinants of outcomes. The 
Consolidated Framework for Implementation Research (CFIR) was used 
as framework for the qualitative analysis. 
 We reached saturation after analyzing 23 interviews. The practice 
accreditation program is based on structured quality improvement, 
but only some of its elements were identified as determinants of 
change. Factors that were perceived to facilitate implementation of the 
program were: designating one person responsible for the program, 
ensuring clear lines of communication within the whole practice team 
and having affinity with or stimulate enthusiasm for improving quality 
of care. Contextual factors such as participation in a care group and 
  Chapter 1
In the first chapter we present the outline of this thesis which concerns 
the effectiveness of a practice accreditation program on the quality 
of care in general practice with respect to patients with established 
cardiovascular diseases. Accreditation is a widely used method to 
asses and improve the quality of healthcare organizations. We explore 
the effectiveness of practice accreditation in general practice and 
its influence on quality of care and we explore which contextual 
factors contribute to its impact. We focus on patients with established 
cardiovascular diseases, which remains high on the professional and 
societal agenda.
 Chapter 2
In this chapter the study protocol on a cluster randomized trial on 
the effectiveness and efficiency of a practice accreditation program 
on cardiovascular risk management in general practice is described. 
Accreditation of healthcare organizations has been introduced across 
the world with a range of aims, including the improvement of clinical 
processes and outcomes. The Dutch College of General Practitioners has 
launched a program for accreditation of primary care practices, which 
focuses on chronic illness care. A two-arm cluster randomized trial with 
a block design was planned. Seventy primary care practices from the 
Netherlands were to be recruited from those who volunteer to participate 
in the practice accreditation program. The intervention group (n=35 
practices) was instructed to focus improvement on cardiovascular risk 
management. The control group was instructed to focus improvement 
on other domains in the first year of the program. Baseline and follow-
up measurements at 12 months after receiving the accreditation 
certificate are based on a standardized version of the audit in the 
practice accreditation program. Primary outcomes were selected from 
the 20 quality indicators for established cardiovascular diseases and 
included controlled blood pressure, serum cholesterol, and prescription 
of recommended preventive medication. Secondary outcomes are 
15 process indicators and two outcome indicators of established 
cardiovascular diseases, self-reported achievement of improvement 
goals and perceived unintended consequences.
 Chapter 3
In chapter 3 we present the results of the two-arm cluster randomized 
trial on the effectiveness and efficiency of a practice accreditation 
program on cardiovascular risk management (CVRM) in general practice. 
Our aim was to determine the effectiveness of improvement plans in a 
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 Chapter 6
In chapter 6 we describe a study based on secondary analysis of 
data from the European Practice Assessment of Cardiovascular risk 
management project (EPA Cardio project), an observational study on 
CVRM in 315 primary care practices in 10 countries in 2008-2009. We 
aimed to explore nurse involvement in cardiovascular risk management 
(CVRM) in primary care and how this involvement was associated with 
the degree of structured chronic illness care. Therefore we conducted  
a cross-sectional observational study in seven European countries.
 Five aspects of nurse involvement in CVRM and 35 specific 
components of structured chronic illness care were documented in 202 
primary care practices from Austria, Belgium, Germany, the Netherlands, 
Slovenia, Spain and Switzerland. An overall measure for chronic care 
management with a range from 0 to 5 was constructed derived from 
elements of the Chronic Care Model (CCM). Random coefficient 
regression modelling was used to explore associations.
 A majority of practices involved nurses for organization of CVRM 
in administrative tasks (82.2 %), risk factor monitoring (78.5%) and patient 
education (57.1%). Fewer practices involved nurses in defining protocol 
and the organization for CVRM (45%) or diagnosis and treatment (34.6%). 
With an increasing number of tasks taken up by nurses, overall median 
adoption of CCM increased from 2.7 (95% CI 1.5-3.6) to 4.2 (95% CI 3.8-4.1). 
When the number of nurse tasks increased by one, the adoption of CCM 
increased with 0.13 (p<0.05; 95% CI 0.03-0.22). Some practices with low 
nurse involvement had high adoption of CCM, while variation of adoption 
of CCM across practices reduced substantially with an increasing level of 
nurse involvement.
 We concluded that nurses were involved in the delivery of CVRM 
at varying degree. Higher involvement of nurses was associated with 
higher degree of structured chronic illness care with less variation.
 Chapter 7
Chapter 7 describes a study which aims to examine the consistency 
of indicator selection across different procedures and across different 
panels. Delphi procedures are frequently used to develop performance 
indicators, but little is known about the validity of this method. Therefore 
three indicator set development procedures were analyzed related 
to CVRM: the EPA Cardio project, which used international GP panels; 
the UniRap project, a Dutch GP indicator project; and the Vitale Vaten 
project, which used a national multidisciplinary health professional panel 
and a stakeholder panel.
being connected to the GP educational institute were important for 
actual change. The accreditation program was perceived to have positive 
effects on team climate and commitment to quality of care in the practice 
team. The perception was that patient care was not directly influenced 
by the accreditation program. Receiving a certificate for completing the 
accreditation program seemed to have little added value to participants. 
The practice accreditation program may have positive outcomes on 
quality of care, but not all planned elements may contribute to its 
outcomes. Both factors in the accreditation process and in the context 
were perceived as determinants of quality improvement. The challenge 
is to build on facilitating factors, while reducing the elements  
of accreditation that do not contribute to its impact. 
 Chapter 5
Many patients with cardiovascular disease do not attain the targets for 
health-related lifestyle and preventive treatment recommended in practice 
guidelines. In chapter 5 the results of a study with the aim to assess 
the impact of diabetes mellitus (DM) and chronic obstructive pulmonary 
disease (COPD) on the quality of cardiovascular risk management in 
patients with established cardiovascular diseases (CVD) were presented.
 Patients with established CVD were randomly selected in primary 
care practices using recorded diagnoses. Structured case forms were 
used to review data on 20 performance indicators concerning CVD from 
medical records. Descriptive and multilevel regression analyses were 
conducted.
 In 45 primary care practices with 106 physicians in the 
Netherlands, 1614 medical records of patients with CVD (37.9% women) 
were reviewed. A total of 1076 (66.7%) patients had recorded CVD only 
(reference group); 7.8% had CVD and COPD; 22.4% had CVD and DM; 3.1% 
patients had CVD, COPD and DM. Compared with the reference group, 
patients with CVD and DM yielded higher scores on 17 of 20 indicators; 
patients with CVD, DM and COPD on 14 indicators; and patients with CVD 
and COPD on three indicators. Of the patients with CVD and DM, fewer 
patients had LDL-cholesterol levels over 2.5 mmol/l (OR=0.36; 95% CI 
0.26-0.50), more had antiplatelet drugs prescribed (OR=1.72; 95% CI 1.17-
2.54), and more had systolic blood pressure measurement (OR=4.12; 95% 
CI 2.80-6.06).
 We found evidence that comorbidity was associated with more 
comprehensive cardiovascular risk management. However, this only 
applied to DM and not to COPD. This finding adds to cumulating evidence 
that presence of DM is associated with better preventive treatment of 
cardiovascular risk.
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With respect to clinical indicators, consistency between procedures 
varied according to the origin of the indicators. In Vitale Vaten the 
multidisciplinary panel of health professionals validated 63% from the 
international EPA Cardio indicators again. From the UniRap GP set only 
13% was rated valid again. Considering organizational indicators, 27 
indicators were rated in both EPA Cardio and Vitale Vaten. In the Vitale 
Vaten project 17 indicators (63%) were validated, including eight of the 
nine indicators validated in EPA Cardio. Consistency between panels was 
moderate, giving a decisive role to the health professional panel, being 
the most critical.
 The consistency of selected performance indicators varied 
across procedures and panels. Further research is needed to identify 
underlying determinants of this variation.
 Chapter 8
In this chapter we present the general discussion of this thesis. We 
summarize and discuss the main findings of our studies, methodological 
issues, and implications for practice and future research.
 The practice accreditation program for general practices 
encourages practice teams to use a planned and cyclic approach to 
learning and improving their performance. Nevertheless, not all planned 
elements of accreditation appeared to contribute to its outcomes, so 
there may be room for improving efficiency of the program. Furthermore, 
to improve patient outcomes it is recommended that improvement plans 
should focus more on improvement of outcome measures. Interventions 
to improve healthcare should be tailored to relevant enablers and 
barriers for change. It is important to elucidate these enablers and 
barriers and contextual factors, that can be of great importance for 
practice change, in future accreditation research.
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Hoofdstuk 3
In hoofdstuk 3 presenteren we de resultaten van de twee-armige 
cluster gerandomiseerde trial naar de effectiviteit en efficiëntie van 
een praktijkaccrediteringsprogramma betreffende CVRM in de huis- 
artsenpraktijk. Ons doel was het bepalen van de effectiviteit van
verbeterplannen als onderdeel van het praktijkaccreditateringspro-
gramma voor huisartsenpraktijken, gericht op CVRM. Huisartsenpraktijken 
in de interventiegroep (n=22) kregen de opdracht om verbeterplannen 
tijdens de interventieperiode op CVRM te richten, terwijl praktijken in 
de controlegroep (n= 23) zich konden richten op elk domein behalve op 
CVRM en diabetes mellitus. De primaire uitkomsten waren systolische 
bloeddruk <140 mmHg, LDL-cholesterol <2,5 mmol/l en het voorschrijven 
van trombocytenaggregatieremmers. Secundaire uitkomsten waren 
17 indicatoren betreffende CVRM en het door de deelnemers ervaren 
bereiken van de doelen van het gekozen verbeterproject. De voor- en 
nameting werden verricht in onafhankelijke groepen patiënten.
 Er werd geen effect gevonden op de primaire uitkomsten. 
Streefdoelen voor bloeddruk werden bij 39,8% van de patiënten in de 
interventiegroep en bij 38,7% van de patiënten in de controlegroep 
bereikt; bij 44,5% respectievelijk 49,0% werden cholesterol streefniveaus 
bereikt; trombocytenaggregatieremmers werden in beide groepen bij 
82,7% van de patiënten voorgeschreven. Zes secundaire uitkomsten 
verbeterden: rookstatus, controle van bewegen, dieet controle, registratie 
van alcoholgebruik, het meten van de middelomtrek, en het meten van 
de nuchtere glucose. Het door de deelnemers ervaren bereiken van de 
doelen was hoog in beide groepen: gemiddelde scores van 7,9 en 8,2 op 
een 10-puntsschaal.
 We hebben ondervonden dat door dit programma een aantal 
aspecten van professionele prestaties met betrekking tot CVRM 
verbeterden in de praktijken die hun verbeterplannen op CVRM richtten, 
maar de primaire uitkomsten verbeterden niet. De deelnemers bereikten 
in ruime mate de doelstellingen van hun verbeterprojecten.
Hoofdstuk 4
Het doel van het onderzoek beschreven in dit hoofdstuk was het 
identificeren van determinanten van verandering betreffende het 
praktijkaccrediteringsprogramma, gebaseerd op de ervaringen van 
de eerstelijns gezondheidszorg professionals die deelnamen aan het 
programma. We voerden een interviewstudie uit naar de ervaringen 
van 33 deelnemende eerstelijns gezondheidszorg professionals om 
determinanten van uitkomsten te identificeren. Het Consolidated 
Framework for Implementation Research (CFIR) werd gebruikt als 
Hoofdstuk 1
In het eerste hoofdstuk geven we een overzicht van de inhoud van dit 
proefschrift dat de effectiviteit van een praktijkaccrediteringsprogramma 
voor de kwaliteit van zorg in de huisartsenpraktijk met betrekking 
tot patiënten met vastgestelde hart- en vaatziekten beschrijft. 
Accreditatie is een veel gebruikte methode om de kwaliteit van 
gezondheidszorgorganisaties te toetsen en te verbeteren. We exploreren 
de effectiviteit van praktijkaccreditering in de huisartsenpraktijk en de 
invloed ervan op kwaliteit van zorg. Ook onderzoeken we de contextuele 
factoren die bijdragen aan de impact van praktijkaccreditering. 
Onze focus ligt op patiënten met vastgestelde hart- en vaatziekten, 
wat een belangrijk punt van aandacht blijft op de professionele en 
maatschappelijke agenda.
Hoofdstuk 2
In dit hoofdstuk wordt het studieprotocol van een cluster 
gerandomiseerde trial beschreven welke de effectiviteit en efficiëntie 
van een praktijkaccrediteringsprogramma met betrekking tot 
cardiovasculair risicomanagement (CVRM) onderzoekt. Accreditatie 
van gezondheidszorgorganisaties is wereldwijd ingevoerd met een 
scala aan doelstellingen, waaronder de verbetering van klinische 
processen en uitkomsten. Het Nederlands Huisartsen Genootschap 
heeft een programma voor de accreditatie van huisartsenpraktijken 
geïntroduceerd, dat zich richt op zorg omtrent chronische ziekten. 
Een twee-armige cluster gerandomiseerde trial met een blok ontwerp 
werd gepland. 
 Zeventig huisartsenpraktijken uit Nederland zouden worden 
gerekruteerd uit praktijken die zich vrijwillig aanmeldden voor het 
praktijkaccrediteringsprogramma. De interventiegroep (n=35 praktijken) 
kreeg de opdracht om zich te richten op verbetering van CVRM. 
De controlegroep kreeg de opdracht zich in het eerste jaar van het 
programma te richten op verbetering van andere domeinen. 
De voormeting en nameting, 12 maanden na ontvangst van het 
accreditatie-certificaat, waren gebaseerd op een gestandaardiseerde 
versie van de audit in het praktijkaccrediteringsprogramma. Primaire 
uitkomsten werden geselecteerd uit de 20 kwaliteitsindicatoren 
voor vastgestelde hart- en vaatziekten, te weten bloeddrukcontrole, 
het meten van het cholesterolgehalte en het voorschrijven van 
aanbevolen preventieve medicatie. Secundaire uitkomsten waren 15 
procesindicatoren en twee uitkomstindicatoren voor vastgestelde hart- 
en vaatziekten, daarnaast de mate van het behalen van verbeterdoelen 
en de door de deelnemers ervaren onbedoelde consequenties.
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In 45 huisartsenpraktijken in Nederland met 106 artsen, werden 1614 
medische dossiers van patiënten met HVZ (37,9% vrouwen) beoordeeld. 
Een totaal van 1076 (66,7%) patiënten had alleen een registratie van 
HVZ (referentiegroep); 7.8% had HVZ en COPD; 22,4% had HVZ en DM; 
3.1% van de patiënten had HVZ, COPD en DM. In vergelijking met de 
referentiegroep, hadden patiënten met HVZ en DM betere scores op 
17 van de 20 indicatoren; voor patiënten met HVZ, DM en COPD gold 
dat voor 14 indicatoren; en voor patiënten met HVZ en COPD voor drie 
indicatoren. Van de patiënten met HVZ en DM, hadden minder patiënten 
een LDL-cholesterol waarde boven de 2,5 mmol/l (OR=0,36; 95% BI 
0,26-0,50), meer patiënten kregen trombocytenaggregatieremmers 
voorgeschreven (OR=1,72; 95% BI 1,17-2,54) en bij meer patiënten was de 
systolische bloeddruk gemeten (OR=4,12; 95% BI 2,80-6,06).
We hebben bewijs gevonden dat comorbiditeit gepaard ging met 
uitgebreider cardiovasculair risicomanagement. Echter, dit was alleen 
van toepassing bij DM en niet bij COPD. Deze bevinding geeft een 
aanvulling aan het groeiende bewijs dat de aanwezigheid van DM 
wordt geassocieerd met een betere preventieve behandeling van 
cardiovasculair risico.
Hoofdstuk 6
In hoofdstuk 6 beschrijven we een studie op basis van secundaire 
analyse van gegevens uit het European Practice Assessment of 
Cardiovascular risk management project (EPA Cardio project), een 
observationele studie betreffende CVRM in 315 huisartsenpraktijken 
in 10 landen in 2008-2009. Ons doel was om de verpleegkundige 
betrokkenheid bij CVRM in de huisartsenpraktijk te onderzoeken 
alsmede hoe deze betrokkenheid verband houdt met de mate van 
gestructureerde chronische zorg. Derhalve hebben we een cross-
sectionele observationele studie in zeven Europese landen uitgevoerd.
Vijf aspecten van verpleegkundige betrokkenheid bij CVRM en 35 
specifieke onderdelen van gestructureerde chronische zorg werden 
vastgelegd in 202 huisartsenpraktijken uit Oostenrijk, België, Duitsland, 
Nederland, Slovenië, Spanje en Zwitserland. Een algemene maat voor 
management van chronische zorg werd geconstrueerd uit elementen 
van het Chronic Care Model (CCM) met een bereik van 0 tot 5. Random 
coëfficiënt regressie modellering werd gebruikt om verbanden te 
onderzoeken.
 In een meerderheid van de praktijken werd verpleegkundigen 
betrokken bij de organisatie van administratieve taken betreffende 
CVRM (82,2%), bij het monitoren van risicofactoren (78,5%) 
en patiëntenvoorlichting (57,1%). Minder praktijken betrokken 
kader voor de kwalitatieve analyse. We bereikten verzadiging na het 
analyseren van 23 interviews. Het praktijkaccrediteringsprogramma is 
gebaseerd op structurele kwaliteitsverbetering, maar slechts enkele 
van de elementen uit het programma werden geïdentificeerd als 
determinanten voor verandering. Factoren die de uitvoering van het 
programma zouden faciliteren waren: het aanwijzen van een persoon 
die verantwoordelijk is voor het programma, zorgen voor duidelijke 
communicatielijnen binnen het gehele praktijk team en het hebben van 
affiniteit met of het stimuleren van enthousiasme voor het verbeteren 
van kwaliteit van de zorg. Contextuele factoren, zoals deelname aan een 
zorggroep en verbonden zijn aan de huisartsopleiding waren belangrijk 
voor feitelijke verandering. Het praktijkaccrediteringsprogramma werd als 
positief ervaren voor het teamklimaat en de betrokkenheid bij kwaliteit 
van zorg van het praktijkteam. De perceptie was dat de patiëntenzorg 
niet direct beïnvloed werd door het praktijkaccrediteringsprogramma. 
Het ontvangen van een certificaat voor het voltooien van het 
praktijkaccrediteringsprogramma leek weinig meerwaarde voor de 
deelnemers hebben. 
 Het praktijkaccrediteringsprogramma kan positieve 
gevolgen hebben op de kwaliteit van zorg, maar niet alle geplande 
elementen zouden bijdragen aan de resultaten. Zowel factoren in 
het accreditatieproces als factoren in de context werden gezien als 
determinanten van kwaliteitsverbetering. De uitdaging is voort te  
bouwen op de faciliterende factoren van accreditatie, en de accreditatie-
elementen die niet bijdragen aan het effect ervan te verminderen.
Hoofdstuk 5
Veel patiënten met hart- en vaatziekten bereiken niet de leefstijldoelen 
en doelen voor preventieve behandeling die worden aanbevolen in 
praktijkrichtlijnen. In hoofdstuk 5 worden de resultaten gepresenteerd 
van een onderzoek met als doel het onderzoeken van de invloed van 
diabetes mellitus (DM) en chronische obstructieve longziekte (COPD) 
op de kwaliteit van CVRM bij patiënten met vastgestelde hart- en 
vaatziekten (HVZ).
 Patiënten met vastgestelde HVZ werden willekeurig geselecteerd 
in huisartsenpraktijken door middel van geregistreerde diagnoses. 
Gestructureerde formulieren werden gebruikt om gegevens voor 
20 prestatie indicatoren betreffende HVZ uit medische dossiers te 
beoordelen. Beschrijvende en multilevel regressie analyses werden 
uitgevoerd.
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Hoofdstuk 8
In dit hoofdstuk presenteren we de discussie van dit proefschrift. 
We vatten de belangrijkste bevindingen van onze studies samen en 
bediscussiëren deze, en we bespreken methodologische aspecten en 
implicaties voor de praktijk en toekomstig onderzoek. 
 Het praktijkaccrediteringsprogramma voor huisartsenpraktijken 
stimuleert praktijkteams om een planmatige en cyclische aanpak te 
gebruiken voor het verbeteren van hun prestaties. Desondanks bleken 
niet alle geplande elementen van het accreditatieprogramma bij te 
dragen aan de resultaten ervan, dus is er wellicht ruimte voor verbetering 
van de efficiëntie van het programma. Bovendien is het aan te bevelen 
om verbeterplannen meer te richten op verbetering van uitkomstmaten 
teneinde patiëntuitkomsten te verbeteren. Interventies om de 
gezondheidszorg te verbeteren, zouden moeten worden afgestemd op 
relevante bevorderende factoren en barrières voor verandering. Het is 
belangrijk om deze bevorderende factoren, barrières en contextuele 
factoren, die van groot belang kunnen zijn voor praktijkverandering, in 
toekomstig accreditatie onderzoek te belichten.
verpleegkundigen bij het definiëren van het protocol en de organisatie 
voor CVRM (45%) en diagnose en behandeling (34,6%). Bij een 
toenemend aantal taken voor verpleegkundigen, steeg de mediaan van 
CCM van 2,7 (95% BI 1,5-3,6) tot 4,2 (95% BI 3,8-4,1). Wanneer het aantal 
verpleegkundige taken met één werd verhoogd, verhoogde de CCM 
met 0,13 (p <0,05; 95% BI 0,03-0,22). Sommige praktijken met een lage 
betrokkenheid van verpleegkundigen hadden een hoge score voor CCM, 
terwijl de variatie van de score op CCM aanzienlijk verminderde bij een 
hogere mate van verpleegkundige betrokkenheid.
 We concludeerden dat verpleegkundigen in wisselende mate 
betrokken werden bij het leveren van CVRM. Hogere betrokkenheid 
van verpleegkundigen werd geassocieerd met beter gestructureerde 
chronische zorg met minder variatie.
Hoofdstuk 7
In hoofdstuk 7 beschrijven we een onderzoek met als doel het bepalen 
van de consistentie van verschillende procedures en verschillende 
panels bij indicatorontwikkeling. Delphi procedures worden vaak gebruikt 
om kwaliteitsindicatoren te ontwikkelen, maar er is weinig bekend 
over de validiteit van deze methode. Hiervoor zijn drie procedures 
voor de ontwikkeling van een set indicatoren gerelateerd aan CVRM 
geanalyseerd: het EPA Cardio project, waarin gewerkt werd met 
internationale huisartsenpanels; het Unirap project, een Nederlands 
indicatorproject in de huisartsenzorg; en het Vitale Vaten project, waarin 
gebruik werd gemaakt van een nationaal multidisciplinair panel van 
zorgverleners en een stakeholderpanel.
 Met betrekking tot klinische indicatoren was de consistentie 
tussen de procedures verschillend. In het Vitale Vaten project 
valideerden de zorgverleners uit het multidisciplinaire panel 63% van de 
indicatoren van het internationale EPA Cardio project opnieuw. Slechts 
13% van de Unirap indicatoren werd opnieuw gevalideerd. Met betrekking 
tot organisatorische indicatoren, werden 27 indicatoren beoordeeld in 
zowel EPA Cardio als Vitale Vaten. In het Vitale Vaten project werden 
17 indicatoren (63%) gevalideerd, waaronder 8 van de 9 indicatoren 
gevalideerd in EPA Cardio. Consistentie tussen de panels was matig, 
waardoor aan zorgprofessionals een beslissende rol werd toebedeeld, 
het meest kritische panel.
 De consistentie van geselecteerde prestatie indicatoren varieerde 
tussen procedures en panels. Verder onderzoek is noodzakelijk om 
determinanten te identificeren die ten grondslag liggen aan deze 
verschillen.
 P
R
A
C
TI
C
E 
A
C
C
R
ED
IT
AT
IO
N
 T
O
 IM
P
R
O
V
E 
C
A
R
D
IO
VA
S
C
U
LA
R
 R
IS
K
 M
A
N
A
G
EM
EN
T 
IN
 G
EN
ER
A
L 
P
R
A
C
TI
C
E
18
1
18
0
D
A
N
K
W
O
O
R
D
Dankwoord
 P
R
A
C
TI
C
E 
A
C
C
R
ED
IT
AT
IO
N
 T
O
 IM
P
R
O
V
E 
C
A
R
D
IO
VA
S
C
U
LA
R
 R
IS
K
 M
A
N
A
G
EM
EN
T 
IN
 G
EN
ER
A
L 
P
R
A
C
TI
C
E
18
3
18
2
D
A
N
K
W
O
O
R
D
Lieve collega’s van MCNO-Fysio De Wedren, bedankt voor jullie interesse 
in mij en mijn bezigheden, de fijne samenwerking tot nu toe en vooral 
het vertrouwen dat jullie in mij tonen. Lambert, je kruiste mijn pad als 
stagebegeleider en hebt me in die rol de boost gegeven die ik op dat 
moment zo nodig had. Bedankt voor de kansen en vooral ook de ruimte 
die jij en Fem me geven in mijn professionele ontwikkeling. Fem, tegen 
alle verwachtingen in…geniet ik van onze zangsessies. Je bent een 
topper!
Astrid, we hebben een bijzondere vriendschap met de daarbij behorende 
ups-and-downs (maar wat mij betreft nu nog alleen maar in de up). Je 
hebt me enorm geholpen bij het zoeken en uiteindelijk vinden van mijn 
pad en ik kan je niet vertellen hoe dankbaar ik je daarvoor ben. Dat je me 
mee hebt genomen naar Curaçao vind ik een grote eer. Dennis, dushi, 
bijzonder mens, de inzichten die je me hebt gegeven zijn me ontzettend 
waardevol en hebben gezorgd dat ik een aantal grote hobbels heb 
kunnen nemen. Zo ook de afronding van dit proefschrift, Curaçao heeft 
blijkbaar een uitstekend werkklimaat. Ik dank jou en Jessica voor het 
openstellen van jullie huis.   
Lieve Kim, we leerden elkaar kennen op de praktijk maar al snel was er 
op persoonlijk vlak nog een veel betere klik dan de professionele. Je 
bent er altijd voor me en met je ruimdenkende, wereldse blik, weet je me 
altijd weer met beide benen op de grond te krijgen. En hoe fantastisch 
was onze trip naar New York! Ik hoop nog veel avonturen met je te 
mogen beleven en nog veel meer mee te pikken van je wijsheid.
Aap, Eef en Broos…ik ga op zoek naar wie ik ben, verleg de grenzen die 
ik ken…in een korte tijd zijn jullie veel voor me gaan betekenen. Ik blijf 
genieten van jullie real-life-soap en ben blij dat ik daar deel van uit maak. 
Bedankt voor de inzichten die jullie me hebben gegeven, de gezelligheid 
in Gassel en natuurlijk de fantastische avonden in de JC-straat met 
als hoogtepunt (op meerdere vlakken) het jaarlijkse straatfeest. Door 
jullie wordt mijn wereld verrijkt met nieuwe mensen...Paul, there ain’t no 
guarantee but I’ll take a chance on we…
Nienke, tegelijkertijd zijn we begonnen bij IQ en er was een directe klik 
tussen ons. Bedankt voor alle fijne avondjes eten, kletsen over onze 
gemeenschappelijke interesse fysiotherapie en vooral over het leven in 
het algemeen. En uhh…Extase…need I say more?
Vandaag is het een grote dag en iedereen moet het horen, vandaag is 
het de mooiste dag want mijn proefschrift is geboren. Dus Emiel, maak 
die Kopke 1977 maar open.
Bij deze blijde gebeurtenis, zijn woorden van dank wel op zijn plaats.
Michel, ik wil je bedanken voor jouw structurele, heldere en concrete 
manier van begeleiden. Ik heb veel van je mogen leren en heb 
bewondering voor je manier van denken. Jan, bedankt voor je kritische 
toevoegingen maar met name ook voor je humor. Jullie samen vormen 
wat mij betreft een dynamic duo. Jozé, ook jij hartelijk bedankt voor je 
bijdrage aan dit proefschrift.
Woorden van dank voor de mensen die hebben geholpen bij de 
uitvoering van mijn onderzoek. Hans Witmer en Suzanne Jongert van 
het NPA, Marianne Meulepas, Daniëlle en Camiel van Meetpunt Kwaliteit, 
Marjan Knippenberg, Frederique Brouwer, Irma Maassen en Reinier 
Akkermans bedankt voor de fijne ondersteuning. Hans van den Hoogen 
en Margot Tacken bedankt voor de discussies over de manier van data 
verzamelen. Het bleek toch nog een hele klus.
Ook mijn mede-auteurs die de artikelen uit dit proefschrift tot stand 
hebben gebracht wil ik bedanken voor hun kritische input, Eddy Adang, 
Margriet Bouma, Pieter van den Hombergh, Miranda Laurant en Cor 
Spreeuwenberg. 
Ria, ik heb veel van je geleerd tijdens onze samenwerking voor het 
klinische fysiotherapie project, je weet me altijd weer te enthousiasmeren 
en bovenal waren de autoritjes erg gezellig! Samen met Raoul, Jaap, 
André, Ellen en Linda hebben we een mooi project neergezet. Hartelijk 
dank voor deze ervaring. 
Jolanda, bedankt voor je medewerking aan de totstandkoming van dit 
proefschrift. Grappig dat we erachter kwamen dat ik vroeger altijd bij 
jouw tantes eitjes ging halen.
Ook alle andere collega’s van IQ healthcare en vooral mijn kamer-
genootjes Irma, Annelies, Wytske, Karin, Caroline, Christantie en Anita, 
bedankt voor alle steun en gezelligheid de afgelopen jaren.
En niet te vergeten grote dank aan alle huisartsen, doktersassistenten 
en praktijkondersteuners patiënten die hebben deelgenomen aan mijn 
onderzoek. Zonder jullie was dit proefschrift niet tot stand gekomen.
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Lieve Kirs, we hebben al veel meegemaakt, middelbare school, samen 
op kamers, en uiteindelijk ook collega’s bij IQ. Ongelooflijk om te zien 
hoe jij je in de loop der jaren ontwikkeld hebt. Ik heb het je al eens 
gezegd, je bent mijn rots in de branding en met jou naast me tijdens 
mijn promotie als paranimf heb ik het vertrouwen in mezelf dat ik zo 
nodig heb. Ik ben mega trots op jou.
Lieve Mel, sisters by chance, friends by choice. Je sprak de 
legendarische woorden ‘nu zijn we eindelijk met zijn viertjes’ toen ik 
werd geboren en gaf me mijn naam. Dat je blij bent dat ik er ben,  
laat je nog altijd blijken. Ik kan me geen betere grote zus wensen, en 
ben enorm vereerd dat je mijn paranimf wilt zijn op mijn grote dag.
Pap en mam, ik weet zeker dat zonder jullie stimulans dit proefschrift 
er niet was gekomen. Jullie hebben ervoor gezorgd dat Mel en ik 
zelfstandig, zelfvoorzienend en zelfbewust zijn. Ik hoor je nog zeggen 
mam: ‘zorg dat je jezelf kan bedruipen’. Jullie zijn een bijzonder stel,  
yin & yang, zo verschillend maar vullen elkaar bijzonder goed aan.  
Een fantastisch voorbeeld voor ons. Bedankt dat jullie er zijn. 
En dan tot slot…door de jaren heen is er inmiddels een groot aantal 
mensen mijn behandelkamer gepasseerd. Een aantal van hen wil 
ik in het bijzonder bedanken. Arjen, je maakt me altijd vrolijk met je 
scherpe blik en kritische opmerkingen. Arno, onze gesprekken gaan 
altijd binnen no time de diepte in, ik hoop ze nog vaak met je te mogen 
voeren. Cindy, af en toe leidt de lamme de blinde, fijn dat we zoveel in 
elkaar herkennen. Mary, je zou mijn oma kunnen zijn maar ook een hele 
goede vriendin, bedankt voor je wijze raad. Pieter, hoeveel life-events 
gaan we nog meemaken samen? Willem, geen wonder dat jij op mijn 
pad kwam…soulmate. Niet alleen jullie maar al mijn patiënten drukken 
op een of andere manier een stempel op mijn bestaan en zijn een 
bron van inspiratie. Bedankt dat ik jullie mag begeleiden. Ik hoop dat ik 
jullie iets kan leren en kan inspireren, dat het andersom zo werkt moge 
duidelijk zijn.
Carla, mijn roomie van het eerste uur. Allebei geboren op 8 oktober 
en of het nou daaraan ligt of niet, de gemeenschappelijkheden die we 
hebben zijn treffend. Op het werk maar meer nog daarbuiten waardeer 
ik je (levens)wijsheid, reflecties, humor en warmte.   
Christel, Miranda en Tonique, lieve moedermeiden, we kennen 
elkaar inmiddels al vele jaren en hebben het nodige meegemaakt 
met elkaar. Even een korte greep uit ons ‘bestaan’: gangfeest op 
de Onderwijsboulevard, carnaval in Winssen en in Oeteldonk, Guus 
Meeuwis, weekend Maastricht, weekend Bloemendaal, weekend 
Antwerpen, high tea-en, borrelen in de Cosmo, verhuizen, twee 
vrijgezellenfeesten, twee trouwerijen, ceremoniemeesters, vier baby’s 
geboren, nieuwe vriendjes voorstellen, heel veel lachen en ook heel 
veel huilen. Ook al is de frequentie van onze dates wat afgenomen,  
de intensiteit is dat gelukkig niet. Bedankt voor jullie vriendschap.
Inge, Ilse, Patty en Sanne, lieve, gekke meiden. Bij Loeffen in de slagerij 
hebben we elkaar gevonden…memorabele avondjes uit, borrels in 
de tuin, vierdaagsefeesten vieren (volgend jaar gaan we echt lopen 
hè Pat), Lowlands, Bloemendaal, kamperen in Frankrijk en vooral veel 
Martini drinken. Ing, super wat je tot nu toe allemaal hebt bereikt 
met studioRUIG, dankzij jullie hangt mijn kast vol en hoef ik niet na 
te denken over wat ik tijdens mijn promotie aan moet. Ik waardeer je 
eerlijkheid en oprechtheid maar vooral hou ik van je gekke fratsen. 
Ils, beetje jammer dat je niet meer in Nijmegen woont maar de reden 
waarom vind ik plausibel. Bedankt voor je lieve berichtjes en kaartjes in 
tijden dat ik het zo nodig heb. Pat, met je heerlijke nuchterheid weet je 
me altijd weer rustig te krijgen. San, uit het oog is zeker niet uit het hart. 
Lieverds, ik kan niet vertellen hoezeer ik onze vriendschap waardeer.  
Ik word echt blij van jullie.
Femke…mag het een onsje meer zijn? Blijkbaar ontstaan tussen de 
kipfilets en verse worst de mooiste vriendschappen. Van slagersmeisje 
naar internationaal gewaardeerd kunstenares. Wat ben ik trots op 
jou en op het feit dat jij mijn boekje hebt vormgegeven. Ik kan je 
niet vaak genoeg bedanken daarvoor! Maar vooral bedankt voor 
je onvoorwaardelijke vriendschap, hoe gek en idioot mijn verhalen, 
belevenissen en hersenspinsels ook zijn, jij zal me nooit veroordelen 
om wat ik doe of wat ik zeg. 
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Curriculum Vitae
Elvira Nouwens werd geboren op 8 oktober 1981 in Winssen. Zij groeide 
hier op met haar oudere zus Melanie. Ze rondde in 2000 het VWO af 
aan het Pax Christi College in Druten. Van 2000 tot 2005 studeerde zij 
Gezondheidswetenschappen aan de Universiteit Maastricht. Daar koos zij 
voor de afstudeerrichting Zorgwetenschappen en volgde keuzeblokken 
op het gebied van genderstudies en palliatieve zorg. Tijdens haar 
afstudeerstage richtte zij haar onderzoek op de voorkeuren van de plaats 
van bevallen voor zwangeren en hun partners. Na een kort uitstapje naar 
de opleiding Vroedkunde in Turnhout, startte zij in 2005 met de Verkorte 
Opleiding Fysiotherapie aan de Hogeschool Utrecht. Zij liep stage 
bij eerstelijns fysiotherapiepraktijken in Engelen en Nijmegen, en bij 
verpleeghuis Regina Pacis in Arnhem. Haar afstudeeronderzoek richtte 
zij op man/vrouwverschillen binnen de hartrevalidatie en ze behaalde in 
2008 haar diploma. 
In juli 2008 werd zij aangenomen als algemeen fysiotherapeut bij 
MCNO-Fysio De Wedren en in september van dat jaar startte zij haar 
promotieonderzoek ‘Practice accreditation to improve cardiovascular 
risk management in general practice’ bij de afdeling IQ healthcare aan 
de Radboud Universiteit Nijmegen. Daarnaast was zij betrokken bij het 
project ‘De klinische fysiotherapie bij thorax- en abdominale chirurgie in 
beeld’ in opdracht van het Wetenschappelijk College voor Fysiotherapie. 
Momenteel werkt ze als fysiotherapeut en kwaliteitsmedewerker 
bij MCNO-Fysio De Wedren met de geriatrische patiënt als 
aandachtsgebied.
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